
<html lang="en"     class="pb-page"  data-request-id="a22cec0d-87e2-4431-91fd-40f3a37be186"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-2;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b01550;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain" /></meta><meta name="dc.Creator" content="Guanglin  Luo" /></meta><meta name="dc.Creator" content="Ling  Chen" /></meta><meta name="dc.Creator" content="Amy  Easton" /></meta><meta name="dc.Creator" content="Amy  Newton" /></meta><meta name="dc.Creator" content="Clotilde  Bourin" /></meta><meta name="dc.Creator" content="Eric  Shields" /></meta><meta name="dc.Creator" content="Kathy  Mosure" /></meta><meta name="dc.Creator" content="Matthew G.  Soars" /></meta><meta name="dc.Creator" content="Ronald J.  Knox" /></meta><meta name="dc.Creator" content="Michele  Matchett" /></meta><meta name="dc.Creator" content="Rick L.  Pieschl" /></meta><meta name="dc.Creator" content="Debra J.  Post-Munson" /></meta><meta name="dc.Creator" content="Shuya  Wang" /></meta><meta name="dc.Creator" content="James  Herrington" /></meta><meta name="dc.Creator" content="John  Graef" /></meta><meta name="dc.Creator" content="Kimberly  Newberry" /></meta><meta name="dc.Creator" content="Digavalli V.  Sivarao" /></meta><meta name="dc.Creator" content="Arun  Senapati" /></meta><meta name="dc.Creator" content="Linda J.  Bristow" /></meta><meta name="dc.Creator" content="Nicholas A.  Meanwell" /></meta><meta name="dc.Creator" content="Lorin A.  Thompson" /></meta><meta name="dc.Creator" content="Carolyn  Dzierba" /></meta><meta name="dc.Description" content="3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complet..." /></meta><meta name="Description" content="3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complet..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 21, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01550" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01550" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01550" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01550" /></link>
        
    
    

<title>Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01550" /></meta><meta property="og:title" content="Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0025.jpeg" /></meta><meta property="og:description" content="3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, respectively, following intraperitoneal (IP) doses of 30 mg/kg. The observed efficacy could be correlated with the mouse dorsal root ganglion exposure and NaV1.7 potency associated with 29." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01550"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01550">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01550&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01550&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01550&amp;href=/doi/10.1021/acs.jmedchem.8b01550" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 831-856</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01527" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01590" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.9b00202"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na<sub>V</sub>1.7 Inhibitors for the Treatment of Pain</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Guanglin Luo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guanglin Luo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 609-252-4946. Fax: 203-677-7702. E-mail: <a href="/cdn-cgi/l/email-protection#80e7f5e1eee7ece9eeaeecf5efc0e2edf3aee3efed"><span class="__cf_email__" data-cfemail="5f382a3e313833363171332a301f3d322c713c3032">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guanglin++Luo">Guanglin Luo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9465-3330" title="Orcid link">http://orcid.org/0000-0002-9465-3330</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ling Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ling Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ling++Chen">Ling Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amy Easton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amy Easton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amy++Easton">Amy Easton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amy Newton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amy Newton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amy++Newton">Amy Newton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clotilde Bourin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clotilde Bourin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clotilde++Bourin">Clotilde Bourin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric Shields</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric Shields</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Shields">Eric Shields</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kathy Mosure</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kathy Mosure</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Mosure">Kathy Mosure</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew G. Soars</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew G. Soars</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+G.++Soars">Matthew G. Soars</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ronald J. Knox</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ronald J. Knox</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+J.++Knox">Ronald J. Knox</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michele Matchett</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michele Matchett</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michele++Matchett">Michele Matchett</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rick L. Pieschl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rick L. Pieschl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rick+L.++Pieschl">Rick L. Pieschl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Debra J. Post-Munson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Debra J. Post-Munson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Debra+J.++Post-Munson">Debra J. Post-Munson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuya Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuya Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuya++Wang">Shuya Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James Herrington</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James Herrington</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James++Herrington">James Herrington</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Graef</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Graef</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Graef">John Graef</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kimberly Newberry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kimberly Newberry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Newberry">Kimberly Newberry</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Digavalli V. Sivarao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Digavalli V. Sivarao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Digavalli+V.++Sivarao">Digavalli V. Sivarao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Arun Senapati</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arun Senapati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arun++Senapati">Arun Senapati</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Linda J. Bristow</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Linda J. Bristow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Linda+J.++Bristow">Linda J. Bristow</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicholas A. Meanwell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicholas A. Meanwell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+A.++Meanwell">Nicholas A. Meanwell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8857-1515" title="Orcid link">http://orcid.org/0000-0002-8857-1515</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lorin A. Thompson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lorin A. Thompson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lorin+A.++Thompson">Lorin A. Thompson</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Carolyn Dzierba</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carolyn Dzierba</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carolyn++Dzierba">Carolyn Dzierba</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01550&amp;href=/doi/10.1021%2Facs.jmedchem.8b01550" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 831–856</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 21, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 October 2018</li><li><span class="item_label"><b>Published</b> online</span>21 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01550" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01550</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D831%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuanglin%2BLuo%252C%2BLing%2BChen%252C%2BAmy%2BEaston%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D2%26contentID%3Dacs.jmedchem.8b01550%26title%3DDiscovery%2Bof%2BIndole-%2Band%2BIndazole-acylsulfonamides%2Bas%2BPotent%2Band%2BSelective%2BNaV1.7%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BPain%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D856%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01550"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2310</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01550" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guanglin&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Ling&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Easton&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Newton&quot;},{&quot;first_name&quot;:&quot;Clotilde&quot;,&quot;last_name&quot;:&quot;Bourin&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Shields&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Mosure&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;G. Soars&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;J. Knox&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;Matchett&quot;},{&quot;first_name&quot;:&quot;Rick&quot;,&quot;last_name&quot;:&quot;L. Pieschl&quot;},{&quot;first_name&quot;:&quot;Debra&quot;,&quot;last_name&quot;:&quot;J. Post-Munson&quot;},{&quot;first_name&quot;:&quot;Shuya&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Herrington&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Graef&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Newberry&quot;},{&quot;first_name&quot;:&quot;Digavalli&quot;,&quot;last_name&quot;:&quot;V. Sivarao&quot;},{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;Senapati&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;J. Bristow&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;A. Meanwell&quot;},{&quot;first_name&quot;:&quot;Lorin&quot;,&quot;last_name&quot;:&quot;A. Thompson&quot;},{&quot;first_name&quot;:&quot;Carolyn&quot;,&quot;last_name&quot;:&quot;Dzierba&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;831-856&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01550&quot;},&quot;abstract&quot;:&quot;3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, respectively, following intraperitoneal (IP) doses of 30 mg/kg. The observed efficacy could be correlated with the mouse dorsal root ganglion exposure and NaV1.7 potency associated with 29.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01550&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01550" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01550&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01550" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01550&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01550" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01550&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01550&amp;href=/doi/10.1021/acs.jmedchem.8b01550" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01550" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01550" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01550%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DLuo%26date%3D2019%26atitle%3DDiscovery%2Bof%2BIndole-%2Band%2BIndazole-acylsulfonamides%2Bas%2BPotent%2Band%2BSelective%2BNaV1.7%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D2%26spage%3D831%26epage%3D856%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/jmcmar.2019.62.issue-2/20190124/jmcmar.2019.62.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Na<sub>v</sub>1.7 inhibitors. Compound <b>29</b> was shown to be efficacious in the mouse formalin assay and also reduced complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, respectively, following intraperitoneal (IP) doses of 30 mg/kg. The observed efficacy could be correlated with the mouse dorsal root ganglion exposure and Na<sub>V</sub>1.7 potency associated with <b>29</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chronic pain is an immense unmet medical need that affects about 20% of the adult population in the United States and incurs costs of approximately $600 billion annually.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Current pain therapeutics, including opioids and general analgesics, have many issues such as intolerable side effects, limited efficacy, and the potential for drug abuse and diversion.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> New safe and efficacious analgesic agents are greatly needed, and one attractive strategy is to develop drugs with novel mechanisms of action that would avoid some of the problems observed with existing drugs.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The voltage-gated sodium channel Na<sub>V</sub>1.7 has emerged as a promising target for a new class of analgesics based on genetic studies.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4−7)</a> Na<sub>V</sub>1.7, which is one of nine human Na<sub>V</sub> channel subtypes (Na<sub>V</sub>1.1–1.9), controls the passage of sodium ions into sensory neurons and plays a key role in the perception of pain in humans.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Na<sub>V</sub>1.7 is highly expressed in nociceptive sensory neurons within the dorsal root ganglia (DRG) and mutations in <i>SCN9A</i>, the gene encoding for Na<sub>V</sub>1.7, have been linked to a variety of pain disorders.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Loss-of-function mutations in SCN9A are associated with congenital insensitivity to pain,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> while gain-of-function mutations result in painful conditions such as inherited erythromelalgia and paroxysmal extreme pain disorder.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Other than anosmia, patients with loss-of-function mutations in the Na<sub>V</sub>1.7 gene appear to be normal.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In addition, knockout studies in mice have recapitulated the human phenotype and show the absence of pain-related behaviors following application of nociceptive stimuli.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> These results suggest that the selective inhibition of Na<sub>V</sub>1.7 will not incur on-target safety issues. However, one challenge with targeting Na<sub>V</sub>1.7 for the treatment of pain is obtaining selectivity for this channel over other Na<sub>V</sub> family members. Selectivity over Na<sub>V</sub>1.5, which is expressed in atrial and ventricular myocytes, is particularly important in order to reduce the potential for adverse cardiovascular events such as arrhythmia.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Given the high level of target validation, there has been significant documented effort to identify selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain, with representative hNa<sub>V</sub>1.7 inhibitors shown in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25">(18−25)</a> One class of arylsulfonamide, represented by PF-05089711 (<b>1</b>), was advanced into phase II clinical trials, while <b>2</b> was reported to be orally efficacious in animal models of pain,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> a result that was reproducible in our hands. Another major class of hNa<sub>V</sub>1.7 inhibitors are based on acylsulfonamides, with <b>3</b> and <b>4</b> representative, although detailed structure–activity relationships (SARs) for these compounds have not been described.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> In previous work, we have disclosed a series of potent and selective sulfonamide-based Na<sub>V</sub>1.7 blockers.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28−30)</a> In other studies, we have been interested in retaining the acylsulfonamide functionality associated with Na<sub>V</sub>1.7 inhibitors while replacing the middle linker region with saturated or unsaturated monocyclic or bicyclic scaffolds. While several prototype molecules were prepared, potent hNa<sub>V</sub>1.7 inhibition was discovered in a series of 3-aryl indoles and 3-aryl indazoles related to <b>4</b> but which were specifically configured to provide an opportunity to more broadly study substitution patterns around the core heterocycle, notably at the 2-position where substituents would be anticipated to affect the conformation of the 3-aryl moiety (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Herein we disclose SAR studies around these cores and profile <b>29</b> as one of the more promising compounds that demonstrates activity in multiple models of pain.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0026.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Representative Na<sub>V</sub>1.7 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design principles leading to 3-arylindole and 3-arylindazole acylsulfonamide-based Na<sub>v</sub>1.7 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The inhibitory activity of target compounds toward hNa<sub>V</sub>1.7 and hNa<sub>V</sub>1.5 channels was assessed using an automated 384-well IonWorks Barracuda patch-clamp assay designed to measure the potency of test compounds on the inactivated channel. The data for compounds <b>5</b>–<b>27</b>, compiled in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, reveals good inhibitory selectivity for hNa<sub>V</sub>1.7 compared to hNa<sub>V</sub>1.5. In the methyl sulfonamide series, the simple unsubstituted phenyl analogue <b>5</b> inhibited hNa<sub>V</sub>1.7 activity with an IC<sub>50</sub> value of 740 nM with no significant activity toward hNa<sub>V</sub>1.5 (>30 μM), data that meets targeted selectivity. Substitution of the pendent phenyl ring at the <i>meta</i>- or <i>para</i>-position with Me or Et groups (<b>6</b>–<b>9</b>) showed comparable or improved hNa<sub>V</sub>1.7 potency. Interestingly, the introduction of a 4-CF<sub>3</sub> phenyl substituent (<b>10</b>) greatly increased hNa<sub>V</sub>1.7 potency (Na<sub>V</sub>1.7 IC<sub>50</sub> = 88 nM), while 3-CF<sub>3</sub> substitution (<b>11</b>) was associated with significantly lower potency (Na<sub>V</sub>1.7 IC<sub>50</sub> = 1420 nM). Bis-substitution, especially at the <i>ortho</i>-position (<b>12</b> and <b>13</b>), generally led to a reduction in potency. Larger aliphatic substitutions at the <i>para</i>-position of the phenyl ring had only a modest effect on the potency, as exemplified by <b>14</b> and <b>15</b>. While a 4-OCF<sub>3</sub> substituent (<b>16</b>) showed inhibitory activity comparable to <b>10</b>, the removal of a single fluorine atom from <b>10</b> to afford <b>17</b> led to a 3-fold reduction in potency relative to prototype <b>10</b>. Further SARs around the methylsulfonamide group were explored in the context of <b>18</b>–<b>23</b>. Replacing the methyl group in <b>10</b> with a cyclopropane moiety retained potency but, interestingly, in this series the 4-CHF<sub>2</sub> analogue <b>18</b> exhibited modestly more potent Na<sub>V</sub>1.7 inhibition than the 4-CF<sub>3</sub> analogue <b>19</b> that was accompanied by better selectivity over hNa<sub>V</sub>1.5. Other groups in the R<sup>3</sup> position, compounds <b>20</b>–<b>23</b>, showed poorer potency relative to the methyl or cyclopropyl substituents. Fluorine substitution in the R<sup>2</sup> position next to the amide group was also explored in <b>24</b>–<b>27</b> with the result that this pattern generally improved the potency, particularly when combined with a cyclopropyl sulfonamide moiety.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and hNa<sub>V</sub>1.7 and hNa<sub>V</sub>1.5 Inhibition IC<sub>50</sub> Data for Compounds <b>5</b>–<b>27</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0019.gif" alt="" id="GRAPHIC-d7e666-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0020.gif" alt="" id="gr20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values are the means of at least two separate experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The hNa<sub>V</sub>1.7 inhibition data were collected using an IonWorks Barracuda automated electrophysiology platform using a protocol where cells were held at −60 mV.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">The hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV. NT = not tested.</p></div></div><div></div></div><div class="NLM_p">The SARs surrounding the 3-pyridinyl analogues are documented in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. While the unsubstituted pyridine analogue <b>28</b> was inactive, substitution at the 5- and/or 6-positions of the pyridine generally led to improved activity. Introduction of the substituent groups found in <b>3</b> and <b>4</b> afforded analogue <b>29</b>, which exhibited potent hNa<sub>V</sub>1.7 inhibition (IC<sub>50</sub> = 108 nM) and good selectivity (hNa<sub>V</sub>1.5 IC<sub>50</sub> = 19 μM). Removal of the Cl group modestly compromised potency (<b>30</b>), while replacement of the <i>iso</i>-butyl group with the cyclopropylmethyl group found in <b>31</b> had little effect on activity. However, replacement of the Cl group with CN gave <b>32</b>, which exhibited enhanced potency while maintaining selectivity, while substitution with a OMe group (<b>33</b>) substantially diminished the potency. Replacing the <i>iso</i>-butyl group in <b>29</b> with a difluoroethyl moiety (<b>34</b>) substantially decreased the potency but, interestingly, trifluoroethyl substitution provided an analogue <b>35</b> with very good inhibitory potency. To improve the physicochemical properties of the series, a hydroxyl group was added to the <i>iso</i>-butyl substituent to give <b>36</b>; however, this change abrogated potency, indicating that hydrophilic polar groups are not tolerated in this region. SARs around the methyl sulfonamide group were explored in the context of <b>37</b>–<b>44</b>, where, as observed in the phenyl series, the cyclopropyl derivatives <b>37</b>–<b>39</b> maintained or improved potency compared to the methyl homologue. The hNa<sub>V</sub>1.7 inhibition potency gradually decreased as the substituent size increased, as exemplified by <b>40</b>–<b>42</b>. In addition, replacing the methyl sulfonamide in this pyridinyl series with a sulfamoyl group, probed by <b>43</b> and <b>44</b>, also led to a decrease in inhibitory activity. 5-Fluoro-substituted indole analogues with a cyclopropyl in the R<sup>5</sup> position, compounds <b>45</b>–<b>48</b>, were more potent than the corresponding methyl analogues while analogues with a chlorine at R<sup>2</sup> were less potent than the <i>des</i>-Cl analogues. Compound <b>48</b> expressed potent hNa<sub>v</sub>1.7 inhibition with an IC<sub>50</sub> value of 59 nM. Finally, the larger <i>N</i>-substituents explored in the context of <b>49</b>–<b>51</b> substantially lowered the hNa<sub>V</sub>1.7 inhibitory potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and hNa<sub>V</sub>1.7 and hNa<sub>V</sub>1.5 IC<sub>50</sub> Inhibition Data for Compounds <b>28</b>–<b>51</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0021.gif" alt="" id="GRAPHIC-d7e843-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0022.gif" alt="" id="gr21" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values are the means of at least two separate experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The hNa<sub>V</sub>1.7 inhibition data were collected using an IonWorks Barracuda automated electrophysiology platform using a protocol where cells were held at −60 mV.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">The hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Tested only once. NT = not tested.</p></div></div><div></div></div><div class="NLM_p">The SARs around the indazole core were also studied, and the results of this phase of the survey are documented in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. When compared to the indole core, the indazole derivatives were equally potent, with good levels of selectivity. In the trifluoromethylphenyl series <b>52</b>–<b>54</b>, the potency was increased with addition of a 5-F on the indazole core incorporating a cyclopropyl sulfonamide moiety, leading to <b>54</b> with an IC<sub>50</sub> value of 13 nM for hNa<sub>V</sub>1.7 inhibition. In the substituted pyridine series <b>55</b>–<b>59</b>, methyl and cyclopropylsulfonamides were both well tolerated. Removal of the chlorine from the pyridyl led to improved selectivity over Na<sub>V</sub>1.5 (compare <b>55</b> and <b>57</b>). The addition of fluorine in the R<sup>2</sup> position of the indazole (<b>58</b>) led to increased potency and further modification of the sulfonamide to a cyclopropyl further increased potency, with the Na<sub>V</sub>1.7 IC<sub>50</sub> value for <b>59</b> = 45 nM.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structures and hNa<sub>V</sub>1.7 and hNa<sub>V</sub>1.5 Inhibition IC<sub>50</sub> Data for Compounds <b>52</b>–<b>59</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0023.gif" alt="" id="GRAPHIC-d7e946-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0024.gif" alt="" id="gr22" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values are the means of at least two separate experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The hNa<sub>V</sub>1.7 inhibition data were collected using an IonWorks Barracuda automated electrophysiology platform using a protocol where cells were held at −60 mV.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">The hNa<sub>V</sub>1.5 data were collected on the same platform using a protocol where cells were held at −50 mV.</p></div></div><div></div></div><div class="NLM_p">The additional indazole derivatives shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> were prepared and tested in order to evaluate the effect of the <i>N</i>-methyl substituent and its site of deployment on inhibitory potency. The <i>N</i>-unsubstituted indazole <b>60</b> exhibited lowered potency compared to the methylated prototype <b>55</b> as did the isomeric <i>N</i>-2 methyl indazoles <b>61</b> and <b>62</b> when compared to their <i>N</i>-1 methyl matched pairs <b>55</b> and <b>56</b>. The latter SAR reflects observations made with the indole series, where a bromo or chloro substituent attached to the 2-position of the indole heterocycle resulted in a 3–7-fold reduction potency (data not shown). However, indole 2-substitution was more readily tolerated in a related series of Na<sub>v</sub>1.7 inhibitors that was spawned by observations made with this study and this aspect of the SARs was pursued in that chemotype.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures and Na<sub>v</sub>1.7 inhibition data for indazole derivatives <b>60</b>–<b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The series of azaindole derivatives depicted in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> was prepared and evaluated in an effort to further probe aspects of electronic properties of the core heterocycle and its relationship with inhibitory activity. Both the 7-azaindole derivatives <b>63</b>–<b>65</b> and the 4-azaindole derivatives <b>66</b> and <b>67</b> exhibited lowered but measurable hNa<sub>V</sub>1.7 inhibitory activity when compared to the corresponding indazole core derivatives while the activity of the 5-azaindole analogue <b>68</b> was poor, with an IC<sub>50</sub> value of >30 μM.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures and Na<sub>v</sub>1.7 inhibition data for the series of azaindole derivatives <b>63</b>–<b>68</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Those compounds demonstrating potent activity in the Barracuda assay were further profiled in a series of in vitro developability assays, with the results compiled in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. These compounds were tested in a manual patch clamp electrophysiology (EP) assay, with the results confirming the potency measured in the Barracuda assay. In general, this set of compounds exhibited good metabolic stability in human, rat, and mouse liver microsomes but was associated with high plasma protein binding, with free fractions of <1.5% in both human and mouse plasma. Unlike the aryl sulfonamides,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> all of the acyl sulfonamide derivatives described here did not significantly inhibit CYP 3A4 and there was no evidence of time-dependent inhibition (data not shown). For example, both <b>29</b> and <b>47</b> exhibited acceptable CYP profiles (HLM-CYP IC<sub>50</sub>s for compound <b>29</b> = 9.7 μM (2B6), 1.0 μM (2C8), 9.9 μM (2C9), 28 μM (2C19), >40 μM (2D6), >40 μM (3A4), and for <b>47</b> = >40 μM (2B6), 1.0 μM (2C8), 27 μM (2C9), 4.0 μM (2C19), >40 μM (2D6), 15 μM (3A4)), with no evidence of time-dependent inhibition. Moreover, both <b>29</b> and <b>47</b> showed PXR IC<sub>50</sub> values of >50 μM. Although the permeability of many of these analogues in a Caco-2 cell assay appeared to be high, several compounds showed high efflux ratios. Notably, the addition of a 5-F substituent adjacent to the acylsulfonamide moiety, compounds <b>24</b>, <b>25</b>, <b>27</b>, <b>45</b>, <b>47</b>, and <b>48</b>, reduced the efflux ratios in Caco-2 cells and also plasma protein binding.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, this effect did not extend to the 5-fluoro indazole analogue <b>54</b>, which exhibited a Caco-2 cell efflux ratio of >21.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Further Profiling of Potent Compounds<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hNa<sub>V</sub>1.7 EP IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">metabolic stability in liver microsomes<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (H/R/M)</th><th class="colsep0 rowsep0" align="center"><i>F</i><sub>u</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> H/M (%free)</th><th class="colsep0 rowsep0" align="center">PAMPA permeability pH = 5.5/7.4 (nm/s)</th><th class="colsep0 rowsep0" align="center">Caco2 A–B/B–A (nm/s)</th><th class="colsep0 rowsep0" align="center">Caco2 efflux ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">96</td><td class="colsep0 rowsep0" align="center">100/74/54</td><td class="colsep0 rowsep0" align="center"><0.10/<0.10</td><td class="colsep0 rowsep0" align="center">972/171</td><td class="colsep0 rowsep0" align="center"><15/76</td><td class="colsep0 rowsep0" align="center">>5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">100/94/100</td><td class="colsep0 rowsep0" align="center">0.10/0.30</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center"><15/78</td><td class="colsep0 rowsep0" align="center">>6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">87/92/87</td><td class="colsep0 rowsep0" align="center">0.20/0.40</td><td class="colsep0 rowsep0" align="center">525/135</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">97/99/95</td><td class="colsep0 rowsep0" align="center">0.20/0.50</td><td class="colsep0 rowsep0" align="center">712/140</td><td class="colsep0 rowsep0" align="center">∼20/125</td><td class="colsep0 rowsep0" align="center">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">100/100/-</td><td class="colsep0 rowsep0" align="center">0.25/0.35</td><td class="colsep0 rowsep0" align="center">1660/323</td><td class="colsep0 rowsep0" align="center">46/86</td><td class="colsep0 rowsep0" align="center">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">93/82/86</td><td class="colsep0 rowsep0" align="center">0.30/0.70</td><td class="colsep0 rowsep0" align="center">325/60</td><td class="colsep0 rowsep0" align="center">81/195</td><td class="colsep0 rowsep0" align="center">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">95/66/100</td><td class="colsep0 rowsep0" align="center"><0.10/0.20</td><td class="colsep0 rowsep0" align="center">443/216</td><td class="colsep0 rowsep0" align="center"><15/168</td><td class="colsep0 rowsep0" align="center">>5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="center">27</td><td class="colsep0 rowsep0" align="center">97/77/93</td><td class="colsep0 rowsep0" align="center"><0.10/0.20</td><td class="colsep0 rowsep0" align="center">–/391</td><td class="colsep0 rowsep0" align="center"><15/114</td><td class="colsep0 rowsep0" align="center">>7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center">100/85/100</td><td class="colsep0 rowsep0" align="center">0.10/0.20</td><td class="colsep0 rowsep0" align="center">495/205</td><td class="colsep0 rowsep0" align="center">20/67</td><td class="colsep0 rowsep0" align="center">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">3.3</td><td class="colsep0 rowsep0" align="center">100/37/100</td><td class="colsep0 rowsep0" align="center"><0.10/0.20</td><td class="colsep0 rowsep0" align="center">335/310</td><td class="colsep0 rowsep0" align="center">34/102</td><td class="colsep0 rowsep0" align="center">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">98/98/99</td><td class="colsep0 rowsep0" align="center">0.80/1.40</td><td class="colsep0 rowsep0" align="center">802/164</td><td class="colsep0 rowsep0" align="center">61/186</td><td class="colsep0 rowsep0" align="center">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">100/78/98</td><td class="colsep0 rowsep0" align="center">2.4/0.60</td><td class="colsep0 rowsep0" align="center">851/254</td><td class="colsep0 rowsep0" align="center">120/189</td><td class="colsep0 rowsep0" align="center">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">100/100/100</td><td class="colsep0 rowsep0" align="center">NT/0.80</td><td class="colsep0 rowsep0" align="center">592/102</td><td class="colsep0 rowsep0" align="center"><15/312</td><td class="colsep0 rowsep0" align="center">>21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">100/100/100</td><td class="colsep0 rowsep0" align="center">NT/0.20</td><td class="colsep0 rowsep0" align="center">1160/417</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="center">43</td><td class="colsep0 rowsep0" align="center">91/88/92</td><td class="colsep0 rowsep0" align="center">NT/1.1</td><td class="colsep0 rowsep0" align="center">762/100</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Data are from previous tables.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Values are percentage remaining after 10 min with 0.5 μM compounds incubated in liver microsomes.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Unbound percentage free fraction in human (H) and mouse (M) plasma. NT = not tested.</p></div></div></div><div class="NLM_p">Selected compounds were next examined in the manual EP assay using the mouse Na<sub>V</sub>1.7 channel isoform and the mouse PK profiles determined as a prelude to selecting compounds for evaluation in the mouse formalin model of pain. The results are compiled in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, with the PK profiles of <b>29</b> and <b>47</b> following oral and IP dosing captured in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. The mouse formalin model of pain measures spontaneous, nociceptive-like paw flinching/licking responses after peripheral nociceptor activation and was chosen for in vivo efficacy screening because formalin-induced nociceptive behaviors were abolished in global Na<sub>V</sub>1.7 knockout mice.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The injection of formalin elicits a biphasic behavioral flinching response; phase I occurs during the first 5 min postinjection and results from direct nociceptor activation, whereas phase II occurs 15–45 min after the injection and is thought to reflect a tonic state of pain similar to the relatively long-lasting stimuli in human disease such as neuropathic pain.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Treatment of mice with compound <b>2</b> (30 mg/kg, PO), used as a positive control, 60 min prior to the injection of formalin, had no effect on the phase I responses but abolished phase II nociceptive behaviors (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). When compound <b>29</b> was dosed IP at 3 or 10 mg/kg, there was no significant effect on either phase I or phase II responses in mice (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). However, phase II nociceptive behaviors were completely abolished when <b>29</b> was dosed at 30 mg/kg, IP, but with no effect on the phase I symptoms. The percent reversal of nociceptive behaviors in the second phase is plotted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. All other compounds shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> were also tested at 30 mg/kg, PO, but failed to show significant efficacy in this model. Interestingly, when the indazole <b>55</b> was assessed in the mouse formalin model, dosing of the drug resulted in prostration, possibly due to sedation, as well as hypothermia (see note in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). In contrast, none of the mice dosed with indole derivatives showed any detrimental side effects during the course of the in vivo pain model studies, indicating that small structural changes in this series can lead to significantly different profiles.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Compound <b>55</b> is structurally analogous to <b>4</b> but, unfortunately, details on the in vivo pharmacology of <b>4</b> that might place this observation in perspective have not been disclosed although this compound was advanced into clinical trials as part of a microdosing study.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Mouse Data for Potent Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="/" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">mNa<sub>V</sub>1.7 EP IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">mNa<sub>V</sub>1.7 mDRG IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>F</i><sub>u</sub> mDRG (%free)</th><th class="colsep0 rowsep0" align="center">dose<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> PO/IP (mg/kg)</th><th class="colsep0 rowsep0" align="center">plasma conc<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">free plasma conc (nM)</th><th class="colsep0 rowsep0" align="center" char="/">DRG conc total/free (nM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">active in formalin Test</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">3.9</td><td class="colsep0 rowsep0" align="center">1.8</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">340</td><td class="colsep0 rowsep0" align="char" char="/">340/340</td><td class="colsep0 rowsep0" align="center">yes</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">27</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">140 ± 7.8</td><td class="colsep0 rowsep0" align="center">490</td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="center">no</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">231</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">173 ± 3.5</td><td class="colsep0 rowsep0" align="center">1211</td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="center">no</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">35</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">3.5</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">59 ± 5</td><td class="colsep0 rowsep0" align="center">118</td><td class="colsep0 rowsep0" align="char" char="/">2720/95</td><td class="colsep0 rowsep0" align="center">yes</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">58 ± 20</td><td class="colsep0 rowsep0" align="center">116</td><td class="colsep0 rowsep0" align="char" char="/">11000/–</td><td class="colsep0 rowsep0" align="center">no</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">115</td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">8.5</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">44 ± 11</td><td class="colsep0 rowsep0" align="center">616</td><td class="colsep0 rowsep0" align="char" char="/">990/84</td><td class="colsep0 rowsep0" align="center">no</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="center">37</td><td class="colsep0 rowsep0" align="center">24</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">132 ± 15</td><td class="colsep0 rowsep0" align="center">792</td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="center">no</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">3<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">0.28 ± 0.18</td><td class="colsep0 rowsep0" align="center">0.56</td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="center">no</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Compound dosed PO to male mice in 0.5% Methocel/0.1% Tween/99.4% water (10 mL/kg) and measured at 75 min, with the exception of <b>29</b>, which was dosed IP.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Results are presented as the mean, <i>n</i> = 3–9 per group.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Compound <b>55</b> at 30 mg/kg caused prostration or sedation and hypothermia in three mice and was tested at a lower 3 mg/kg dose.</p></div></div></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Mouse PK profiles of compounds <b>29</b> and <b>47</b> dosed at 30 mg/kg IP and PO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>2</b> (30 mg/kg, PO) or <b>29</b> (3, 10, 30 mg/kg, IP) on phase I/II formalin-induced nociceptive behaviors. Results are presented as the mean ± SEM response (<i>n</i> = 12–15 per group) and were analyzed by ANOVA followed by Dunnett’s posthoc tests; ***<i>P</i> < 0.001 compared to vehicle/formalin group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of <b>2</b> (30 mg/kg, PO) or <b>29</b> (3, 10, 30 mg/kg, IP) or <b>47</b> (3, 10, 30 mg/kg, PO) on percentage reversal of phase II formalin-induced nociceptive behaviors. Results are presented as the mean ± SEM response (<i>n</i> = 12–15 per group) and were analyzed by ANOVA followed by Dunnett’s posthoc tests; ***<i>P</i> < 0.001 compared to vehicle/formalin group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Why compound <b>29</b> demonstrated complete reversal of nociceptive behavior, while <b>47</b>, a close analogue with similar in vitro properties, was not efficacious is enigmatic. Analogous discrepancies between PK and efficacy of the formalin test model have been reported with aminotriazine-based Na<sub>V</sub>1.7 inhibitors<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and arylsulfonamide-based Na<sub>V</sub>1.7 inhibitors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In an effort to further investigate this anomaly, we studied additional aspects of the biochemical pharmacology of the compounds. Kinetic studies with <b>29</b> and <b>47</b> on hNa<sub>V</sub>1.7 also showed that both compounds exhibited similar on- and off-rates (onset at −70 mV, tau on for <b>29</b> and <b>47</b> were 9.6 and 12.1 s, respectively; recovery times at −120 mV, tau off for <b>29</b> and <b>47</b> were 45 and 99 s, respectively). The tissue binding of both <b>29</b> and <b>47</b> in dorsal root ganglia (DRG) and trigeminal ganglia (TGG) tissue from both mouse and rat were examined because these are believed to be key sites of action of Na<sub>v</sub>1.7 inhibitors. It was found that <b>29</b> had similar unbound free fractions in the DRG and TGG tissues of mouse (3.5%) and rat (3.4%). The unbound free fractions for <b>47</b> were more variable; in the mouse, these were 8.4% (DRG) and 6.9% (TGG), whereas lower free fractions were seen in the rat DRG (3.9%) and TGG (4.5%). It was our belief that compounds able to achieve free tissue concentrations in the DRG above the Na<sub>V</sub>1.7 manual EP IC<sub>50</sub> would show efficacy in the formalin-induced pain model. As can be seen from <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, using the total mouse DRG exposure at 30 mg/kg (2724 nM for <b>29</b> and 910 nM for <b>47</b>), mouse DRG binding (3.5% free for <b>29</b> and 8.5% free for <b>47</b>), and mouse DRG Na<sub>V</sub>1.7 manual EP IC<sub>50</sub> (11 nM for <b>29</b> and 14 nM for <b>47</b>), we can calculate the free[DRG]/IC<sub>50</sub> values for <b>29</b> and <b>47</b> as 8.7 and 5.5, respectively. This small difference in values fails to adequately explain why <b>29</b> is efficacious in the formalin-induced pain model, but <b>47</b> is not. However, the ability to accurately measure the in vitro properties of very lipophilic compounds can be challenging and precise determination of the free fraction in plasma is often less accurate for compounds that are highly protein bound. Determining the free fraction in DRG tissue is also technically challenging. Assuming the free drug concentration in the DRG needs to cover the mNaV1.7 IC<sub>50</sub> by 10-fold, a 2-fold decrease in the calculated DRG free fraction may be enough to predict that compound <b>47</b> would be inactive. With regard to activity at other Na<sub>V</sub> subtypes, both compounds exhibit similarly advantageous selectivity (for <b>29</b>: Barracuda assay results were IC<sub>50</sub> values of 16, >30, 4.8, 18.5 μM for hNa<sub>V</sub>1.2, -1.3, -1.4, -1.5, respectively). PK studies with <b>47</b> showed that plasma exposures in CD1 mice were similar following either oral or IP administration at 30 mg/kg, so the route of administration does not appear to explain the cause of the lack of efficacy with this analogue (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). No off-target activities were seen in an in-house, CEREP-like, safety panel assay for either <b>29</b> or <b>47</b> that could explain their different profiles (data not shown). It is worth noting that in some of the efficacy models, including the formalin mouse model, there is a steep dose–response curve which may suggest that a somewhat modest increase or decrease in the dose may have a dramatic effect on the behavioral response based on tissue exposure. The doses tested in the formalin mouse model were limited to 30 mg/kg in an effort to avoid potential off-target activities, particularly because the plasma exposures at this dose were high (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><div class="NLM_p">Compounds <b>29</b> and <b>47</b> were also tested in the mouse complete Freund’s adjuvant (CFA) model of inflammatory pain.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> It has been shown that Na<sub>V</sub>1.7 knockout mice do not develop CFA-induced thermal hyperalgesia.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Treatment with compound <b>29</b> (30 mg/kg, IP) significantly reduced CFA-induced thermal hyperalgesia without affecting thermal response latency of the untreated, contralateral (left) paw. Compound <b>29</b> was efficacious in reversing thermal hyperalgesia at 60 min post-treatment but not at 180 min after treatment (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Similar to previous results, <b>47</b> (30 mg/kg, PO) was not effective in the CFA thermal hyperalgesia model. Plasma exposures at these doses/routes, determined in satellite groups of mice, were 63 ± 4.8 and 38 ± 10 μM for <b>29</b> and <b>47</b>, respectively. This corresponded to a mouse free plasma concentration of 126 nM for <b>29</b> (0.2% plasma free fraction) and 532 nM for <b>47</b> (1.4% plasma free fraction), corresponding to ∼4–5-fold coverage of the mouse cellular IC<sub>50</sub> values that were determined by electrophysiology (mNa<sub>v</sub>1.7 IC<sub>50</sub> = 35 nM for <b>29</b>, mNa<sub>v</sub>1.7 IC<sub>50</sub> = 115 nM for <b>47</b>).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>2</b> (60 mg/kg, PO) or <b>29</b> (3, 10, 30 mg/kg, IP) on latency of thermal hyperalgesia in CFA mice. Results are presented as the mean ± SEM response (<i>n</i> = 12–14/group) and were analyzed by ANOVA followed by Dunnett’s posthoc tests; ***<i>P</i> < 0.001 compared to vehicle/control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, <b>29</b> was tested in the mouse chronic constriction injury (CCI) model in which three ligatures are loosely tied around the left sciatic nerve to simulate the conditions associated with nerve compression injury.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In contrast to mice receiving sham surgery, CCI mice showed increased sensitivity to cold and a faster latency to exhibit nociceptive-like behaviors when placed on a cold plate maintained at 5 °C. CD1 mice receiving CCI or sham surgery were tested 5 weeks later and were treated IP with either vehicle or <b>29</b> 30 min prior to testing. As can be seen from <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> (left), an IP dose of 30 mpk <b>29</b> produced a significant increase in the latency in the response to cold in CCI mice. <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> (right) shows that the cold allodynia response in CCI mice was reversed by a modest 25% following treatment with a dose of 30 mpk of <b>29</b>. The total plasma exposures at 60 min postdose were 3.3 ± 1.0, 27 ± 6.8, and 68 ± 31 μM following administration of 3, 10, and 30 mg/kg, respectively, which corresponds to a free plasma concentrations of 6.6, 54, and 136 nM, respectively.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of compound <b>2</b> (60 mg/kg, PO) or <b>29</b> (3, 10, 30 mg/kg, IP) on latency of cold allodynia in CCI mice. Results are presented as the mean ± SEM response (<i>n</i> = 12–14 per group) and were analyzed by ANOVA followed by Dunnett’s posthoc tests; ***<i>P</i> < 0.001, *<i>p</i> < 0.05 compared to vehicle/control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further explore the differences between <b>29</b> and <b>47</b>, sural fascicle recording studies were performed in order to determine if the compounds would differentially affect mechanoreceptor-mediated afferent transmission in wild-type mice, a modified form of the model described by Koltzenburg et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The assay was validated with systemic mexiletine (IP; 10 mg/kg) and local tetrodotoxin (300 nM applied to the nerve) applications (data not shown). Systemic IP dosing of either <b>29</b> or <b>47</b> at doses of 30 mg/kg was followed by recording of the sural nerve mechanosensitivity at 5, 30, 60, 90, and 120 min postdose. While brush and low-threshold pressure (1.6 mN) did not show any difference between treated and nontreated animals, differences were noted at the higher pressures of 98 and 980 mN, as shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>. At the longer time points of 90–120 min, both <b>29</b> and <b>47</b> showed significant reductions in mechanically elicited afferent firing, with the systemic exposures measured 2 h after IP dosing determined to be 89 and 57 μM, respectively. In a second study, <b>29</b> or <b>47</b> were applied directly onto the nerve fascicle, with the effects summarized in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>. Intriguingly, in this study, only compound <b>29</b> and not compound <b>47</b> showed a significant effect.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of <b>29</b> and <b>47</b> (30 mg/kg) on mechanosensitivity of the mouse sural nerve when dosed IP. *indicates significant difference from vehicle (two-way ANOVA followed by Dunnett’s test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effects of <b>29</b> and <b>47</b> on mechanosensitivity of the mouse sural nerve when applied directly to the nerve. *indicates significant difference from vehicle (two-way ANOVA followed by Dunnett’s test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> describes the general synthesis of compounds <b>5</b>–<b>15</b>. Bromination of methylindole-6-carboxylate (<b>69</b>) using NBS afforded bromide <b>70</b>, which, after methylation of the indole nitrogen atom, provided <b>71</b>. Following hydrolysis of <b>71</b>, the resultant acid <b>72</b> was converted to the acylsulfonamide <b>73</b> using the Mukaiyama reagent for the acid activation.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Finally, a Suzuki coupling of bromide <b>73</b> with a phenylboronic acid derivative afforded the aryl indoles <b>5</b>–<b>15</b>.</div><figure id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Approaches to Indoles <b>5</b>–<b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, DMF, rt, 2 h, 93%; (b) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 18 h, 90%; (c) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h, 92%; (d) methansulfonamide, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1.5 h, 93%; (e) R-ArB(OH)<sub>2</sub>, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 2 h.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> describes the synthesis routes employed to prepare <b>16</b>–<b>23</b>. Indole <b>69</b> was converted to the <i>N</i>-methylated iodoindole <b>75</b> through the intermediacy of <b>74</b>.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The stable boronate <b>76</b>, prepared from iodide <b>75</b>, was purified and characterized.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Boronate <b>76</b> reacted with bromide <b>80</b>, which was prepared from <b>79</b> under standard Mitsunobu conditions, to generate <b>77a</b>. After hydrolysis, the acid <b>78a</b> was converted to <b>16</b> as described above. Alternatively, the boronate formation and Suzuki coupling from <b>75</b> could be carried out in a single pot<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> to afford intermediates <b>77b</b>/<b>c</b>, which led to compounds <b>17</b>–<b>23</b>.</div><figure id="sch2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Approaches to the Preparation of <b>16</b>–<b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) I<sub>2</sub>, KOH, DMF, rt, 18 h, 91%; (b) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 18 h, 89%; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h, 81%; (d) 4-isobutoxyphenyl bromide, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 12 h; (e) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h, 88%; (f) DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, R<sup>1</sup>SO<sub>2</sub>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 28%; (g) PPh<sub>3</sub>, DIAD, THF, rt, 2 h, 40%; (h) Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h, then MeOH, R-Ar-Br, Cs<sub>2</sub>CO<sub>3</sub>, 80 °C, 4 h, 60–63%.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> describes the synthesis of the 5-fluoroindole derivatives <b>24</b>–<b>27</b>. The 5-fluoro-6-indole ester <b>84</b> was prepared from intermediate <b>83</b>, which, in turn, was generated by using the Leimgruber–Batcho reaction in which <b>81</b> is exposed to <b>82</b>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Iodination and methylation of <b>84</b> took place in one pot to generate intermediate <b>85</b>, which could be converted into <b>24</b>–<b>27</b> as described previously.</div><figure id="sch3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Approaches to the Preparation of <b>24</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DMF, 100 °C, 1 h, 86%; (b) Pd/C, H<sub>2</sub>, EtOAc, rt, 2 h, 70%; (c) I<sub>2</sub>, KOH, DMF, rt, 16 h; then MeI, rt, 5 h, 85%; (d) Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h; (e) MeOH, R-Ar-Br, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 4 h; (f) LiOH, THF, H<sub>2</sub>O, rt, 18 h; (g) DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, R<sup>1</sup>SO<sub>2</sub>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> describes the synthetic approaches to 3-(3-pyrindinyl)indole derivatives <b>28</b>–<b>48</b>. Boronate <b>76</b> or iodide <b>75</b> were converted into <b>28</b>–<b>31</b>, <b>33</b>, and <b>36</b>–<b>44</b> as described above. Intermediate bromide <b>92</b> was conveniently prepared from the 2-fluoropyridine <b>91</b>, while bromide <b>94</b> was prepared by the reaction of hydroxypyridine <b>93</b> with 2,2-dimethyloxirane. All other bromides used were commercially available. Cyano derivative <b>32</b> was directly prepared from the chloride <b>29</b>,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> while <b>34</b> and <b>35</b> were prepared from bromide <b>73</b> and boronates <b>97a</b>/<b>b</b>, respectively, which, in turn, were prepared from the pyridine intermediates <b>96a</b>/<b>b</b> following a literature procedure.<a onclick="showRef(event, 'ref27 ref45'); return false;" href="javascript:void(0);" class="ref ref27 ref45">(27,45)</a> Intermediates <b>96a</b>/<b>b</b> were prepared from 2-fluoro-3-chloro-pyridine (<b>95</b>), while the 5-fluoro-indole derivatives <b>45</b>–<b>48</b> were prepared from the boronate <b>86</b> and the corresponding bromides following the established conditions.</div><figure id="sch4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Approaches to the Preparation of <b>28</b>–<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R-pyridyl bromide, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 12 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h, then MeOH, R-pyridyl bromide, Cs<sub>2</sub>CO<sub>3</sub>, 80 °C, 4 h; (c) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (d) R<sup>1</sup>SO<sub>2</sub>NH<sub>2</sub>, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (e) Cs<sub>2</sub>CO<sub>3</sub>, 2-methylpropanol, DMSO, 90 °C, 10 h, 91%; (f) (1,1′-binaphthalen)-2-yl di-<i>tert</i>-butylphosphine, Zn, Pd(O<sub>2</sub>CCF<sub>3</sub>)<sub>2</sub>, Zn(CN)<sub>2</sub>, DMAC, 95 °C, 3 h, 56%; (g) R<sup>2</sup>CH<sub>2</sub>OH, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 80 °C, 18 h; (h) (1,5-cyclooctadiene)(methoxy)iridium(i) dimer, bis(pinacolato)diboron, 4,4′-di-<i>tert</i>-butyl-2,2′-bipyridine, tBuOMe, 80 °C, 30 min; (i) PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 2 h; (j) K<sub>2</sub>CO<sub>3</sub>, 2,2-dimethyloxirane, 2-butanone, 80 °C, 18 h, 19%.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a> describes the synthesis of the <i>N</i>-alkylated indole derivatives <b>49</b>–<b>51</b>. Alkylation of the 3-bromoindole <b>70</b> with either 2-iodoprapane or 1-iodo-2-methylpropane led to formation of intermediates <b>100a</b>/<b>b</b>, respectively. Suzuki coupling to install the pyridyl side chain followed by hydrolysis of the acid and coupling with a sulfonamide led to acylsulfonamides <b>49</b>–<b>51</b>.</div><figure id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0015.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Approaches to the <i>N</i>-Alkylated Indole Derivatives <b>49</b>–<b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>1</sup>-I, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 18 h, 44–46%; (b) 5-bromo-3-chloro-2-isobutoxypyridine, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 12 h; (c) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (d) R<sup>2</sup>SO<sub>2</sub>NH<sub>2</sub>, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a> describes the synthetic routes used to procure the indazole derivatives <b>52</b>, <b>55</b>–<b>57</b>, and <b>60</b>–<b>62</b>. Methylation of indazole <b>103</b><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> led to two separable isomers, <b>104</b> and <b>105</b>, with the major isomer <b>105</b> subjected to a selective Suzuki coupling at the iodo substituent to afford bromide <b>106</b>, which, in turn, was transformed into <b>52</b> following literature conditions.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Methylation of the indazole <b>107</b> led to the formation of the two separable isomers <b>108</b> and <b>109</b>, whose structures were identified by NOE studies. Isomer <b>109</b> was converted to the <i>N</i>-1 methyl indazole analogues <b>55</b> and <b>56</b>, while isomer <b>108</b> was converted to the <i>N</i>-2 methyl indazole derivatives <b>61</b> and <b>62</b> following the established conditions. Derivatives <b>57</b> and <b>60</b> were prepared from the bromides <b>114a</b>/<b>b</b>, which were obtained from iodides <b>105</b> and <b>103</b>, respectively, following the previously outlined conditions.</div><figure id="sch6" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0016.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Approaches to the Preparation of Indazole Derivatives <b>52</b>, <b>55</b>–<b>57</b>, and <b>60</b>–<b>62</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, MeI, rt, 72 h, <b>104</b> (14%), <b>105</b> (48%); (b) 4-trifluoromethylphenyl bromide, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 1 h; (c) methanesulfonamide, Mo(CO)<sub>6</sub>, DBU, tri-<i>tert</i>-butylphosphonium tetrafluoroborate, <i>trans</i>-di-μ-acetatobis[2-[bis(2-methylphenyl)phosphino]benzyl]dipalladium, dioxane, 140 °C, 10 min, 61%; (d) NaH, THF, MeI, rt, 18 h, <b>108</b> (18%), <b>109</b> (34%); (e) 5-bromo-3-chloro-2-isobutoxypyridine, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 2 h; (f) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (g) RSO<sub>2</sub>N<sub>2</sub>, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a> describes the synthesis route leading to 5-fluoroindazole derivatives <b>53</b>, <b>54</b>, <b>58</b>, and <b>59</b>. Nitration of <b>115</b> in concentrated H<sub>2</sub>SO<sub>4</sub>/HNO<sub>3</sub> afforded nitro derivative <b>116</b>. After ester formation and nitro reduction, the indazole intermediate <b>119</b> was formed from 2-methylaniline precursor <b>118</b>. Iodination and methylation of <b>119</b> in one pot led to intermediate <b>120</b> along with small amounts of the minor isomer. The isomers were separable and identified by NOE studies. Iodide <b>120</b> was transformed into the final products, <b>53</b>, <b>54</b>, <b>58</b>, and <b>59</b>, through the established routes and conditions.</div><figure id="sch7" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0017.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthetic Approaches to the 5-Fluoroindazole Derivatives <b>53</b>, <b>54</b>, <b>58</b>, and <b>59</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, HNO<sub>3</sub>, 0 °C, 3 h; (b) H<sub>2</sub>SO<sub>4</sub>, MeOH, 65 °C, 20 h, 92% for 2 steps; (c) Pd/C, H<sub>2</sub>, EtOAc, rt, 2 h, 95%; (d) KOAc, AcOH, isoamyl nitrite, CHCl<sub>3</sub>, rt, 3 h, 13%; (e) I<sub>2</sub>, KOH, DMF, rt, 18 h, then MeI, 20 h, 59%; (f) PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 18 h; (g) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (h) sulfonamides, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a> describes routes to access the azaindole derivatives <b>63</b>–<b>68</b>. The synthesis of the 7-azaindole derivatives <b>63</b>–<b>65</b> originated with <b>123</b>. Ester formation, iodination, and indole methylation led to intermediate <b>126</b>, which was converted into analogues <b>63</b>–<b>65</b> following previously outlined conditions. The 4-azaindole derivatives <b>66</b> and <b>67</b> were prepared from bromide <b>131</b>, which, in turn, was generated from <b>129</b> after iodination and methylation, following the established conditions. Finally the 5-azaindazole <b>68</b> originated from <b>132</b>, which was prepared using literature conditions.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Iodination of <b>132</b> provided iodide <b>133</b> which reacted with 4-trifluoromethylphenyl boronic acid to afford <b>134</b>. After hydrolysis of <b>134</b> to acid intermediate <b>135</b>, analogue <b>68</b> was obtained after acylsulfonamide formation.</div><figure id="sch8" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0018.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Approaches to the Azaindole Derivatives <b>63</b>–<b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, MeOH, 70 °C, 4 h; (b) I<sub>2</sub>, KOH, DMF, rt, 18 h; (c) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 18 h; (d) <b>127a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h, then MeOH, R-Ar-Br, Cs<sub>2</sub>CO<sub>3</sub>, 80 °C, 4 h; (e) <b>127b</b>, AR-B(OH)<sub>2</sub>, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 18 h; (f) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (g) sulfonamides, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (h) RSO<sub>2</sub>NH<sub>2</sub>, Mo(CO)<sub>6</sub>, DBU, tri-<i>tert</i>-butylphosphonium tetrafluoroborate, <i>trans</i>-di-μ-acetatobis[2-[bis(2-methylphenyl)phosphino]benzyl]dipalladium, dioxane, 140 °C, 10 min.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16244" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16244" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have described the discovery and profiling of a series of 3-arylindole-derived acylsulfonamides that are potent and selective hNa<sub>V</sub>1.7 inhibitors. Extensive structure–activity relationship studies were conducted in an effort to understand aspects of the core heterocycle as well as the side chains and led to the identification of several analogues that demonstrated potent channel inhibitory activity for both hNa<sub>V</sub>1.7 and mNa<sub>V</sub>1.7. Within this series, <b>29</b> was efficacious in several mouse models of neuropathic pain following doses of 30 mg/kg. It is noteworthy that the closely related analogue <b>47</b>, which was also orally bioavailable, did not demonstrate any efficacy in two of these models. However, application of these two compounds directly to the mouse fascial sural nerve did suggest a modest difference between the efficacies of these two closely related analogues. However, additional work would need to be carried out to more fully understand all of the parameters that drive the efficacy of these Na<sub>V</sub>1.7 inhibitors in vivo.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Patch Clamp Electrophysiology</h3><div class="NLM_p last">Na<sub>V</sub>1.7 currents were recorded using whole-cell patch clamp of HEK293 cells stably expressing recombinant human or mouse Na<sub>V</sub>1.7. Glass microelectrodes filled with internal solution containing (in mM) 50 CsCl, 90 CsF, 10 NaF, 2 MgCl<sub>2</sub>, 10 EGTA, and 10 HEPES, pH 7.2, with CsOH had resistances of 1–4 MΩ The external solution was (in mM): 150 NaCl, 4 KCl, 1 MgCl<sub>2</sub>, 1.8 CaCl<sub>2</sub>, 10 HEPES, and 10 glucose, pH 7.4, with NaOH. Series resistance was kept below 10 MΩ and electronically compensated at least 50%. Currents were acquired at 50 kHz via an EPC-10 amplifier with Patchmaster software (HEKA Instruments Inc., Bellmore, NY). Leakage subtraction was performed with the P/N method. Solution exchange was performed with a 16-well Dynaflow Resolve glass chip (Cellectricon, Sweden). The holding potential was −70 mV unless otherwise indicated. Following a 100 ms prepulse to −130 mV, Na<sub>V</sub>1.7 current was elicited by a 10 ms step to +10 mV. Peak inward current was measured with PatchMaster software and percent inhibition calculated. IC<sub>50</sub> values were obtained by fits of the Hill equation to the average percent inhibition data.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Automated Electrophysiology Methods: Ion Works Barracuda Population Patch Clamp (PPC)</h3><div class="NLM_p">PPC measurements from HEK293 cells expressing Na<sub>V</sub>1.7 and Na<sub>V</sub>1.5 channels were performed using an IonWorks Barracuda instrument (Molecular Devices Corporation, Union City, CA) using a proprietary PPC PatchPlate substrate (Molecular Devices Corporation) with 64 patch clamp apertures per well. The ability to average Na<sub>V</sub>1.<i>x</i> currents from 64 recordings from each well greatly improves data consistency and recording success rates in the measurement of Na<sub>V</sub>1.<i>x</i> mediated ionic currents. Calculated leak current was digitally subtracted from the total cell Na<sub>V</sub>1.<i>x</i> current for each sample data point acquired.</div><div class="NLM_p">Na<sub>V</sub>1.7 currents were elicited by a voltage clamp protocol designed to strongly bias the Na<sub>V</sub>1.7 channels toward their inactivated state as follows. From a holding potential of −60 mV, cells were briefly hyperpolarized to −100 mV for 1.25 , then stepped to −20 mV for 20 s to inactivate the channels. This was followed by a relatively brief hyperpolarization to −100 mv for 300 ms, then a 20 ms test pulse to −20 mV to elicit the Na<sub>V</sub>1.7 current used to measure the pharmacology of all test compounds. Compounds were incubated for 600 s between the pre- and postcompound reads. The external recording solution used was (in mM) 137 NaCl, 4 KCl, 1 MgCl<sub>2</sub>, 1.8 CaCl<sub>2</sub>, 10 Hepes, and 10 glucose, pH to 7.4 with NaOH, and the internal solution used was (in mM) 100 K-gluconate, 40 KCl, 3.2 MgCl<sub>2</sub>, 5 EGTA, and 10 HEPES, pH to 7.2 with KOH. The same solutions were used to record Na<sub>V</sub>1.5 currents following a voltage clamp protocol in which Na<sub>V</sub>1.5 currents were elicited by a voltage clamp protocol designed to bias the Na<sub>V</sub>1.5 channels to their inactivated state as follows. From a holding potential of −40 mV, cells were briefly hyperpolarized to −100 mV for 300 ms and then stepped to −10 mV for 20 s to inactivate the channels. This was followed by a relatively brief hyperpolarization to −100 mV for 30 ms, then a 20 ms test pulse to −10 mV to elicit the Na<sub>V</sub>1.5 current used to measure the pharmacology of all test compounds.</div><div class="NLM_p">HEK293 cells expressing Na<sub>V</sub>1.7 and Na<sub>V</sub>1.5 channels were used (Essen Biosciences, Ann Arbor, Michigan). Cells were cultured in T-175 flasks and passaged every 2 to 3 days at 1:3 to 1:6 seeding density dilutions. Cells were grown to 70% to 90% confluence in a flask and removed from the incubator (37 °C, 5% CO<sub>2</sub>) 1 to 3 days after plating. Growth medium was aspirated from the culture flasks. Cells were gently rinsed with 10 mL of phosphate-buffered saline (PBS) to remove residual media. Next, a total of 2 mL of TrypLE (Gibco) solution was added and the flasks containing cells sat for 3 min at rt, after which the cells became visibly rounded and were easily dislodged from the bottom of the flask with a few brief taps on a solid surface. A total of 8 mL of media was added to the flask to inactivate the TrypLE, and the mixture was centrifuged at 910 rpm for 4 min. The cell supernatant was decanted, and the cell pellets were resuspended in 5–6 mL of external solution followed by gentle trituration using a 10 mL pipet and transferred to a 15 mL conical tube and immediately brought to the IW Barracuda instrument. The cell suspension had a final concentration of ∼2–3 million cells per mL; this corresponds to 10000 cells added per well.</div><div class="NLM_p last">Peak membrane currents were analyzed with IW Barracuda software and exported to MicroSoft Excel for further analysis. Concentration–response curve fitting was performed with BMS in-house software. IC<sub>50</sub> values were obtained by fits of the Hill equation to the average percent inhibition data plotted versus compound concentration. Concentration–response curves for all test compounds were fitted to a four-parameter equation: % of control = 100(1 + ([drug]/IC<sub>50</sub>)<i>p</i>) – 1, where IC<sub>50</sub> is the concentration of drug required to inhibit current by 50% and <i>p</i> is the Hill slope. Data for Na<sub>V</sub>1.7 are presented as mean ± SEM.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Formalin Test</h3><div class="NLM_p last">Studies were conducted in male CD1 mice. Persistent pain was induced with an injection of formalin in the dorsum of one hind paw as previously described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Formalin-induced flinching was quantified with an automated system (Automated Nociception Analyzer, UCSD, La Jolla, CA, USA). A metal band was placed on the right hind paw, and the mouse was then acclimated for 60 min in an individual Plexiglas test chamber. Each mouse was dosed with test compound (10 mL/kg, IP or PO) or vehicle 30 min before formalin injection. The right hind paw was injected with 20 μL of saline or 5% w/v formalin, and the animal was immediately placed back into the chamber. Each time the band broke the electromagnetic field located under the mouse, a signal was generated and a nociceptive response and behavior was recorded for 45 min.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Sural Fascicle Recording Studies</h3><div class="NLM_p last">In an isoflurane-anesthetized mouse, the sural branch that runs from the lateral foot region was identified and exposed and a fine bared silver wire (0.005” diameter; A-M Systems, Sequim, WA) was wrapped around the nerve. A reference wire electrode was placed in the nearby connective tissue. The other ends of the wires were fused to gold plated male pins and plugged into the head stage (10× amplification) of an ExoAmp KB AC-coupled extracellular amplifier (200–20000× amplification; Kation Scientific, Minneapolis, MN) for monopolar recording. A viscous mixture of petroleum jelly and paraffin oil was used to cover and stabilize the nerve. Baseline mechanosensitivity was characterized by application of graded stimuli (brush and von Frey filaments) within the field of innervation. Sural nerve preparation was used to investigate the effect of Na<sub>V</sub>1.7 inhibitors <b>29</b> and <b>47</b> or vehicle after IP dosing over a 2 h period, and terminal blood was collected for determination of drug exposure. For direct application on the nerve, the petroleum jelly paraffin oil mixture was sucked out and the drug or vehicle was applied in a 50 μL volume of 1% DMSO in PBS, and after 20 min of incubation time, the applied fluid was sucked back and replaced by the oil and mechanical testings were performed. This process was repeated for additional applications as needed.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Complete Freund’s Adjuvant (CFA) Thermal Hyperalgesia Model</h3><div class="NLM_p last">Studies were conducted in 7–8 week old male CD1 mice, and thermal responses were assessed using the Hargreave’s test. Mice were acclimated to the equipment (IITC Plantar) for at least 60 min each day for up to 3 days prior to testing. On the last day of acclimation, the baseline of thermal response latency was taken by applying a radiant heat stimulus to the plantar surface of each hind paw. Upon lifting of the paw, the light beam was shut off and the timer stopped. The average of three tests was recorded. Each mouse was then injected with either saline or 20 μL CFA (Sigma F5881) subcutaneously into the intraplantar region of the right paw. Then 72 h later, mice were dosed with test compound or vehicle (10 mL/kg) and the average thermal response latency to three applications recorded 60 min after dosing.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chronic Constriction Injury (CCI) Cold Allodynia Model</h3><div class="NLM_p last">Male CD1 mice (8–9 weeks of age) were anesthetized with isoflurane, and three ligatures of 5–0 chromic gut loosely tied around the sciatic nerve 1 mm apart and proximal to the trifurcation using aseptic surgical techniques. All mice received 1 mL of a warmed lactated Ringer’s solution, administered subcutaneously, for fluid replacement at the end of surgery. Five weeks following surgery, mice were dosed with compound or vehicle (10 mL/kg) and tested 60 min post-treatment on a 5 °C cold plate (IITC model 400, series 8). Upon lifting of the left hind paw, the timer was stopped and the mouse removed from the plate.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Chemistry</h3><div class="NLM_p last">Proton magnetic resonance (<sup>1</sup>H NMR) spectra were recorded on either a Bruker Avance 400 or a JEOL Eclipse 500 spectrometer and are reported in ppm relative to the reference solvent of the sample in which they were run. HPLC and LC–MS analyses were conducted using a Shimadzu SCL-10A liquid chromatograph and a SPD UV–vis detector at 220 nm, with the MS detection performed with either a Micromass Platform LC spectrometer or a Waters Micromass ZQ spectrometer. All flash column chromatography was performed on EM Science silica gel 60 (particle size of 40–60 μm). All reagents were purchased from commercial sources and used without further purification unless otherwise noted. All reactions were performed under an inert atmosphere. HPLC analyses were performed using the following conditions. All final compounds had an HPLC purity of ≥95% unless specifically mentioned.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> HPLC Methods</h3><div class="NLM_p">Analytical HPLC analyses were carried out following methods A and B, and preparatory reverse-phase scale purifications were performed using methods C.</div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Method A</h4><div class="NLM_p last">A linear gradient using 5% CH<sub>3</sub>CN, 95% H<sub>2</sub>O, and 0.05% CF<sub>3</sub>CO<sub>2</sub>H (solvent A), and 95% acetonitrile, 5% H<sub>2</sub>O, and 0.05% CF<sub>3</sub>CO<sub>2</sub>H (solvent B) (<i>t</i> = 0 min, 10% B; <i>t</i> = 15 min, 100% B) was employed on a SunFire C18 3.5 μm 3.5 mm × 150 mm column. Flow rate was 0.5 mL/min, and UV detection was set to 220 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Method B</h4><div class="NLM_p last">A linear gradient using 5% CH<sub>3</sub>CN, 95% H<sub>2</sub>O, and 0.05% CF<sub>3</sub>CO<sub>2</sub>H (solvent A), and 95% CH<sub>3</sub>CN, 5% H<sub>2</sub>O, and 0.05% CF<sub>3</sub>CO<sub>2</sub>H (solvent B) (<i>t</i> = 0 min, 10% B; <i>t</i> = 15 min, 100% B (20 min)) was employed on a XBridge Ph 3.5 μm 3.0 mm × 150 mm column. Flow rate was 0.5 mL/min, and UV detection was set to 220 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Method C</h4><div class="NLM_p last">Column: XBridge C18, 19 mm × 200 mm, 5-μm particles. Mobile phase A: 5:95 CH<sub>3</sub>CN:H<sub>2</sub>O with 10 mM NH<sub>4</sub>OAc. Mobile phase B: 95:5 CH<sub>3</sub>CN:H<sub>2</sub>O with 10 mM NH<sub>4</sub>OAc. Gradient: 10–50% B over 20 min, then a 5 min hold at 100% B. Flow: 20 mL/min. Fractions containing the desired product were combined and dried via centrifugal evaporation.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Chemistry Details</h3><div class="NLM_p">All commercially available reagents and solvents were used without further purification unless otherwise stated. All reactions were carried out under an inert atmosphere of dry N<sub>2</sub> gas in oven- or flame-dried glassware unless otherwise stated. Flash column chromatography was performed using 40–60 μm Silica Gel 60 (EMD Chemicals, Inc.) as the stationary phase, or prepacked columns from ISCO Inco., Biotage, or Thomson Instrument Co. <sup>1</sup>H NMR spectra were recorded on a Bruker 400 or 500 MHz machine with tetramethylsilane or residual protiated solvent used as a reference. <sup>13</sup>C NMR were recorded on a Bruker DRX-500 instrument operating at 125 MHz with residual <sup>12</sup>C solvent used as a reference. Low resolution mass spectra were recorded using a Waters Micromass ZQ with electrospray ionization. High resolution mass spectra were recorded using a Waters Micromass LCT time-of-flight mass spectrometer with electrospray ionization. The purity of all compounds was determined by either liquid chromatography–mass spectrometry (LCMS) or analytical HPLC and was confirmed to be greater than 95% purity.</div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-phenyl-1<i>H</i>-indole-6-carboxamide (<b>5</b>)</h4><div class="NLM_p last">A mixture of Na<sub>2</sub>CO<sub>3</sub> (0.19 mL, 0.37 mmol), PdCl<sub>2</sub>(dppf) (3.4 mg, 4.7 μmol), PhB(OH)<sub>2</sub> (0.011 g, 0.093 mmol), and 3-bromo-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>73</b>) (0.031 g, 0.093 mmol) in dioxane (0.5 mL) was heated at 100 °C for 2 h. The desired product was purified by prep-HPLC (method C) to afford the desired product (5.6 mg, 17%). MS (ESI) (<i>m</i>/<i>z</i>): 329.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (s, 1H), 7.96–7.92 (m, 2H), 7.74 (d, <i>J</i> = 9.2 Hz, 1H), 7.69 (d, <i>J</i> = 7.3 Hz, 2H), 7.46 (t, <i>J</i> = 7.7 Hz, 2H), 7.27 (t, <i>J</i> = 7.5 Hz, 1H), 3.93 (s, 3H), 3.34 (s, 3H).</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Chloro-<i>N</i>-(4-methoxypyridin-3-yl)isonicotinamide (<b>6</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (4.9 mg, 13%). MS (ESI) (<i>m</i>/<i>z</i>): 343.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (s, 1H), 7.91 (d, <i>J</i> = 1.0 Hz, 1H), 7.89 (s, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.57 (d, <i>J</i> = 8.1 Hz, 2H), 7.27 (d, <i>J</i> = 8.1 Hz, 2H), 3.92 (s, 3H), 3.35 (br s, 3H), 2.35 (s, 3H).</div></div><div id="sec5_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-(<i>m</i>-tolyl)-1<i>H</i>-indole-6-carboxamide (<b>7</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (6.0 mg, 17%). MS (ESI) (<i>m</i>/<i>z</i>): 343.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (s, 1H), 7.93 (d, <i>J</i> = 8.1 Hz, 1H), 7.91 (s, 1H), 7.74 (d, <i>J</i> = 8.4 Hz, 1H), 7.50 (s, 1H), 7.48 (d, <i>J</i> = 8.1 Hz, 1H), 7.34 (t, <i>J</i> = 7.5 Hz, 1H), 7.09 (d, <i>J</i> = 8.1 Hz, 1H), 3.92 (s, 3H), 3.31–3.30 (m, 3H), 2.39 (s, 3H).</div></div><div id="sec5_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(4-Ethylphenyl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>8</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (3.8 mg, 11%). MS (ESI) (<i>m</i>/<i>z</i>): 357.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (s, 1H), 7.94 (d, <i>J</i> = 8.4 Hz, 1H), 7.91 (s, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.59 (d, <i>J</i> = 8.1 Hz, 2H), 7.30 (d, <i>J</i> = 8.1 Hz, 2H), 3.93 (s, 3H), 3.39 (s, 3H), 2.69–2.62 (m, 2H), 1.23 (t, <i>J</i> = 7.5 Hz, 3H).</div></div><div id="sec5_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(3-Ethylphenyl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>9</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (4.5 mg, 13%). MS (ESI) (<i>m</i>/<i>z</i>): 357.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (s, 1H), 7.98–7.94 (m, 2H), 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.52–7.48 (m, 2H), 7.37 (t, <i>J</i> = 7.5 Hz, 1H), 7.15–7.10 (m, 1H), 3.93 (s, 3H), 3.41 (s, 3H), 2.69 (q, <i>J</i> = 7.5 Hz, 2H), 1.25 (t, <i>J</i> = 7.5 Hz, 3H).</div></div><div id="sec5_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>10</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (7.0 mg, 18%). MS (ESI) (<i>m</i>/<i>z</i>): 397.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (s, 1H), 8.14 (s, 1H), 8.03 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.1 Hz, 2H), 7.79 (d, <i>J</i> = 8.1 Hz, 3H), 3.95 (s, 3H), 2.55 (s, 3H).</div></div><div id="sec5_9_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-(3-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>11</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (8.4 mg, 16%). MS (ESI) (<i>m</i>/<i>z</i>): 397.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (s, 1H), 8.15 (s, 1H), 8.03 (d, <i>J</i> = 8.1 Hz, 1H), 7.98–7.93 (m, 2H), 7.79 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.70 (t, <i>J</i> = 7.7 Hz, 1H), 7.61 (d, <i>J</i> = 8.1 Hz, 1H), 3.95 (s, 3H) (3H of methyl sulfonamide was buried in solvent peak). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −61.09 (s, 3F).</div></div><div id="sec5_9_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(2,3-Difluorophenyl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>12</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (4.7 mg, 15%). MS (ESI) (<i>m</i>/<i>z</i>): 365.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (s, 1H), 7.96 (s, 1H), 7.78–7.76 (m, 2H), 7.56–7.51 (m, 1H), 7.37–7.29 (m, 2H), 3.96 (s, 3H), 3.35–3.34 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −138.59 (s, 1F), −141.82 (s, 1F).</div></div><div id="sec5_9_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-(2-Chloro-4-(trifluoromethyl)phenyl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>13</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (8.4 mg, 16%). MS (ESI) (<i>m</i>/<i>z</i>): 431.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (s, 1H), 8.02 (s, 1H), 8.00 (s, 1H), 7.81 (s, 2H), 7.76–7.72 (m, 1H), 7.63 (d, <i>J</i> = 8.4 Hz, 1H), 3.98 (s, 3H), 3.40 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −60.97 (s, 3F).</div></div><div id="sec5_9_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-(4-Isobutylphenyl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>14</b>)</h4><div class="NLM_p last">Prepared using the procedures described for <b>5</b> (7.7 mg, 20%). MS (ESI) (<i>m</i>/<i>z</i>): 385.1.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (s, 1H), 7.95 (d, <i>J</i> = 8.4 Hz, 1H), 7.92 (s, 1H), 7.73 (dd, <i>J</i> = 8.1, 0.7 Hz, 1H), 7.59 (d, <i>J</i> = 8.1 Hz, 2H), 7.25 (d, <i>J</i> = 7.7 Hz, 2H), 3.93 (s, 3H), 2.48 (d, <i>J</i> = 6.2 Hz, 2H), 1.92–1.83 (m, 1H), 0.91 (d, <i>J</i> = 6.6 Hz, 6H) (3H of methyl sulfonamide was buried in solvent peak).</div></div><div id="sec5_9_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-(4-(trifluoromethoxy)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>15</b>)</h4><div class="NLM_p last">Prepared from <b>73</b> using the procedures described for <b>5</b> (2.2 mg, 5.5%). MS (ESI) (<i>m</i>/<i>z</i>): 365.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (s, 1H), 7.99 (s, 1H), 7.95 (d, <i>J</i> = 8.4 Hz, 1H), 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.76 (d, <i>J</i> = 8.4 Hz, 1H), 7.44 (d, <i>J</i> = 8.8 Hz, 2H), 3.93 (s, 3H), 3.33–3.32 (m, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −56.76 (s, 3F).</div></div><div id="sec5_9_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-(4-Isobutoxyphenyl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>16</b>)</h4><div class="NLM_p last">2-Chloro-1-methylpyridin-1-ium iodide (0.021 g, 0.081 mmol), methanesulfonamide (0.019 g, 0.201 mmol), and TEA (0.028 mL, 0.201 mmol) was added to the CH<sub>2</sub>Cl<sub>2</sub> (0.2 mL) suspension of 3-(4-isobutoxyphenyl)-1-methyl-1<i>H</i>-indole-6-carboxylic acid (<b>78a</b>, 0.022 g, 0.067 mmol) and DMAP (0.4 mg, 3.4 μmol) at rt. The reaction was stirred at rt for 1.5 h. The solvent was removed via vacuum, and the crude was purified by prep-HPLC (method C) (7.6 mg, 28%). MS (ESI) (<i>m</i>/<i>z</i>): 401.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.98 (br s, 1H), 8.26 (s, 1H), 7.89 (d, <i>J</i> = 8.5 Hz, 1H), 7.84 (s, 1H), 7.74–7.71 (m, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.03 (d, <i>J</i> = 8.5 Hz, 2H), 3.91 (s, 3H), 3.79 (d, <i>J</i> = 6.7 Hz, 2H), 3.36 (s, 3H), 2.05 (dt, <i>J</i> = 13.5, 6.8 Hz, 1H), 1.01 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-(2,3-Difluorophenyl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>17</b>)</h4><div class="NLM_p last">Prepared from <b>78b</b> using the procedures described for <b>16</b> (6.1 mg, 39%). MS (ESI) (<i>m</i>/<i>z</i>): 379.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (s, 1H), 8.08 (s, 1H), 8.02 (d, <i>J</i> = 8.5 Hz, 1H), 7.84 (d, <i>J</i> = 7.9 Hz, 2H), 7.77 (dd, <i>J</i> = 8.7, 1.4 Hz, 1H), 7.65 (d, <i>J</i> = 7.9 Hz, 2H), 7.06 (t, <i>J</i> = 56.0 Hz, 1H), 3.95 (s, 3H), 3.40 (br s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −108.62 (s, 2F).</div></div><div id="sec5_9_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(Cyclopropylsulfonyl)-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>18</b>)</h4><div class="NLM_p last">Prepared from <b>78c</b> using the procedures described for <b>16</b> (6.9 mg, 44%). MS (ESI) (<i>m</i>/<i>z</i>): 423.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.00 (br s, 1H), 8.31 (s, 1H), 8.16 (s, 1H), 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.1 Hz, 2H), 7.81–7.75 (m, 3H), 3.96 (s, 3H), 3.22–3.15 (m, 1H), 1.21–1.10 (m, 4H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −60.63 (s, 3F).</div></div><div id="sec5_9_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(Cyclopropylsulfonyl)-3-(4-(difluoromethyl)phenyl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>19</b>)</h4><div class="NLM_p last">Prepared from <b>78b</b> using the procedures described for <b>16</b> (10.5 mg, 75%). MS (ESI) (<i>m</i>/<i>z</i>): 405.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.99 (br s, 1H), 8.29 (s, 1H), 8.08 (s, 1H), 8.02 (d, <i>J</i> = 8.2 Hz, 1H), 7.84 (d, <i>J</i> = 7.9 Hz, 2H), 7.77 (dd, <i>J</i> = 8.5, 1.2 Hz, 1H), 7.65 (d, <i>J</i> = 8.2 Hz, 2H), 7.06 (t, <i>J</i> = 56.0 Hz, 1H), 3.95 (s, 3H), 3.22–3.14 (m, 1H), 1.20–1.09 (m, 4H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −108.64 (s, 2F).</div></div><div id="sec5_9_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-Methyl-3-(4-(trifluoromethyl)phenyl)-<i>N</i>-((trifluoromethyl)sulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>20</b>)</h4><div class="NLM_p last">Prepared from <b>78c</b> using the procedures described for <b>16</b> (9.1 mg, 61%). MS (ESI) (<i>m</i>/<i>z</i>): 449.0 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11 (s, 1H), 8.01 (s, 1H), 7.94–7.89 (m, 3H), 7.83 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.77 (d, <i>J</i> = 8.4 Hz, 2H), 3.92 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −60.57 (s, 3F), −76.66 (s, 3F).</div></div><div id="sec5_9_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(<i>N</i>,<i>N</i>-Dimethylsulfamoyl)-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>21</b>)</h4><div class="NLM_p last">Prepared from <b>78c</b> using the procedures described for <b>16</b> (9.8 mg, 74%). MS (ESI) (<i>m</i>/<i>z</i>): 426.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (s, 1H), 8.04 (s, 1H), 8.01 (d, <i>J</i> = 8.5 Hz, 1H), 7.90 (d, <i>J</i> = 8.2 Hz, 2H), 7.75 (br d, <i>J</i> = 8.2 Hz, 3H), 3.94 (s, 3H), 2.92 (s, 6H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −61.25 (s, 3F).</div></div><div id="sec5_9_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-Methyl-<i>N</i>-(thiophen-2-ylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>22</b>)</h4><div class="NLM_p last">Prepared from <b>78c</b> using the procedures described for <b>16</b> (9.5 mg, 59%). MS (ESI) (<i>m</i>/<i>z</i>): 465.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (s, 1H), 8.06 (s, 1H), 7.98–7.89 (m, 3H), 7.85–7.69 (m, 4H), 7.23–6.96 (m, 3H), 3.93 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −60.60 (s, 3F).</div></div><div id="sec5_9_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-((3,4-Difluorophenyl)sulfonyl)-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>23</b>)</h4><div class="NLM_p last">Prepared from <b>78c</b> using the procedures described for <b>16</b> (7.7 mg, 49%). MS (ESI) (<i>m</i>/<i>z</i>): 495.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (s, 1H), 8.15 (s, 1H), 8.10–8.04 (m, 1H), 8.00 (d, <i>J</i> = 8.8 Hz, 1H), 7.96–7.88 (m, 3H), 7.80–7.68 (m, 4H), 3.95 (s, 3H).</div></div><div id="sec5_9_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 5-Fluoro-1-methyl-<i>N</i>-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>24</b>)</h4><div class="NLM_p last">Prepared from <b>88a</b> using the procedures described for <b>16</b> (8.0 mg, 55%). MS (ESI) (<i>m</i>/<i>z</i>): 415.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (s, 1H), 7.92 (dd, <i>J</i> = 15.1, 7.2 Hz, 3H), 7.80–7.72 (m, 3H), 3.93 (s, 3H), 3.26 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −60.64, −123.71.</div></div><div id="sec5_9_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(Cyclopropylsulfonyl)-5-fluoro-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxamide (<b>25</b>)</h4><div class="NLM_p last">Prepared from <b>88a</b> using the procedures described for <b>16</b> (6.3 mg, 44%). MS (ESI) (<i>m</i>/<i>z</i>): 441.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (s, 1H), 7.93 (dd, <i>J</i> = 17.8, 7.0 Hz, 3H), 7.81–7.75 (m, 3H), 3.94 (s, 3H), 3.12 (ddd, <i>J</i> = 12.9, 7.8, 4.8 Hz, 1H), 1.23–1.07 (m, 4H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −60.66, −123.65.</div></div><div id="sec5_9_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-(4-(Difluoromethyl)phenyl)-5-fluoro-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>26</b>)</h4><div class="NLM_p last">Prepared from <b>88b</b> using the procedures described for <b>16</b> (4.4 mg, 32%). MS (ESI) (<i>m</i>/<i>z</i>): 397.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (s, 1H), 7.96 (d, <i>J</i> = 5.9 Hz, 1H), 7.83 (d, <i>J</i> = 8.0 Hz, 2H), 7.77 (d, <i>J</i> = 12.0 Hz, 1H), 7.64 (d, <i>J</i> = 8.1 Hz, 2H), 7.07 (t, <i>J</i> = 56.1 Hz, 1H), 3.94 (s, 3H), 3.38 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −108.71, −124.14.</div></div><div id="sec5_9_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(Cyclopropylsulfonyl)-3-(4-(difluoromethyl)phenyl)-5-fluoro-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>27</b>)</h4><div class="NLM_p last">Prepared from <b>88b</b> using the procedures described for <b>16</b> (6.1 mg, 47%). MS (ESI) (<i>m</i>/<i>z</i>): 423.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (s, 1H), 7.94 (d, <i>J</i> = 6.0 Hz, 1H), 7.83 (d, <i>J</i> = 8.0 Hz, 2H), 7.77 (d, <i>J</i> = 12.0 Hz, 1H), 7.64 (d, <i>J</i> = 8.0 Hz, 2H), 7.07 (t, <i>J</i> = 56.1 Hz, 1H), 3.94 (s, 3H), 3.14 (tt, <i>J</i> = 7.9, 4.9 Hz, 1H), 1.23–1.10 (m, 4H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −108.70, −123.94.</div></div><div id="sec5_9_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-(pyridin-3-yl)-1<i>H</i>-indole-6-carboxamide (<b>28</b>)</h4><div class="NLM_p last">Prepared from <b>90a</b> using the procedures described for <b>16</b> (8.4 mg, 38%). MS (ESI) (<i>m</i>/<i>z</i>): 330.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.92 (s, 1H), 8.47 (d, <i>J</i> = 4.6 Hz, 1H), 8.26 (s, 1H), 8.08 (d, <i>J</i> = 7.9 Hz, 1H), 8.01 (s, 1H), 7.93 (d, <i>J</i> = 8.2 Hz, 1H), 7.79 (d, <i>J</i> = 8.9 Hz, 1H), 7.47 (dd, <i>J</i> = 7.8, 4.7 Hz, 1H), 3.95 (s, 3H), 3.28 (s, 3H).</div></div><div id="sec5_9_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>29</b>)</h4><div class="NLM_p last">Prepared from <b>90b</b> using the procedures described for <b>16</b> (300 mg, 63%). MS (ESI) (<i>m</i>/<i>z</i>): 434.2 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.00 (br s, 1H), 8.43 (d, <i>J</i> = 2.0 Hz, 1H), 8.30 (d, <i>J</i> = 1.3 Hz, 1H), 8.14 (d, <i>J</i> = 2.0 Hz, 1H), 8.03 (s, 1H), 7.93 (d, <i>J</i> = 8.5 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 4.17 (d, <i>J</i> = 6.5 Hz, 2H), 3.92 (s, 3H), 3.40 (s, 3H), 2.09 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.01 (d, <i>J</i> = 6.8 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.8, 156.8, 142.2, 136.7, 136.3, 132.0, 128.4, 125.5, 124.7, 120.2, 119.1, 117.4, 111.9, 110.6, 72.6, 41.6, 33.1, 27.6, 19.1.</div></div><div id="sec5_9_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 3-(6-Isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>30</b>)</h4><div class="NLM_p last">Prepared from <b>90c</b> using the procedures described for <b>16</b> (12.3 mg, 54%). MS (ESI) (<i>m</i>/<i>z</i>): 402.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.01 (br s, 1H), 8.45 (d, <i>J</i> = 2.4 Hz, 1H), 8.28 (s, 1H), 7.99 (dd, <i>J</i> = 8.5, 2.7 Hz, 1H), 7.93 (s, 1H), 7.89 (d, <i>J</i> = 8.5 Hz, 1H), 7.74 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 6.92 (d, <i>J</i> = 8.5 Hz, 1H), 4.09 (d, <i>J</i> = 6.4 Hz, 2H), 3.93 (s, 3H), 3.37 (s, 3H), 2.07 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.00 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 3-(5-Chloro-6-(cyclopropylmethoxy)pyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>31</b>)</h4><div class="NLM_p last">Prepared from <b>90d</b> using the procedures described for <b>16</b> (20.7 mg, 75%). MS (ESI) (<i>m</i>/<i>z</i>): 434.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43 (d, <i>J</i> = 1.8 Hz, 1H), 8.28 (s, 1H), 8.12 (d, <i>J</i> = 1.8 Hz, 1H), 7.99 (s, 1H), 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.77 (d, <i>J</i> = 8.2 Hz, 1H), 4.28 (d, <i>J</i> = 7.0 Hz, 2H), 3.94 (s, 3H), 3.37 (s, 3H), 1.37–1.27 (m, 1H), 0.63–0.57 (m, 2H), 0.43–0.38 (m, 2H).</div></div><div id="sec5_9_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 3-(5-Cyano-6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>32</b>)</h4><div class="NLM_p last">The mixture of [1,1′-binaphthalen]-2-yldi-<i>tert</i>-butylphosphine (2.0 mg, 5.1 μmol), zinc (0.66 mg, 10 μmol), palladium(II) trifluoroacetate (0.84 mg, 2.5 μmol), 3-(5-chloro-6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>29</b>, 0.022 g, 0.051 mmol), and zinc cyanide (3.6 mg, 0.030 mmol) in dimethylacetamide (0.5 mL) underwent vacuum/N<sub>2</sub> fill cycle three times. The reaction was heated at 95 °C for 3 h. The reaction mixture was diluted with DMF, filtered, and purified by prep-HPLC (method C) (12.7 mg, 56%). MS (ESI) (<i>m</i>/<i>z</i>): 427.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.87 (br s, 1H), 8.75 (d, <i>J</i> = 2.4 Hz, 1H), 8.49 (d, <i>J</i> = 2.4 Hz, 1H), 8.30 (s, 1H), 8.04 (s, 1H), 7.98 (d, <i>J</i> = 8.5 Hz, 1H), 7.77 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 4.27 (d, <i>J</i> = 6.4 Hz, 2H), 3.95 (s, 3H), 3.39 (s, 3H), 2.13 (dt, <i>J</i> = 13.3, 6.8 Hz, 1H), 1.04 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-(6-Isobutoxy-5-methoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>33</b>)</h4><div class="NLM_p last">Prepared from <b>90e</b> using the procedures described for <b>16</b> (9.1 mg, 56%). MS (ESI) (<i>m</i>/<i>z</i>): 432.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (s, 1H), 8.00 (d, <i>J</i> = 1.8 Hz, 1H), 7.89–7.86 (m, 2H), 7.77 (d, <i>J</i> = 9.5 Hz, 1H), 7.50 (d, <i>J</i> = 1.8 Hz, 1H), 4.12 (d, <i>J</i> = 6.7 Hz, 2H), 3.92 (s, 3H), 3.90 (s, 3H), 3.25 (s, 3H), 2.10 (dt, <i>J</i> = 13.4, 6.6 Hz, 1H), 1.01 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 3-(5-Chloro-6-(2,2-difluoroethoxy)pyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>34</b>)</h4><div class="NLM_p last">The mixture of sodium carbonate (0.14 mL, 0.275 mmol), PdCl<sub>2</sub>(dppf) (5.0 mg, 6.9 μmol), 3-chloro-2-(2,2-difluoroethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (<b>95a</b>, 0.044 g, 0.137 mmol), and 3-bromo-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (0.045 g, 0.137 mmol) in dioxane (1 mL) was heated at 80 °C for 4 h. The reaction mixture was diluted with ethyl acetate, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The product was purified by prep-HPLC (method C) (6.0 mg, 9.8%). MS (ESI) (<i>m</i>/<i>z</i>): 444.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (d, <i>J</i> = 2.1 Hz, 1H), 8.26 (s, 1H), 8.20 (d, <i>J</i> = 2.1 Hz, 1H), 8.00 (s, 1H), 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.77 (dd, <i>J</i> = 8.5, 1.2 Hz, 1H), 6.44 (tt, <i>J</i> = 54.6, 3.5 Hz, 1H), 4.72 (td, <i>J</i> = 14.9, 3.5 Hz, 2H), 3.93 (s, 3H), 3.32 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −125.62 (s, 2F).</div></div><div id="sec5_9_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 3-(5-Chloro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>35</b>)</h4><div class="NLM_p last">Prepared from <b>95b</b> using the procedures described for <b>34</b> (19.9 mg, 23%). MS (ESI) (<i>m</i>/<i>z</i>): 462.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (d, <i>J</i> = 1.8 Hz, 1H), 8.26–8.22 (m, 2H), 8.01 (s, 1H), 7.89 (d, <i>J</i> = 8.2 Hz, 1H), 7.79 (d, <i>J</i> = 7.9 Hz, 1H), 5.12 (q, <i>J</i> = 8.9 Hz, 2H), 3.93 (s, 3H), 3.27 (br s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −72.35 (s, 3F).</div></div><div id="sec5_9_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 3-(5-Chloro-6-(2-hydroxy-2-methylpropoxy)pyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>36</b>)</h4><div class="NLM_p last">Prepared from <b>90f</b> using the procedures described for <b>16</b> (20.6 mg, 56%). MS (ESI) (<i>m</i>/<i>z</i>): 452.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.18 (s, 1H), 8.05 (d, <i>J</i> = 2.1 Hz, 1H), 7.99 (d, <i>J</i> = 2.4 Hz, 1H), 7.83–7.77 (m, 2H), 7.77–7.73 (m, 1H), 4.88 (s, 1H), 4.11 (s, 2H), 3.88 (s, 3H), 3.17 (s, 3H), 1.16 (s, 6H).</div></div><div id="sec5_9_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(cyclopropylsulfonyl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>37</b>)</h4><div class="NLM_p last">Prepared from <b>90b</b> using the procedures described for <b>16</b> (17.0 mg, 87%). MS (ESI) (<i>m</i>/<i>z</i>): 462.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (d, <i>J</i> = 2.1 Hz, 1H), 8.24 (s, 1H), 8.15 (d, <i>J</i> = 2.1 Hz, 1H), 7.99 (s, 1H), 7.89 (d, <i>J</i> = 8.2 Hz, 1H), 7.76 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 4.18 (d, <i>J</i> = 6.4 Hz, 2H), 3.92 (s, 3H), 3.18–3.11 (m, 1H), 2.10 (dt, <i>J</i> = 13.4, 6.6 Hz, 1H), 1.10 (br s, 2H), 1.02 (m, 8H).</div></div><div id="sec5_9_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 3-(5-Chloro-6-(cyclopropylmethoxy)pyridin-3-yl)-<i>N</i>-(cyclopropylsulfonyl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>38</b>)</h4><div class="NLM_p last">Prepared from <b>90d</b> using the procedures described for <b>16</b> (13.4 mg, 60%). MS (ESI) (<i>m</i>/<i>z</i>): 460.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43 (d, <i>J</i> = 2.1 Hz, 1H), 8.27 (s, 1H), 8.12 (d, <i>J</i> = 1.8 Hz, 1H), 7.99 (s, 1H), 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.76 (d, <i>J</i> = 8.5 Hz, 1H), 4.28 (d, <i>J</i> = 7.0 Hz, 2H), 3.94 (s, 3H), 1.38–1.28 (m, 1H), 1.23–1.18 (m, 2H), 1.15–1.09 (m, 2H), 0.63–0.58 (m, 2H), 0.40 (q, <i>J</i> = 4.8 Hz, 2H) (1H was buried under the water signal).</div></div><div id="sec5_9_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-(Cyclopropylsulfonyl)-3-(6-isobutoxy-5-methoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>39</b>)</h4><div class="NLM_p last">Prepared from <b>90e</b> using the procedures described for <b>16</b> (9.1 mg, 64%). MS (ESI) (<i>m</i>/<i>z</i>): 458.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (s, 1H), 8.00 (d, <i>J</i> = 1.2 Hz, 1H), 7.92 (t, <i>J</i> = 4.3 Hz, 2H), 7.74 (d, <i>J</i> = 8.2 Hz, 1H), 7.49 (s, 1H), 4.12 (d, <i>J</i> = 6.4 Hz, 2H), 3.94 (s, 3H), 3.90 (s, 3H), 3.42–3.34 (m, 1H), 2.09 (dt, <i>J</i> = 13.4, 6.6 Hz, 1H), 1.22–1.17 (m, 2H), 1.15–1.10 (m, 2H), 1.00 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(ethylsulfonyl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>40</b>)</h4><div class="NLM_p last">Prepared from <b>90b</b> using the procedures described for <b>16</b> (7.6 mg, 46%). MS (ESI) (<i>m</i>/<i>z</i>): 450.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (d, <i>J</i> = 1.8 Hz, 1H), 8.29 (s, 1H), 8.12 (d, <i>J</i> = 1.8 Hz, 1H), 7.98 (s, 1H), 7.90 (d, <i>J</i> = 8.9 Hz, 1H), 7.78–7.75 (m, 1H), 4.21 (d, <i>J</i> = 6.4 Hz, 2H), 3.94 (s, 3H), 3.51 (q, <i>J</i> = 7.4 Hz, 2H), 2.12 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.30 (t, <i>J</i> = 7.3 Hz, 3H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(isopropylsulfonyl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>41</b>)</h4><div class="NLM_p last">Prepared from <b>90b</b> using the procedures described for <b>16</b> (13.7 mg, 85%). MS (ESI) (<i>m</i>/<i>z</i>): 464.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43 (d, <i>J</i> = 2.1 Hz, 1H), 8.28 (s, 1H), 8.12 (d, <i>J</i> = 2.1 Hz, 1H), 7.99 (s, 1H), 7.90 (d, <i>J</i> = 8.5 Hz, 1H), 7.78–7.74 (m, 1H), 4.21 (d, <i>J</i> = 6.7 Hz, 2H), 3.94 (s, 3H), 3.89 (dt, <i>J</i> = 13.7, 6.8 Hz, 1H), 2.12 (dt, <i>J</i> = 13.4, 6.6 Hz, 1H), 1.36 (d, <i>J</i> = 6.7 Hz, 6H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-(<i>tert</i>-Butylsulfonyl)-3-(5-chloro-6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>42</b>)</h4><div class="NLM_p last">Prepared from <b>90b</b> using the procedures described for <b>16</b> (11.9 mg, 70%). MS (ESI) (<i>m</i>/<i>z</i>): 478.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (d, <i>J</i> = 1.8 Hz, 1H), 8.23 (s, 1H), 8.12 (d, <i>J</i> = 1.8 Hz, 1H), 7.97 (s, 1H), 7.89 (d, <i>J</i> = 8.5 Hz, 1H), 7.74 (d, <i>J</i> = 8.2 Hz, 1H), 4.21 (d, <i>J</i> = 6.4 Hz, 2H), 3.94 (s, 3H), 2.12 (dt, <i>J</i> = 13.2, 6.7 Hz, 1H), 1.46 (s, 9H), 1.04 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(N,<i>N</i>-dimethylsulfamoyl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>43</b>)</h4><div class="NLM_p last">Prepared from <b>90b</b> using the procedures described for <b>16</b> (14.0 mg, 78%). MS (ESI) (<i>m</i>/<i>z</i>): 465.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.72 (s, 1H), 8.44 (d, <i>J</i> = 2.1 Hz, 1H), 8.30 (s, 1H), 8.15 (d, <i>J</i> = 2.1 Hz, 1H), 8.03 (s, 1H), 7.93 (d, <i>J</i> = 8.5 Hz, 1H), 7.74 (dd, <i>J</i> = 8.5, 1.2 Hz, 1H), 4.18 (d, <i>J</i> = 6.4 Hz, 2H), 3.93 (s, 3H), 2.93 (s, 6H), 2.10 (dt, <i>J</i> = 13.4, 6.6 Hz, 1H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(piperidin-1-ylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>44</b>)</h4><div class="NLM_p last">Prepared from <b>90b</b> using the procedures described for <b>16</b> (13.5 mg, 65%). MS (ESI) (<i>m</i>/<i>z</i>): 505.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.70 (s, 1H), 8.44 (d, <i>J</i> = 2.1 Hz, 1H), 8.29 (s, 1H), 8.15 (d, <i>J</i> = 2.1 Hz, 1H), 8.03 (s, 1H), 7.93 (d, <i>J</i> = 8.5 Hz, 1H), 7.73 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 4.18 (d, <i>J</i> = 6.7 Hz, 2H), 3.93 (s, 3H), 2.14–2.06 (m, 1H), 1.62–1.55 (m, 4H), 1.54–1.48 (m, 2H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H) (4H of sulfonamide piperidine was buried in the solvent peak).</div></div><div id="sec5_9_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-5-fluoro-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>45</b>)</h4><div class="NLM_p last">Prepared from <b>99a</b> using the procedures described for <b>16</b> (10.7 mg, 74%). MS (ESI) (<i>m</i>/<i>z</i>): 454.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 2.2 Hz, 1H), 8.13 (d, <i>J</i> = 2.2 Hz, 1H), 7.97 (s, 1H), 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.60 (d, <i>J</i> = 11.8 Hz, 1H), 4.17 (d, <i>J</i> = 6.6 Hz, 2H), 3.89 (s, 3H), 2.55 (s, 3H), 2.10 (dt, <i>J</i> = 13.5, 6.8 Hz, 1H), 1.01 (d, <i>J</i> = 6.7 Hz, 6H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −123.94.</div></div><div id="sec5_9_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(cyclopropylsulfonyl)-5-fluoro-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>46</b>)</h4><div class="NLM_p last">Prepared from <b>99a</b> using the procedures described for <b>16</b> (8.8 mg, 59%). MS (ESI) (<i>m</i>/<i>z</i>): 480.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (d, <i>J</i> = 2.2 Hz, 1H), 8.14 (d, <i>J</i> = 2.2 Hz, 1H), 8.05 (s, 1H), 7.92 (d, <i>J</i> = 5.9 Hz, 1H), 7.72 (d, <i>J</i> = 11.9 Hz, 1H), 4.17 (d, <i>J</i> = 6.6 Hz, 2H), 3.91 (s, 3H), 3.19–3.09 (m, 1H), 2.11 (dq, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.21–1.12 (m, 4H), 1.01 (d, <i>J</i> = 6.7 Hz, 6H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −124.04.</div></div><div id="sec5_9_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 5-Fluoro-3-(6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>47</b>)</h4><div class="NLM_p last">Prepared from <b>99b</b> using the procedures described for <b>16</b> (7.9 mg, 49%). MS (ESI) (<i>m</i>/<i>z</i>): 420.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 2.7 Hz, 1H), 7.98 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 7.96 (s, 1H), 7.92 (d, <i>J</i> = 5.9 Hz, 1H), 7.64 (d, <i>J</i> = 11.9 Hz, 1H), 6.91 (d, <i>J</i> = 8.5 Hz, 1H), 4.07 (d, <i>J</i> = 6.6 Hz, 2H), 3.91 (s, 3H), 3.38 (s, 3H), 2.06 (dp, <i>J</i> = 13.5, 6.8 Hz, 1H), 0.99 (d, <i>J</i> = 6.7 Hz, 6H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −124.53.</div></div><div id="sec5_9_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> <i>N</i>-(Cyclopropylsulfonyl)-5-fluoro-3-(6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxamide (<b>48</b>)</h4><div class="NLM_p last">Prepared from <b>99b</b> using the procedures described for <b>16</b> (7.9 mg, 57%). MS (ESI) (<i>m</i>/<i>z</i>): 446.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43 (d, <i>J</i> = 2.5 Hz, 1H), 7.98 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 7.95 (s, 1H), 7.91 (d, <i>J</i> = 6.0 Hz, 1H), 7.63 (d, <i>J</i> = 11.9 Hz, 1H), 6.91 (d, <i>J</i> = 8.6 Hz, 1H), 4.08 (d, <i>J</i> = 6.7 Hz, 2H), 3.91 (s, 3H), 3.12 (ddd, <i>J</i> = 12.8, 8.1, 4.8 Hz, 1H), 2.07 (dp, <i>J</i> = 13.4, 6.8 Hz, 1H), 1.20–1.07 (m, 4H), 1.00 (d, <i>J</i> = 6.7 Hz, 6H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −124.27.</div></div><div id="sec5_9_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-isopropyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>49</b>)</h4><div class="NLM_p last">Prepared from <b>102a</b> using the procedures described for <b>16</b> (9.7 mg, 45%). MS (ESI) (<i>m</i>/<i>z</i>): 464.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (d, <i>J</i> = 2.1 Hz, 1H), 8.34 (s, 1H), 8.20–8.17 (m, 2H), 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.76 (d, <i>J</i> = 8.5 Hz, 1H), 4.91 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 4.21 (d, <i>J</i> = 6.4 Hz, 2H), 3.37 (s, 3H), 2.12 (dt, <i>J</i> = 13.4, 6.6 Hz, 1H), 1.58 (d, <i>J</i> = 6.7 Hz, 6H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-isobutyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>50</b>)</h4><div class="NLM_p last">Prepared from <b>102b</b> using the procedures described for <b>16</b> (12.0 mg, 96%). MS (ESI) (<i>m</i>/<i>z</i>): 478.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (d, <i>J</i> = 2.1 Hz, 1H), 8.28 (s, 1H), 8.18 (d, <i>J</i> = 2.1 Hz, 1H), 8.08 (s, 1H), 7.93 (d, <i>J</i> = 8.5 Hz, 1H), 7.75 (dd, <i>J</i> = 8.7, 1.4 Hz, 1H), 4.18 (d, <i>J</i> = 6.7 Hz, 2H), 4.10 (d, <i>J</i> = 7.3 Hz, 2H), 3.37 (s, 3H), 2.32–2.24 (m, 1H), 2.11 (dt, <i>J</i> = 13.2, 6.7 Hz, 1H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H), 0.92 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(cyclopropylsulfonyl)-1-isobutyl-1<i>H</i>-indole-6-carboxamide (<b>51</b>)</h4><div class="NLM_p last">Prepared from <b>102b</b> using the procedures described for <b>16</b> (15.0 mg, 90%). MS (ESI) (<i>m</i>/<i>z</i>): 504.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (d, <i>J</i> = 2.1 Hz, 1H), 8.26 (s, 1H), 8.18 (d, <i>J</i> = 2.1 Hz, 1H), 8.08 (s, 1H), 7.94 (d, <i>J</i> = 8.5 Hz, 1H), 7.77–7.73 (m, 1H), 4.18 (d, <i>J</i> = 6.7 Hz, 2H), 4.11 (d, <i>J</i> = 7.3 Hz, 2H), 3.22–3.15 (m, 1H), 2.33–2.24 (m, 1H), 2.11 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.19–1.14 (m, 2H), 1.14–1.07 (m, <i>J</i> = 6.4 Hz, 2H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H), 0.92 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indazole-6-carboxamide (<b>52</b>)</h4><div class="NLM_p last">The mixture of 6-bromo-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indazole (<b>106</b>, 0.011 g, 0.032 mmol), molybdenum hexacarbonyl (14 mg, 0.053 mmol), DBU (0.014 mL, 0.095 mmol), tri-<i>tert</i>-butylphosphonium tetrafluoroborate (0.9 mg, 3.2 μmol), methanesulfonamide (15 mg, 0.158 mmol), and <i>trans</i>-di-μ-acetatobis[2-[bis(2-methylphenyl)phosphino]benzyl]dipalladium (1.5 mg, 1.6 μmol) in dioxane (0.3 mL) in a sealed tube was heated at 140 °C for 10 min. The reaction mixture was filtered and purified by prep-HPLC (method A) (8.0 mg, 61%). MS (ESI) (<i>m</i>/<i>z</i>): 398.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.38 (s, 1H), 8.24 (d, <i>J</i> = 8.2 Hz, 2H), 8.17 (d, <i>J</i> = 8.9 Hz, 1H), 7.90–7.85 (m, 3H), 4.21 (s, 3H), 3.22 (br s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −61.03 (s, 3F).</div></div><div id="sec5_9_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 5-Fluoro-1-methyl-<i>N</i>-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indazole-6-carboxamide (<b>53</b>)</h4><div class="NLM_p last">Prepared from <b>123a</b> using the procedures described for <b>16</b> (8.3 mg, 51%). MS (ESI) (<i>m</i>/<i>z</i>): 414.1 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (d, <i>J</i> = 7.6 Hz, 2H), 8.19–8.14 (m, 1H), 8.05 (d, <i>J</i> = 14.3 Hz, 1H), 7.86 (d, <i>J</i> = 7.0 Hz, 2H), 4.22 (s, 3H), 3.40 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −61.08, −123.50.</div></div><div id="sec5_9_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i>-(Cyclopropylsulfonyl)-5-fluoro-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indazole-6-carboxamide (<b>54</b>)</h4><div class="NLM_p last">Prepared from <b>123a</b> using the procedures described for <b>16</b> (8.8 mg, 59%). MS (ESI) (<i>m</i>/<i>z</i>): 442.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (d, <i>J</i> = 8.2 Hz, 2H), 8.16 (d, <i>J</i> = 5.6 Hz, 1H), 8.06 (d, <i>J</i> = 10.8 Hz, 1H), 7.86 (d, <i>J</i> = 8.2 Hz, 2H), 4.23 (s, 3H), 3.13 (dt, <i>J</i> = 8.2, 4.6 Hz, 1H), 1.27–1.14 (m, 4H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −61.09, −123.44.</div></div><div id="sec5_9_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indazole-6-carboxamide (<b>55</b>)</h4><div class="NLM_p last">Prepared from <b>111a</b> using the procedures described for <b>16</b> (6.9 mg, 15%). MS (ESI) (<i>m</i>/<i>z</i>): 437.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (d, <i>J</i> = 2.1 Hz, 1H), 8.41 (s, 1H), 8.35 (d, <i>J</i> = 1.8 Hz, 1H), 8.18 (d, <i>J</i> = 8.5 Hz, 1H), 7.80–7.76 (m, 1H), 4.25 (d, <i>J</i> = 6.7 Hz, 2H), 4.20 (s, 3H), 3.38 (s, 3H), 2.14 (dt, <i>J</i> = 13.2, 6.7 Hz, 1H), 1.04 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(cyclopropylsulfonyl)-1-methyl-1<i>H</i>-indazole-6-carboxamide (<b>56</b>)</h4><div class="NLM_p last">Prepared from <b>111a</b> using the procedures described for <b>16</b> (18.9 mg, 82%). MS (ESI) (<i>m</i>/<i>z</i>): 463.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (d, <i>J</i> = 2.1 Hz, 1H), 8.38–8.34 (m, 2H), 8.14 (d, <i>J</i> = 8.5 Hz, 1H), 7.81 (d, <i>J</i> = 7.9 Hz, 1H), 4.25 (d, <i>J</i> = 6.4 Hz, 2H), 4.19 (s, 3H), 3.13–3.09 (m, 1H), 2.14 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.17–1.11 (m, 2H), 1.07–1.01 (m, <i>J</i> = 6.7 Hz, 8H).</div></div><div id="sec5_9_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 3-(6-Isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indazole-6-carboxamide (<b>57</b>)</h4><div class="NLM_p last">Prepared from <b>114a</b> using the procedures described for <b>52</b> (21.0 mg, 70%). MS (ESI) (<i>m</i>/<i>z</i>): 403.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.75 (d, <i>J</i> = 2.1 Hz, 1H), 8.31 (s, 1H), 8.26 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 8.05 (d, <i>J</i> = 8.5 Hz, 1H), 7.82 (d, <i>J</i> = 8.5 Hz, 1H), 6.97 (d, <i>J</i> = 8.5 Hz, 1H), 4.18–4.13 (m, 5H), 3.17 (s, 3H), 2.10 (dt, <i>J</i> = 13.1, 6.6 Hz, 1H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 5-Fluoro-3-(6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indazole-6-carboxamide (<b>58</b>)</h4><div class="NLM_p last">Prepared from <b>123b</b> using the procedures described for <b>16</b> (12.5 mg, 79%). MS (ESI) (<i>m</i>/<i>z</i>): 421.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (d, <i>J</i> = 2.3 Hz, 1H), 8.25 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 7.99 (d, <i>J</i> = 5.7 Hz, 1H), 7.83 (d, <i>J</i> = 10.8 Hz, 1H), 6.95 (d, <i>J</i> = 8.6 Hz, 1H), 4.15 (s, 3H), 4.14 (s, 2H), 3.16 (s, 3H), 2.10 (dt, <i>J</i> = 13.3, 6.6 Hz, 1H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −123.57.</div></div><div id="sec5_9_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-(Cyclopropylsulfonyl)-5-fluoro-3-(6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indazole-6-carboxamide (<b>59</b>)</h4><div class="NLM_p last">Prepared from <b>123b</b> using the procedures described for <b>16</b> (3.6 mg, 27%). MS (ESI) (<i>m</i>/<i>z</i>): 447.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (d, <i>J</i> = 2.4 Hz, 1H), 8.24 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.98 (d, <i>J</i> = 5.6 Hz, 1H), 7.83 (d, <i>J</i> = 10.7 Hz, 1H), 6.95 (d, <i>J</i> = 8.6 Hz, 1H), 4.14 (d, <i>J</i> = 6.4 Hz, 5H), 3.02 (ddd, <i>J</i> = 13.1, 8.4, 4.9 Hz, 1H), 2.10 (dt, <i>J</i> = 13.5, 6.7 Hz, 1H), 1.10–1.04 (m, 2H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H), 0.96 (dd, <i>J</i> = 8.1, 2.9 Hz, 2H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −123.36.</div></div><div id="sec5_9_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indazole-6-carboxamide (<b>60</b>)</h4><div class="NLM_p last">Prepared from <b>114b</b> using the procedures described for <b>52</b> (28.4 mg, 51%). MS (ESI) (<i>m</i>/<i>z</i>): 423.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.74 (d, <i>J</i> = 1.8 Hz, 1H), 8.38 (d, <i>J</i> = 1.8 Hz, 1H), 8.21 (s, 1H), 8.06 (d, <i>J</i> = 8.9 Hz, 1H), 7.82 (d, <i>J</i> = 8.5 Hz, 1H), 4.25 (d, <i>J</i> = 6.7 Hz, 2H), 3.12 (br s, 3H), 2.14 (dt, <i>J</i> = 13.5, 6.5 Hz, 1H), 1.04 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-2-methyl-<i>N</i>-(methylsulfonyl)-2<i>H</i>-indazole-6-carboxamide (<b>61</b>)</h4><div class="NLM_p last">Prepared from <b>113</b> using the procedures described for <b>16</b> (4.2 mg, 46%). MS (ESI) (<i>m</i>/<i>z</i>): 437.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 2.1 Hz, 1H), 8.34 (s, 1H), 8.24 (d, <i>J</i> = 2.1 Hz, 1H), 7.67–7.59 (m, 2H), 4.27 (d, <i>J</i> = 6.4 Hz, 2H), 4.19 (s, 3H), 3.21 (s, 3H), 2.15 (dt, <i>J</i> = 13.6, 6.6 Hz, 1H), 1.05 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(cyclopropylsulfonyl)-2-methyl-2<i>H</i>-indazole-6-carboxamide (<b>62</b>)</h4><div class="NLM_p last">Prepared from <b>113</b> using the procedures described for <b>16</b> (8.6 mg, 55%). MS (ESI) (<i>m</i>/<i>z</i>): 463.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (d, <i>J</i> = 1.8 Hz, 1H), 8.35 (s, 1H), 8.24 (d, <i>J</i> = 2.1 Hz, 1H), 7.65–7.62 (m, 2H), 4.28 (d, <i>J</i> = 6.7 Hz, 2H), 4.20 (s, 3H), 3.12 (dt, <i>J</i> = 8.4, 4.0 Hz, 1H), 2.16 (dt, <i>J</i> = 13.3, 6.5 Hz, 1H), 1.16–1.12 (m, 2H), 1.07–1.02 (m, 8H).</div></div><div id="sec5_9_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxamide (<b>63</b>)</h4><div class="NLM_p last">Prepared from <b>128a</b> using the procedures described for <b>16</b> (5.6 mg, 16%). MS (ESI) (<i>m</i>/<i>z</i>): 437.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.41 (s, 1H), 8.01 (d, <i>J</i> = 9.2 Hz, 1H), 7.96 (d, <i>J</i> = 2.2 Hz, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 2H), 7.68–7.64 (m, 1H), 7.60–7.57 (m, 1H), 7.14 (d, <i>J</i> = 8.1 Hz, 2H), 7.06 (d, <i>J</i> = 9.2 Hz, 1H), 2.28 (s, 3H).</div></div><div id="sec5_9_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxamide (<b>64</b>)</h4><div class="NLM_p last">Prepared from <b>128b</b> using the procedures described for <b>16</b> (4.8 mg, 27%). MS (ESI) (<i>m</i>/<i>z</i>): 398.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56 (d, <i>J</i> = 8.2 Hz, 1H), 8.38 (s, 1H), 8.00–7.95 (m, 3H), 7.80 (d, <i>J</i> = 8.2 Hz, 2H), 4.07 (s, 3H), 3.40 (s, 3H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −60.79 (s, 3F).</div></div><div id="sec5_9_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>N</i>-(Cyclopropylsulfonyl)-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxamide (<b>65</b>)</h4><div class="NLM_p last">Prepared from <b>128b</b> using the procedures described for <b>16</b> (4.4 mg, 30%). MS (ESI) (<i>m</i>/<i>z</i>): 424.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (d, <i>J</i> = 8.2 Hz, 1H), 8.39 (s, 1H), 7.98 (d, <i>J</i> = 7.9 Hz, 3H), 7.80 (d, <i>J</i> = 8.2 Hz, 2H), 4.07 (s, 3H), 3.16–3.14 (m, 1H), 1.25 (d, <i>J</i> = 3.7 Hz, 2H), 1.14 (d, <i>J</i> = 5.2 Hz, 2H). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −60.80 (s, 3F).</div></div><div id="sec5_9_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carboxamide (<b>66</b>)</h4><div class="NLM_p last">Prepared from <b>131</b> using the procedures described for <b>52</b> (3.7 mg, 16%). MS (ESI) (<i>m</i>/<i>z</i>): 436.9 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) d 9.03 (d, <i>J</i> = 1.5 Hz, 1H), 8.92 (d, <i>J</i> = 1.8 Hz, 1H), 8.69 (d, <i>J</i> = 2.1 Hz, 1H), 8.52 (d, <i>J</i> = 1.5 Hz, 1H), 8.36 (s, 1H), 4.20 (d, <i>J</i> = 6.4 Hz, 2H), 3.94 (s, 3H), 2.16–2.05 (m, 1H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-<i>N</i>-(cyclopropylsulfonyl)-1-methyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine-6-carboxamide (<b>67</b>)</h4><div class="NLM_p last">Prepared from <b>131</b> using the procedures described for <b>52</b> (5.6 mg, 15%). MS (ESI) (<i>m</i>/<i>z</i>): 462.9 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.02 (d, <i>J</i> = 1.5 Hz, 1H), 8.93 (d, <i>J</i> = 1.8 Hz, 1H), 8.69 (d, <i>J</i> = 2.1 Hz, 1H), 8.55 (s, 1H), 8.40 (s, 1H), 4.20 (d, <i>J</i> = 6.4 Hz, 2H), 3.95 (s, 3H), 3.15–3.09 (m, 1H), 2.11 (dt, <i>J</i> = 13.4, 6.6 Hz, 1H), 1.13 (br s, 2H), 1.06–1.04 (m, 2H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 1-Methyl-<i>N</i>-(methylsulfonyl)-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-6-carboxamide (<b>68</b>)</h4><div class="NLM_p last">Prepared from <b>135</b> using the procedures described for <b>16</b> (0.9 mg, 14%). MS (ESI) (<i>m</i>/<i>z</i>): 398.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Methyl 3-Bromo-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>70</b>)</h4><div class="NLM_p last">To the DMF solution (60 mL) of methyl 1<i>H</i>-indole-6-carboxylate (<b>69</b>, 5.1 g, 29.1 mmol) was added dropwise a solution of NBS (5.70 g, 32.0 mmol) in 40 mL ofDMF at −60 °C. The reaction was stirred for 2 h, while it was warmed up to rt. The reaction mixture was poured into iced water (1 L), and the precipitate was collected through filtration. The solid was dissolved in EtOAc and washed twice with brine. The ethyl acetate layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to give the crude product (6.86 g, 93%). MS (ESI) (<i>m</i>/<i>z</i>): 254.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Methyl 3-Bromo-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>71</b>)</h4><div class="NLM_p last">Potassium carbonate (1.68 g, 12.16 mmol) was added to the DMF (10 mL) solution of methyl 3-bromo-1<i>H</i>-indole-6-carboxylate (<b>70</b>, 1.03 g, 4.05 mmol) at rt. The mixture was stirred at rt for 30 min. The reaction was cooled to 0 °C, and methyl iodide (0.30 mL, 4.86 mmol) was added to the reaction mixture. The reaction was stirred overnight while it was warmed up to rt. The reaction was diluted with water and extracted three times with diethyl ether. The diethyl ether layer was combined, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The product was purified via flash column eluted with EtOAc in hexane from 0 to 25% as a white solid (0.98 g, 90%). MS (ESI) (<i>m</i>/<i>z</i>): 267.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.12–8.09 (m, 1H), 7.88 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 7.59 (dd, <i>J</i> = 8.4, 0.6 Hz, 1H), 7.24 (s, 1H), 3.97 (s, 3H), 3.87 (s, 3H).</div></div><div id="sec5_9_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 3-Bromo-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>72</b>)</h4><div class="NLM_p last">The mixture of LiOH (0.172 g, 7.20 mmol) and methyl 3-bromo-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>71</b>, 0.965 g, 3.60 mmol) in THF (4 mL), water (0.8 mL), and MeOH (1 mL) at room temperature for 36 h. The volatile was removed via vacuum, and to the crude was added 1 N HCl (6 mL). The slurry was filtered and the solid was collected and washed with water. The solid was taken up in EtOAc and dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The EtOAc layer was filtered and concentrated to give the crude product (0.84 g, 92%) as a white solid. MS (ESI) (<i>m</i>/<i>z</i>): 254.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1H), 7.93 (dd, <i>J</i> = 8.3, 1.3 Hz, 1H), 7.63 (d, <i>J</i> = 8.5 Hz, 1H), 7.28 (s, 1H), 3.89 (s, 3H).</div></div><div id="sec5_9_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 3-Bromo-1-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-6-carboxamide (<b>73</b>)</h4><div class="NLM_p last">2-Chloro-1-methylpyridin-1-ium iodide (1.01 g, 3.95 mmol), methanesulfonamide (0.94 g, 9.88 mmol), and TEA (1.4 mL, 9.88 mmol) was added to the CH<sub>2</sub>Cl<sub>2</sub> (10 mL) solution of 3-bromo-1-methyl-1<i>H</i>-indole-6-carboxylic acid (<b>72</b>, 0.837 g, 3.29 mmol) and DMAP (0.020 g, 0.165 mmol) at rt. The reaction was stirred at rt for 1.5. The solvent was removed via vacuum, and to the crude was added 1H HCl (3 mL) and water (20 mL). The aqueous layer was extracted three times with EtOAc. The EtOAc layer was combined, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude was added methanol, and a white suspension formed. The solid was filtered and discarded, and the filtrate was concentrated to afford the desired product (1.02 g, 93%). MS (ESI) (<i>m</i>/<i>z</i>): 329.0 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (s, 1H), 7.81 (s, 1H), 7.75 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.50 (d, <i>J</i> = 8.4 Hz, 1H), 3.88 (s, 3H) (3H of methyl sulfonamide was buried in solvent peak).</div></div><div id="sec5_9_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Methyl 3-Iodo-1<i>H</i>-indole-6-carboxylate (<b>74</b>)</h4><div class="NLM_p last">The mixture of KOH (1.79 g, 31.9 mmol) and methyl 1<i>H</i>-indole-6-carboxylate (2.31 g, 13.17 mmol) in DMF (30 mL) was stirred at rt for 1 h. Iodine (3.34 g, 13.17 mmol) in DMF (7 mL) was added to the reaction mixture at rt. The reaction was continue to stir for 18 h. The reaction was poured into 400 mL of ice–water, and the solid was filtered and washed with water. The solid was dissolved in EtOAc and dried with Na<sub>2</sub>SO<sub>4</sub>. The EtOAc layer was filtered and concentrated to give the crude product (3.61 g, 91%) as a brown solid. MS (ESI) (<i>m</i>/<i>z</i>): 301.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.67–8.53 (s, 1H), 8.15 (d, <i>J</i> = 0.8 Hz, 1H), 7.90 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 7.50 (d, <i>J</i> = 8.5 Hz, 1H), 7.46 (d, <i>J</i> = 2.8 Hz, 1H), 3.96 (s, 3H).</div></div><div id="sec5_9_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Methyl 3-Iodo-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>75</b>)</h4><div class="NLM_p last">Potassium carbonate (2.085 g, 15.09 mmol) was added to the DMF (10 mL) solution of methyl 3-iodo-1<i>H</i>-indole-6-carboxylate (<b>74</b>, 1.514 g, 5.03 mmol) at rt. The mixture was stirred at rt for 30 min. Methyl iodide (0.38 mL, 6.03 mmol) was added to the reaction mixture, and the reaction was stirred for 2 h at rt. The reaction mixture was diluted with water and extracted three times with diethyl ether. The diethyl ether layer was combined, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to the desired product (1.410 g, 89%), MS (ESI) (<i>m</i>/<i>z</i>): 300.0 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06 (d, <i>J</i> = 0.8 Hz, 1H), 7.87 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 7.45 (d, <i>J</i> = 8.0 Hz, 1H), 7.27 (s, 1H), 3.96 (s, 3H), 3.86 (s, 3H).</div></div><div id="sec5_9_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Methyl 1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indole-6-carboxylate (<b>76</b>)</h4><div class="NLM_p last">Tetrakis(triphenylphosphine)palladium (0) (0.076 g, 0.065 mmol) and methyl 3-iodo-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>75</b>, 0.688 g, 2.18 mmol) in dioxane (7.5 mL) in a pressure vial underwent vacuum/N<sub>2</sub> fill for three times. TEA (3.04 mL, 21.83 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.475 mL, 3.27 mmol) were added to the reaction mixture slowly (bubbling generation observed), and the reaction was heated at 80 °C for 2 h. The reaction was cooled to room temperature. Methanol (0.5 mL) was added to the reaction mixture (violent gas evolution observed). The volatile was removed via vacuum, and the crude was purified by flash column eluted with EtOAc in hexane from 0 to 25% to give the desired product (0.555 g, 81%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (d, <i>J</i> = 0.8 Hz, 1H), 8.03 (dd, <i>J</i> = 8.3, 0.5 Hz, 1H), 7.87 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 7.66 (s, 1H), 3.96 (s, 3H), 3.87 (s, 3H), 1.38 (s, 12H).</div></div><div id="sec5_9_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Methyl 3-(4-Isobutoxyphenyl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>77a</b>)</h4><div class="NLM_p last">The mixture of sodium carbonate (2.0 M, 0.104 mL, 0.208 mmol), PdCl<sub>2</sub>(dppf) (6.3 mg, 8.7 μmol), 1-bromo-4-isobutoxybenzene (0.083 g, 0.362 mmol), and methyl 1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indole-6-carboxylate (<b>76</b>, 0.055 g, 0.173 mmol) in dioxane (1 mL) was heated at 80 °C for 12 h. The reaction was diluted with EtOAc and washed with water three times. The EtOAc layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to the crude product (25.8 mg, 31%). MS (ESI) (<i>m</i>/<i>z</i>): 338.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Methyl 3-(4-(Difluoromethyl)phenyl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>77b</b>)</h4><div class="NLM_p last">Tetrakis(triphenylphosphine)palladium (0) (0.013 g, 10.97 μmol) and methyl 3-iodo-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>75</b>, 0.115 g, 0.366 mmol) in dioxane (2.5 mL) in a pressure vial underwent vacuum/N<sub>2</sub> fill for three times. TEA (0.510 mL, 3.66 mmol) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.080 mL, 0.548 mmol) were added to the reaction mixture slowly (bubbling observed). The reaction was heated at 80 °C for 2 h. The reaction was cooled to rt. Methanol (1.5 mL) was added to the reaction mixture (violate gas evolution observed). 1-Bromo-4-(difluoromethyl)benzene (0.123 g, 0.595 mmol) and cesium carbonate (0.298 g, 0.914 mmol) was added to the reaction mixture. The reaction was heated at 80 °C for 4 h. The reaction mixture was filtered and washed with EtOAc. The filtrate was concentrated, and the residue was purified by flash column eluted with EtOAc in hexane from 0 to 25% to 40% to give the desired product (72.8 mg, 63%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.15 (s, 1H), 7.95–7.87 (m, 2H), 7.71 (d, <i>J</i> = 8.3 Hz, 2H), 7.58 (d, <i>J</i> = 8.3 Hz, 2H), 7.40 (s, 1H), 6.71 (t, <i>J</i> = 56.0 Hz, 1H), 3.98 (s, 3H), 3.89 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −109.86 (s, 2F).</div></div><div id="sec5_9_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Methyl 1-Methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxylate (<b>77c</b>)</h4><div class="NLM_p last">Prepared from <b>75</b> using the procedures described for <b>77b</b> (67.0 mg, 60%), MS (ESI) (<i>m</i>/<i>z</i>): 334.0 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1H), 7.95–7.88 (m, 2H), 7.78–7.68 (m, 4H), 7.46 (s, 1H), 3.99 (s, 3H), 3.94 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.31 (s, 3F).</div></div><div id="sec5_9_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 3-(4-Isobutoxyphenyl)-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>78a</b>)</h4><div class="NLM_p last">The mixture of LiOH (9.2 mg, 0.384 mmol) and methyl 3-(4-isobutoxyphenyl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>77a</b>, 0.026 g, 0.076 mmol) in THF (0.5 mL), water (0.2 mL), and MeOH (0.2 mL) was stirred at rt for 40 h. The volatile was removed via vacuum. The crude was added 1 N HCl (0.5 mL) and extracted with EtOAc twice. The EtOAc layer was combined, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the crude product as a brown solid (21.7 mg, 88%). MS (ESI) (<i>m</i>/<i>z</i>): 324.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 3-(4-(Difluoromethyl)phenyl)-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>78b</b>)</h4><div class="NLM_p last">Prepared from <b>77b</b> using the procedures described for <b>78a</b> (62.0 mg, 90%), MS (ESI) (<i>m</i>/<i>z</i>): 300.1 (M – H)<sup>+</sup>.</div></div><div id="sec5_9_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 1-Methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxylic Acid (<b>78c</b>)</h4><div class="NLM_p last">Prepared from <b>77c</b> using the procedures described for <b>78a</b> (64.2 mg, 100%), MS (ESI) (<i>m</i>/<i>z</i>): 318.1 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.15 (s, 1H), 8.09 (s, 1H), 7.99 (d, <i>J</i> = 8.4 Hz, 1H), 7.92 (d, <i>J</i> = 8.1 Hz, 2H), 7.81–7.77 (m, 3H), 3.94 (s, 3H).</div></div><div id="sec5_9_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 1-Bromo-4-isobutoxybenzene (<b>80</b>)</h4><div class="NLM_p last">DIAD (1.911 mL, 9.83 mmol) was added dropwise to the THF (30 mL) solution of triphenylphosphine (2.58 g, 9.83 mmol), 4-bromophenol (<b>79</b>, 1.546 g, 8.93 mmol), and 2-methylpropan-1-ol (0.795 g, 10.72 mmol) at 0 °C. The reaction was stirred for 2 h, and the volatile was removed via vacuum. The crude was purified by flash column eluted with EtOAc in hexane from 0 to 25%. The product was eluted out at solvent front as a clear oil (810 mg, 40%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.40–7.34 (m, 2H), 6.81–6.76 (m, 2H), 3.69 (d, <i>J</i> = 6.5 Hz, 2H), 2.14–2.02 (m, 1H), 1.03 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec5_9_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> (<i>E</i>)-Methyl 4-(2-(Dimethylamino)vinyl)-2-fluoro-5-nitrobenzoate (<b>83</b>)</h4><div class="NLM_p last">In a 250 mL round-bottomed flask was methyl 2-fluoro-4-methyl-5-nitrobenzoate (<b>81</b>, 2.57 g, 12.06 mmol) in DMF (10 mL) to give a colorless solution. 1,1-Dimethoxy-N,<i>N</i>-dimethylmethanamine (<b>82</b>, 1.94 mL, 14.47 mmol) was added. The mixture was stirred under nitrogen at 100 °C for 1 h. After heating for another hour, the mixture was diluted with water. The solids were filtered and dried to obtain the desired product (2.77 g, 86%) as a red solid. MS (ESI) (<i>m</i>/<i>z</i>): 269.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Methyl 5-Fluoro-1<i>H</i>-indole-6-carboxylate (<b>84</b>)</h4><div class="NLM_p last">In a 500 mL round-bottomed flask was (<i>E</i>)-methyl 4-(2-(dimethylamino)vinyl)-2-fluoro-5-nitrobenzoate (<b>83</b>, 2.77 g, 10.33 mmol) in EtOAc (100 mL) to give a red solution. Pd/C (0.110 g, 0.103 mmol) was added. After vacuum and refill, the mixture was stirred under hydrogen (balloon) for 2 h (with deep-red color fainted). After vacuum and refilled with nitrogen, the mixture was filtered and rinsed with EtOAc. The combined organic solution was concentrated. The residue was purified by FCC up to 50% EtOAc/hexane to afford the desired product (1.40 g, 70%) as a yellow solid. MS (ESI) (<i>m</i>/<i>z</i>): 192.1 (M – H)<sup>+</sup>.</div></div><div id="sec5_9_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Methyl 5-Fluoro-3-iodo-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>85</b>)</h4><div class="NLM_p last">The mixture of KOH (0.651 g, 11.60 mmol) and methyl 5-fluoro-1<i>H</i>-indole-6-carboxylate (<b>84</b>, 0.896 g, 4.64 mmol) in DMF (10 mL) was stirred at rt for 30 min. Iodine (1.177 g, 4.64 mmol) in DMF (5 mL) was added to the reaction mixture at rt. The reaction was continue to stir overnight for 16 h. LCMS showed the desired intermediate as the major peak. MS (ESI) (<i>m</i>/<i>z</i>): 318.0 (M – H)<sup>+</sup>. MeI (0.348 mL, 5.57 mmol) was added. The mixture was stirred at rt for 5 h. Excess water was added, and the solids were filtered and further rinsed with water. The solids were further dried overnight to afford the desired product (1.32 g, 85%) as a yellow solid. MS (ESI) (<i>m</i>/<i>z</i>): 334.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98 (d, <i>J</i> = 5.7 Hz, 1H), 7.32 (s, 1H), 7.18 (d, <i>J</i> = 11.3 Hz, 1H), 3.99 (s, 3H), 3.88 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −121.09.</div></div><div id="sec5_9_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> Methyl 5-Fluoro-1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indole-6-carboxylate (<b>86</b>)</h4><div class="NLM_p last">Prepared from <b>85</b> using the procedures described for <b>76</b>. The crude material was divided and used as is.</div></div><div id="sec5_9_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Methyl 5-Fluoro-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxylate (<b>87a</b>)</h4><div class="NLM_p last">In a 5 mL vial was 1-bromo-4-(trifluoromethyl)benzene (68.5 mg, 0.305 mmol) and cesium carbonate (248 mg, 0.761 mmol) under nitrogen. Methyl 5-fluoro-1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indole-6-carboxylate (<b>86</b>, 101 mg, 0.305 mmol) in dioxane (2 mL) was added. The vial was sealed and heated at 80 °C for 5 h. Volatiles were stripped off, and the residue was directly loaded onto a 24 g flash column. FCC purification up to 50% EtOAc/hexane afforded the desired product (72.9 mg, 68% for two steps) as a white solid. MS (ESI) (<i>m</i>/<i>z</i>): 351.9 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04 (d, <i>J</i> = 5.8 Hz, 1H), 7.71 (s, 4H), 7.61 (d, <i>J</i> = 12.0 Hz, 1H), 7.49 (s, 1H), 4.01 (s, 3H), 3.93 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.35, −121.02.</div></div><div id="sec5_9_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> Methyl 3-(4-(Difluoromethyl)phenyl)-5-fluoro-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>87b</b>)</h4><div class="NLM_p last">Prepared from <b>86</b> using the procedures described for <b>87a</b> as a white solid (70.0 mg, 69% for two steps), MS (ESI) (<i>m</i>/<i>z</i>): 334.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (d, <i>J</i> = 6.0 Hz, 1H), 7.68 (d, <i>J</i> = 8.1 Hz, 2H), 7.65–7.58 (m, 3H), 7.47 (s, 1H), 6.71 (t, <i>J</i> = 56.6 Hz, 1H), 4.00 (s, 3H), 3.92 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −110.06, −121.29.</div></div><div id="sec5_9_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 5-Fluoro-1-Methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indole-6-carboxylic Acid (<b>88a</b>)</h4><div class="NLM_p last">Prepared from <b>87a</b> using the procedures described for <b>78a</b> as a light-tan solid (70.0 mg, 100%). MS (ESI) (<i>m</i>/<i>z</i>): 337.2 (M – H)<sup>+</sup>.</div></div><div id="sec5_9_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 3-(4-(Difluoromethyl)phenyl)-5-fluoro-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>88b</b>)</h4><div class="NLM_p last">Prepared from <b>87b</b> using the procedures described for <b>78a</b> as a light-tan solid (67.1 mg, 100%). MS (ESI) (<i>m</i>/<i>z</i>): 320.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Methyl 1-Methyl-3-(pyridin-3-yl)-1<i>H</i>-indole-6-carboxylate (<b>89a</b>)</h4><div class="NLM_p last">Prepared from <b>76</b> using the procedures described for <b>77a</b> as a light-tan solid (33.4 mg, 22%). MS (ESI) (<i>m</i>/<i>z</i>): 267.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Methyl 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>89b</b>)</h4><div class="NLM_p last">Prepared from <b>75</b> using the procedures described for <b>77b</b> as a light-tan solid (356.2 mg, 51%). MS (ESI) (<i>m</i>/<i>z</i>): 373.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> Methyl 3-(6-Isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>89c</b>)</h4><div class="NLM_p last">Prepared from <b>76</b> using the procedures described for <b>77a</b> as a light-tan solid (22.8 mg, 40%). MS (ESI) (<i>m</i>/<i>z</i>): 339.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (dd, <i>J</i> = 2.5, 0.5 Hz, 1H), 8.16 (d, <i>J</i> = 0.8 Hz, 1H), 7.90–7.80 (m, 3H), 7.33 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 0.8 Hz, 1H), 4.13 (d, <i>J</i> = 6.8 Hz, 2H), 3.98 (s, 3H), 3.93 (s, 3H), 2.14 (dt, <i>J</i> = 13.5, 6.7 Hz, 1H), 1.06 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec5_9_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> Methyl 3-(5-Chloro-6-(cyclopropylmethoxy)pyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>89d</b>)</h4><div class="NLM_p last">Prepared from <b>75</b> using the procedures described for <b>77b</b> as a light-tan solid (159.0 mg, 36%). MS (ESI) (<i>m</i>/<i>z</i>): 371.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (d, <i>J</i> = 2.0 Hz, 1H), 8.15 (d, <i>J</i> = 0.8 Hz, 1H), 7.90–7.79 (m, 3H), 7.33 (s, 1H), 4.29 (d, <i>J</i> = 7.0 Hz, 2H), 3.98 (s, 3H), 3.91 (s, 3H), 1.45–1.34 (m, 1H), 0.69–0.62 (m, 2H), 0.46–0.40 (m, 2H).</div></div><div id="sec5_9_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> Methyl 3-(6-Isobutoxy-5-methoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>89e</b>)</h4><div class="NLM_p last">Prepared from <b>75</b> using the procedures described for <b>77b</b> as a light-tan solid (24.6 mg, 38%). MS (ESI) (<i>m</i>/<i>z</i>): 369.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16 (s, 1H), 7.98 (d, <i>J</i> = 2.0 Hz, 1H), 7.90–7.83 (m, 2H), 7.35 (s, 1H), 7.30 (d, <i>J</i> = 2.0 Hz, 1H), 4.22 (d, <i>J</i> = 7.0 Hz, 2H), 3.98 (s, 3H), 3.94 (d, <i>J</i> = 6.5 Hz, 6H), 2.24 (dt, <i>J</i> = 13.6, 6.8 Hz, 1H), 1.07 (d, <i>J</i> = 6.5 Hz, 6H).</div></div><div id="sec5_9_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> Methyl 3-(5-Chloro-6-(2-hydroxy-2-methylpropoxy)pyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>89f</b>)</h4><div class="NLM_p last">Prepared from <b>75</b> and <b>97</b> using the procedures described for <b>77b</b> (64.8 mg, 34%). MS (ESI) (<i>m</i>/<i>z</i>): 389.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 1-Methyl-3-(pyridin-3-yl)-1<i>H</i>-indole-6-carboxylic Acid (<b>90a</b>)</h4><div class="NLM_p last">Prepared from <b>89a</b> using the procedures described for <b>78a</b> as a light-tan solid (16.8 mg, 34%). MS (ESI) (<i>m</i>/<i>z</i>): 253.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>90b</b>)</h4><div class="NLM_p last">Prepared from <b>89b</b> using the procedures described for <b>78a</b> as an off-white solid (582 mg, 89%). MS (ESI) (<i>m</i>/<i>z</i>): 359.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (d, <i>J</i> = 2.1 Hz, 1H), 8.14 (d, <i>J</i> = 1.8 Hz, 2H), 7.99 (s, 1H), 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.75 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 4.18 (d, <i>J</i> = 6.7 Hz, 2H), 3.92 (s, 3H), 2.10 (dt, <i>J</i> = 13.4, 6.6 Hz, 1H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 3-(6-Isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>90c</b>)</h4><div class="NLM_p last">Prepared from <b>89c</b> using the procedures described for <b>78a</b> as an off-white solid (18.5 mg, 85%). MS (ESI) (<i>m</i>/<i>z</i>): 323.3 (M – H)<sup>+</sup>.</div></div><div id="sec5_9_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> 3-(5-Chloro-6-(cyclopropylmethoxy)pyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>90d</b>)</h4><div class="NLM_p last">Prepared from <b>89d</b> using the procedures described for <b>78a</b> as an off-white solid (151.4 mg, 99%). MS (ESI) (<i>m</i>/<i>z</i>): 357.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> 3-(6-Isobutoxy-5-methoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>90e</b>)</h4><div class="NLM_p last">Prepared from <b>89e</b> using the procedures described for <b>78a</b> (25.0 mg, 61%). MS (ESI) (<i>m</i>/<i>z</i>): 355.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> 3-(5-Chloro-6-(2-hydroxy-2-methylpropoxy)pyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>90f</b>)</h4><div class="NLM_p last">Prepared from <b>89f</b> using the procedures described for <b>78a</b> (55.4 mg, 89%). MS (ESI) (<i>m</i>/<i>z</i>): 375.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (s, 1H), 8.05 (s, 1H), 7.99 (d, <i>J</i> = 2.1 Hz, 1H), 7.87 (d, <i>J</i> = 8.5 Hz, 1H), 7.84 (s, 1H), 7.73 (d, <i>J</i> = 8.2 Hz, 1H), 4.85 (s, 1H), 4.11 (s, 2H), 3.90 (s, 3H), 1.17 (s, 6H).</div></div><div id="sec5_9_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> 5-Bromo-3-chloro-2-isobutoxypyridine (<b>92</b>)</h4><div class="NLM_p last">The mixture of cesium carbonate (5.31 g, 16.29 mmol), 5-bromo-3-chloro-2-fluoropyridine (<b>91</b>, 2.857 g, 13.6 mmol), and 2-methylpropan-1-ol (2.012 g, 27.1 mmol) in DMSO (10 mL) was stirred at 90 °C for 10 h. The reaction was diluted with water and extracted with diethyl ether three times. The diethyl ether layer was combined, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified by FCC to afford the desired product (3.26 g, 91%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (d, <i>J</i> = 2.2 Hz, 1H), 7.76 (d, <i>J</i> = 2.2 Hz, 1H), 4.14 (d, <i>J</i> = 6.8 Hz, 2H), 2.15 (dquin, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.05 (d, <i>J</i> = 6.6 Hz, 6H).</div></div><div id="sec5_9_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 1-((5-Bromo-3-chloropyridin-2-yl)oxy)-2-methylpropan-2-ol (<b>94</b>)</h4><div class="NLM_p last">The mixture of potassium carbonate (0.340 g, 2.461 mmol), 5-bromo-3-chloropyridin-2-ol (<b>93</b>, 0.513 g, 2.461 mmol), and 2,2-dimethyloxirane (0.202 g, 2.80 mmol) in 2-butanone (5 mL) was heated at 80 °C for 5 h. The reaction was continued at this temperature for 16 h. The reaction was diluted with EtOAc and washed with water three times. The EtOAc layer was separated, filtered, and concentrated. Flash column eluted with EtOAc in hexane from 0 to 50% and gave the desired product (130.0 mg, 19%). MS (ESI) (<i>m</i>/<i>z</i>): 280.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.64 (d, <i>J</i> = 2.5 Hz, 1H), 7.54 (d, <i>J</i> = 2.5 Hz, 1H), 4.06 (s, 2H), 2.78 (br s, 1H), 1.29 (s, 6H).</div></div><div id="sec5_9_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 3-Chloro-2-(2,2-difluoroethoxy)pyridine (<b>96a</b>)</h4><div class="NLM_p last">The mixture of cesium carbonate (1.918 g, 5.89 mmol), 3-chloro-2-fluoropyridine (<b>95</b>, 0.774 g, 5.89 mmol), and 2,2-difluoroethanol (0.966 g, 11.77 mmol) in DMSO (3 mL) was stirred at 80 °C for 18 h. The reaction was diluted with EtOAc and washed three times with water. The EtOAc layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude residue was purified by flash column eluted with ethyl acetate in hexane from 0 to 10% to afford the desired product (0.79 g, 69%). MS (ESI) (<i>m</i>/<i>z</i>): 194.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (dd, <i>J</i> = 4.9, 1.6 Hz, 1H), 7.68 (dd, <i>J</i> = 7.7, 1.6 Hz, 1H), 6.93 (dd, <i>J</i> = 7.7, 4.9 Hz, 1H), 6.35–6.03 (m, 1H), 4.62 (td, <i>J</i> = 13.3, 4.3 Hz, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −125.54 (s, 2F).</div></div><div id="sec5_9_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> 3-Chloro-2-(2,2,2-trifluoroethoxy)pyridine (<b>96b</b>)</h4><div class="NLM_p last">Prepared from <b>95</b> using the procedures described for <b>96a</b> (214.5 mg, 12%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (dd, <i>J</i> = 4.9, 1.6 Hz, 1H), 7.71 (dd, <i>J</i> = 7.7, 1.6 Hz, 1H), 6.96 (dd, <i>J</i> = 7.7, 4.9 Hz, 1H), 4.84 (q, <i>J</i> = 8.5 Hz, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −73.78 (s, 3F).</div></div><div id="sec5_9_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> 3-Chloro-2-(2,2-difluoroethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (<b>97a</b>)</h4><div class="NLM_p last">The mixture of (1,5-cyclooctadiene)(methoxy)iridium(i) dimer (0.081 g, 0.122 mmol), bis(pinacolato)diboron (1.239 g, 4.88 mmol), 3-chloro-2-(2,2-difluoroethoxy)pyridine (<b>96a</b>, 0.787 g, 4.06 mmol), and 4,4′-di-<i>tert</i>-butyl-2,2′-bipyridine (0.033 g, 0.122 mmol) in <i>tert</i>-butylmethyl ether (12 mL) underwent vacuum/N<sub>2</sub> fill cycle four times. The reaction was heated at 80 °C for 0.5 h. The solvent was removed via vacuum, and the crude was purified by flash column eluted with EtOAc in hexane from 0 to 30% to afford the desired product (0.41 g, 32%). MS (ESI) (<i>m</i>/<i>z</i>): 320.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 1.5 Hz, 1H), 8.02 (d, <i>J</i> = 1.5 Hz, 1H), 6.35–6.01 (m, 1H), 4.64 (td, <i>J</i> = 13.2, 4.1 Hz, 2H), 1.36–1.33 (m, 12H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −125.53 (s, 2F).</div></div><div id="sec5_9_104" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> 3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethoxy)pyridine (<b>97b</b>)</h4><div class="NLM_p last">Prepared from <b>96b</b> using the procedures described for <b>97a</b> (133.0 mg, 39%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 1.8 Hz, 1H), 8.05 (d, <i>J</i> = 1.5 Hz, 1H), 4.86 (q, <i>J</i> = 8.4 Hz, 2H), 1.35 (s, 12H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −73.74 (s, 3F).</div></div><div id="sec5_9_105" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> Methyl 3-(5-Chloro-6-isobutoxypyridin-3-yl)-5-fluoro-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>98a</b>)</h4><div class="NLM_p last">Prepared from <b>86</b> using the procedures described for <b>87a</b> as light-tan solid (56.0 mg, 47% for two steps), MS (ESI) (<i>m</i>/<i>z</i>): 391.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (d, <i>J</i> = 2.1 Hz, 1H), 8.01 (d, <i>J</i> = 5.8 Hz, 1H), 7.82 (d, <i>J</i> = 2.2 Hz, 1H), 7.49 (d, <i>J</i> = 11.8 Hz, 1H), 7.36 (s, 1H), 4.21 (d, <i>J</i> = 6.7 Hz, 2H), 3.99 (s, 3H), 3.90 (s, 3H), 2.20 (hept, <i>J</i> = 6.7 Hz, 1H), 1.09 (d, <i>J</i> = 6.7 Hz, 6H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −121.23.</div></div><div id="sec5_9_106" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> Methyl 5-Fluoro-3-(6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylate (<b>98b</b>)</h4><div class="NLM_p last">Prepared from <b>86</b> using the procedures described for <b>87a</b> as light-tan solid (65.5 mg, 60% for two steps). MS (ESI) (<i>m</i>/<i>z</i>): 357.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39–8.34 (m, 1H), 8.01 (d, <i>J</i> = 5.8 Hz, 1H), 7.77 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 7.50 (d, <i>J</i> = 12.0 Hz, 1H), 7.35 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 0.7 Hz, 1H), 4.13 (d, <i>J</i> = 6.7 Hz, 2H), 3.99 (s, 3H), 3.90 (s, 3H), 2.15 (hept, <i>J</i> = 6.7 Hz, 1H), 1.07 (d, <i>J</i> = 6.7 Hz, 6H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −121.69.</div></div><div id="sec5_9_107" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-5-fluoro-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>99a</b>)</h4><div class="NLM_p last">Prepared from <b>98a</b> using the procedures described for <b>78a</b> as a light-yellow solid (57 mg, 100%). MS (ESI) (<i>m</i>/<i>z</i>): 375.1 (M – H)<sup>+</sup>.</div></div><div id="sec5_9_108" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> 5-Fluoro-3-(6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indole-6-carboxylic Acid (<b>99b</b>)</h4><div class="NLM_p last">Prepared from <b>98a</b> using the procedures described for <b>78a</b> as a light-yellow solid (65 mg, 100%). MS (ESI) (<i>m</i>/<i>z</i>): 343.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_109" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> Methyl 3-Bromo-1-isopropyl-1<i>H</i>-indole-6-carboxylate (<b>100a</b>)</h4><div class="NLM_p last">Prepared from <b>70</b> using the procedures described for <b>71</b> as a white solid (342 mg, 46%). MS (ESI) (<i>m</i>/<i>z</i>): 298.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16 (s, 1H), 7.87 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 7.58 (dd, <i>J</i> = 8.5, 0.5 Hz, 1H), 7.39 (s, 1H), 4.78 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 3.97 (s, 3H), 1.55 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec5_9_110" class="NLM_sec NLM_sec_level_3"><div id="ac_i142" class="anchor-spacer"></div><h4 class="article-section__title" id="_i142"> Methyl 3-Bromo-1-isobutyl-1<i>H</i>-indole-6-carboxylate (<b>100b</b>)</h4><div class="NLM_p last">Prepared from <b>70</b> using the procedures described for <b>71</b> as an off-white solid (318.7 mg, 44%). MS (ESI) (<i>m</i>/<i>z</i>): 312.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.09 (d, <i>J</i> = 0.5 Hz, 1H), 7.86 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 7.60–7.57 (m, 1H), 7.25 (s, 1H), 3.96 (s, 3H), 3.95 (d, <i>J</i> = 7.3 Hz, 2H), 2.20 (dt, <i>J</i> = 13.6, 7.0 Hz, 1H), 0.94 (d, <i>J</i> = 6.5 Hz, 6H).</div></div><div id="sec5_9_111" class="NLM_sec NLM_sec_level_3"><div id="ac_i143" class="anchor-spacer"></div><h4 class="article-section__title" id="_i143"> Methyl 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-isopropyl-1<i>H</i>-indole-6-carboxylate (<b>101a</b>)</h4><div class="NLM_p last">Prepared from <b>100a</b> using the procedures described for <b>77a</b> (58.9 mg, 13%). MS (ESI) (<i>m</i>/<i>z</i>): 401.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (d, <i>J</i> = 2.0 Hz, 1H), 8.22 (s, 1H), 7.90–7.86 (m, 2H), 7.84–7.81 (m, 1H), 7.49 (s, 1H), 4.90–4.74 (m, 1H), 4.21 (d, <i>J</i> = 6.8 Hz, 2H), 3.98 (s, 3H), 2.20 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.61 (d, <i>J</i> = 6.8 Hz, 6H), 1.09 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec5_9_112" class="NLM_sec NLM_sec_level_3"><div id="ac_i144" class="anchor-spacer"></div><h4 class="article-section__title" id="_i144"> Methyl 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-isobutyl-1<i>H</i>-indole-6-carboxylate (<b>101b</b>)</h4><div class="NLM_p last">Prepared from <b>100b</b> using the procedures described for <b>77</b> as a colorless oil (47.0 mg, 23%). MS (ESI) (<i>m</i>/<i>z</i>): 415.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (d, <i>J</i> = 0.5 Hz, 1H), 7.90–7.81 (m, 3H), 7.36 (s, 1H), 4.21 (d, <i>J</i> = 6.8 Hz, 2H), 4.03 (d, <i>J</i> = 7.5 Hz, 2H), 3.98 (s, 3H), 2.28 (dt, <i>J</i> = 13.5, 6.7 Hz, 1H), 2.19 (dt, <i>J</i> = 13.5, 6.7 Hz, 1H), 1.08 (d, <i>J</i> = 6.8 Hz, 6H), 0.99 (d, <i>J</i> = 6.5 Hz, 6H).</div></div><div id="sec5_9_113" class="NLM_sec NLM_sec_level_3"><div id="ac_i145" class="anchor-spacer"></div><h4 class="article-section__title" id="_i145"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-isopropyl-1<i>H</i>-indole-6-carboxylic Acid (<b>102a</b>)</h4><div class="NLM_p last">Prepared from <b>101a</b> using the procedures described for <b>78a</b> (54.0 mg, 73%). MS (ESI) (<i>m</i>/<i>z</i>): 387.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.45–8.42 (m, 1H), 8.18 (s, 1H), 8.17–8.14 (m, 1H), 8.11–8.09 (m, 1H), 7.87 (d, <i>J</i> = 8.5 Hz, 1H), 7.75 (d, <i>J</i> = 8.2 Hz, 1H), 4.93–4.85 (m, 1H), 4.18 (d, <i>J</i> = 6.4 Hz, 2H), 2.14–2.03 (m, 1H), 1.54 (d, <i>J</i> = 6.7 Hz, 6H), 1.01 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_114" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-isobutyl-1<i>H</i>-indole-6-carboxylic Acid (<b>102b</b>)</h4><div class="NLM_p last">Prepared from <b>101b</b> using the procedures described for <b>78a</b> as an off-white solid (45.2 mg, 100%). MS (ESI) (<i>m</i>/<i>z</i>): 401.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_115" class="NLM_sec NLM_sec_level_3"><div id="ac_i147" class="anchor-spacer"></div><h4 class="article-section__title" id="_i147"> 6-Bromo-3-iodo-2-methyl-1<i>H</i>-indazole (<b>104</b>) and 6-Bromo-3-iodo-1-methyl-2<i>H</i>-indazole (<b>105</b>)</h4><div class="NLM_p last">Potassium carbonate (1.146 g, 8.29 mmol) was added to the DMF (20 mL) solution of 6-bromo-3-iodo-1<i>H</i>-indazole (<b>103</b>, 2.231 g, 6.91 mmol) at room temperature. The mixture was stirred at rt for 30 min. Methyl iodide (0.52 mL, 8.29 mmol) was added to the reaction mixture, and the reaction was stirred 72 h at rt. The reaction was diluted with water and extracted three times by diethyl ether. The diethyl ether layer was combined, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The products were separated by flash column eluted with EtOAc in hexane from 0 to 25% to 40%. <b>104</b>: (0.331 g, 14%, yellow solid and more polar). MS (ESI) (<i>m</i>/<i>z</i>): 336.8 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86–7.83 (m, 1H), 7.28–7.24 (m, 1H), 7.21–7.17 (m, 1H), 4.23 (s, 3H). <b>105</b>: (1.115 g, 48%, yellow solid and less polar). MS (ESI) (<i>m</i>/<i>z</i>): 336.8 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.58 (d, <i>J</i> = 0.8 Hz, 1H), 7.37–7.29 (m, 2H), 4.07 (s, 3H).</div></div><div id="sec5_9_116" class="NLM_sec NLM_sec_level_3"><div id="ac_i148" class="anchor-spacer"></div><h4 class="article-section__title" id="_i148"> 6-Bromo-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indazole (<b>106</b>)</h4><div class="NLM_p last">The mixture of sodium carbonate (0.064 mL, 0.128 mmol), PdCl<sub>2</sub>(dppf) (2.3 mg, 3.19 μmol), (4-(trifluoromethyl)phenyl)boronic acid (14.5 mg, 0.077 mmol), and 6-bromo-3-iodo-1-methyl-1<i>H</i>-indazole (<b>105</b>, 21.5 mg, 0.064 mmol) in dioxane (0.5 mL) was heated at 80 °C for 1 h. The reaction was diluted with EtOAc, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The product was purified by flash column eluted with EtOAc in hexane from 0 to 10% (11.2 mg, 49%). MS (ESI) (<i>m</i>/<i>z</i>): 355.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (d, <i>J</i> = 8.0 Hz, 2H), 7.86 (d, <i>J</i> = 8.8 Hz, 1H), 7.76 (d, <i>J</i> = 8.0 Hz, 2H), 7.65 (d, <i>J</i> = 1.0 Hz, 1H), 7.36 (dd, <i>J</i> = 8.8, 1.5 Hz, 1H), 4.12 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.55 (s, 3F).</div></div><div id="sec5_9_117" class="NLM_sec NLM_sec_level_3"><div id="ac_i149" class="anchor-spacer"></div><h4 class="article-section__title" id="_i149"> Methyl 3-Bromo-2-methyl-2<i>H</i>-indazole-6-carboxylate (<b>108</b>) and Methyl 3-Bromo-1-methyl-1<i>H</i>-indazole-6-carboxylate (<b>109</b>)</h4><div class="NLM_p last">Sodium hydride (0.152 g, 3.79 mmol) was added to the THF (10 mL) solution of methyl 3-bromo-1<i>H</i>-indazole-6-carboxylate (<b>107</b>, 0.645 g, 2.53 mmol) at 0 °C. The reaction was stirred for 10 min before addition of methyl iodide (0.237 mL, 3.79 mmol) to the reaction mixture. The reaction was stirred overnight while it was warmed up to rt. The solvent was removed via vacuum, and the crude was partitioned between water and EtOAc. The aqueous layer was separated and extracted two more times with EtOAc. The EtOAc layer was combined, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to give the crude products as a mixture. The starting material was mainly remained in aqueous layer. The product was purified by flash column eluted with EtOAc in hexane from 0 to 25%. Two products were isolated and the structure elucidation was carried out by NOE studies. <b>108</b>: (0.121 g, 18%, off-white solid and more polar). MS (ESI) (<i>m</i>/<i>z</i>): 270.9 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.46 (s, 1H), 7.76 (dd, <i>J</i> = 8.9, 1.2 Hz, 1H), 7.55 (dd, <i>J</i> = 8.9, 0.8 Hz, 1H), 4.25 (s, 3H), 3.98 (s, 3H). <b>109</b>: (0.228 mg, 34%, white solid and less polar). MS (ESI) (<i>m</i>/<i>z</i>): 270.9 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 0.8 Hz, 1H), 7.87–7.83 (m, 1H), 7.64 (dd, <i>J</i> = 8.5, 0.8 Hz, 1H), 4.12 (s, 3H), 3.99 (s, 3H).</div></div><div id="sec5_9_118" class="NLM_sec NLM_sec_level_3"><div id="ac_i150" class="anchor-spacer"></div><h4 class="article-section__title" id="_i150"> Methyl 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indazole-6-carboxylate (<b>110</b>)</h4><div class="NLM_p last">Prepared from <b>109</b> using the procedures described for <b>34</b> (36.4 mg, 37%). MS (ESI) (<i>m</i>/<i>z</i>): 374.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_119" class="NLM_sec NLM_sec_level_3"><div id="ac_i151" class="anchor-spacer"></div><h4 class="article-section__title" id="_i151"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indazole-6-carboxylic Acid (<b>111</b>)</h4><div class="NLM_p last">Prepared from <b>110</b> using the procedures described for <b>78a</b> (33.5 mg, 49%). MS (ESI) (<i>m</i>/<i>z</i>): 358.1 (M – H)<sup>+</sup>.</div></div><div id="sec5_9_120" class="NLM_sec NLM_sec_level_3"><div id="ac_i152" class="anchor-spacer"></div><h4 class="article-section__title" id="_i152"> Methyl 3-(5-Chloro-6-isobutoxypyridin-3-yl)-2-methyl-2<i>H</i>-indazole-6-carboxylate (<b>112</b>)</h4><div class="NLM_p last">Prepared from <b>108</b> using the procedures described for <b>34</b> (17.0 mg, 62%). MS (ESI) (<i>m</i>/<i>z</i>): 374.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.51 (t, <i>J</i> = 1.0 Hz, 1H), 8.21 (d, <i>J</i> = 2.3 Hz, 1H), 7.81 (d, <i>J</i> = 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.8, 1.3 Hz, 1H), 7.56 (dd, <i>J</i> = 8.9, 0.9 Hz, 1H), 4.26 (d, <i>J</i> = 6.5 Hz, 2H), 4.22 (s, 3H), 3.97 (s, 3H), 2.22 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.10 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec5_9_121" class="NLM_sec NLM_sec_level_3"><div id="ac_i153" class="anchor-spacer"></div><h4 class="article-section__title" id="_i153"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-2-methyl-2<i>H</i>-indazole-6-carboxylic Acid (<b>113</b>)</h4><div class="NLM_p last">Prepared from <b>112</b> using the procedures described for <b>78a</b> (16.2 mg, 99%). MS (ESI) (<i>m</i>/<i>z</i>): 358.1 (M – H)<sup>+</sup>.</div></div><div id="sec5_9_122" class="NLM_sec NLM_sec_level_3"><div id="ac_i154" class="anchor-spacer"></div><h4 class="article-section__title" id="_i154"> 6-Bromo-3-(6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indazole (<b>114a</b>)</h4><div class="NLM_p last">Prepared from <b>105</b> using the procedures described for <b>106</b> (63.5 mg, 73%). MS (ESI) (<i>m</i>/<i>z</i>): 360.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (d, <i>J</i> = 2.0 Hz, 1H), 8.11 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 7.79 (d, <i>J</i> = 8.5 Hz, 1H), 7.60 (d, <i>J</i> = 1.3 Hz, 1H), 7.31 (dd, <i>J</i> = 8.7, 1.6 Hz, 1H), 6.88 (dd, <i>J</i> = 8.5, 0.5 Hz, 1H), 4.14 (d, <i>J</i> = 6.8 Hz, 2H), 4.08 (s, 3H), 2.14 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.06 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec5_9_123" class="NLM_sec NLM_sec_level_3"><div id="ac_i155" class="anchor-spacer"></div><h4 class="article-section__title" id="_i155"> 6-Bromo-3-(5-chloro-6-isobutoxypyridin-3-yl)-3a,7a-dihydro-1<i>H</i>-indazole (<b>114b</b>)</h4><div class="NLM_p last">Prepared from <b>103</b> using the procedures described for <b>106</b> (79.0 mg, 24%). MS (ESI) (<i>m</i>/<i>z</i>): 382.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_124" class="NLM_sec NLM_sec_level_3"><div id="ac_i156" class="anchor-spacer"></div><h4 class="article-section__title" id="_i156"> 2-Fluoro-4-methyl-5-nitrobenzoic Acid (<b>116</b>)</h4><div class="NLM_p last">In a 250 mL round-bottomed flask was 2-fluoro-4-methylbenzoic acid (<b>115</b>, 4.0 g, 26.0 mmol) dissolved in 40 mL of concentrated sulfuric acid at 0 °C (completely dissolved) was added dropwise a mixture of H<sub>2</sub>SO<sub>4</sub> (1.70 mL, 31.1 mmol) and nitric acid (2.50 mL, 38.9 mmol) (70%). After stirring for 3 h at 0 °C, an excess of ice water was added. The resulting solid was filtered and dried to obtain the desired product (5.18 g, 100%) as a white solid.</div></div><div id="sec5_9_125" class="NLM_sec NLM_sec_level_3"><div id="ac_i157" class="anchor-spacer"></div><h4 class="article-section__title" id="_i157"> Methyl 2-Fluoro-4-methyl-5-nitrobenzoate (<b>117</b>)</h4><div class="NLM_p last">In a 500 mL round-bottomed flask was 2-fluoro-4-methyl-5-nitrobenzoic acid (<b>116</b>, 5.18 g, 26 mmol) in MeOH (40 mL) to give a colorless solution. H<sub>2</sub>SO<sub>4</sub> (7.1 mL, 130 mmol) was slowly added. The reaction was heated to 65 °C overnight for 20 h. The mixture was concentrated, diluted with ice and water, filtered, and rinsed several times with cold water and air-dried overnight to afford the desired product (5.12 g, 92%) as a white solid. MS (ESI) (<i>m</i>/<i>z</i>): 212.1 (M – H)<sup>+</sup>.</div></div><div id="sec5_9_126" class="NLM_sec NLM_sec_level_3"><div id="ac_i158" class="anchor-spacer"></div><h4 class="article-section__title" id="_i158"> Methyl 5-Amino-2-fluoro-4-methylbenzoate (<b>118</b>)</h4><div class="NLM_p last">In a 250 mL round-bottomed flask was methyl 2-fluoro-4-methyl-5-nitrobenzoate (<b>117</b>, 1.38 g, 6.47 mmol) in EtOAc (40 mL) to give a colorless solution. Pd/C (0.069 g, 0.065 mmol) was added. After vacuum and refill, the mixture was stirred under hydrogen (balloon) for 20 h. After vacuum and refilling with nitrogen, the mixture was filtered and rinsed with EtOAc. The combined organic solution was concentrated to the desired product (1.13 g, 95%) as an off-white solid. MS (ESI) (<i>m</i>/<i>z</i>): 184.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_127" class="NLM_sec NLM_sec_level_3"><div id="ac_i159" class="anchor-spacer"></div><h4 class="article-section__title" id="_i159"> Methyl 5-Fluoro-1<i>H</i>-indazole-6-carboxylate (<b>119</b>)</h4><div class="NLM_p last">In a 500 mL round-bottomed flask was methyl 5-amino-2-fluoro-4-methylbenzoate (<b>118</b>, 1.13 g, 6.17 mmol) and potassium acetate (0.061 g, 0.617 mmol) in CHCl<sub>3</sub> (62 mL) to give a colorless suspension. Acetic acid (3.53 mL, 61.7 mmol) was added, and the mixture was cooled to 0 °C. Isoamyl nitrite (1.25 mL, 9.25 mmol) was added dropwise. After stirring for 10 min, the ice bath was removed and the reaction was stirred at rt for 3 h. The reaction was quenched with aqueous ammonia (the color changed to very dark). Layers were carefully separated. Aqueous phase was extracted 4 times with CH<sub>2</sub>Cl<sub>2</sub>. Combined organics were dried and concentrated to a black oil. The crude oil was purified by FCC up to 100% EtOAc to afford the desired product (0.155 g, 13%) as a tan solid. MS (ESI) (<i>m</i>/<i>z</i>): 195.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.65 (s, 1H), 8.18 (dt, <i>J</i> = 5.5, 0.8 Hz, 1H), 8.13 (d, <i>J</i> = 1.1 Hz, 1H), 7.56–7.46 (m, 1H), 4.01 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −121.16.</div></div><div id="sec5_9_128" class="NLM_sec NLM_sec_level_3"><div id="ac_i160" class="anchor-spacer"></div><h4 class="article-section__title" id="_i160"> Methyl 5-Fluoro-3-iodo-1-methyl-1<i>H</i>-indazole-6-carboxylate (<b>120</b>)</h4><div class="NLM_p last">The mixture of KOH (0.134 g, 2.395 mmol) and methyl 5-fluoro-1<i>H</i>-indazole-6-carboxylate (<b>119</b>, 0.155 g, 0.798 mmol) in DMF (2 mL) was stirred at rt for 30 min. Iodine (0.405 g, 1.597 mmol) was added to the reaction mixture at rt. The reaction was continue to stir overnight for 16 h. LCMS showed the desired intermediate as the major peak (M – H = 318.96). MeI (0.100 mL, 1.597 mmol) was added. The mixture was stirred at rt overnight for 20 h. Excess water and EtOAc were added, and the layers were separated. The organic layer was washed with brine, dried, and concentrated. The residue was purified by FCC up to 50% EtOAc/hexane to afford the desired product (the less polar spot, 157.6 mg, 59%) as a tan solid. MS (ESI) (<i>m</i>/<i>z</i>): 334.9 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.02 (d, <i>J</i> = 5.3 Hz, 1H), 7.19 (d, <i>J</i> = 10.2 Hz, 1H), 4.15 (s, 3H), 4.00 (s, 3H). <sup>19</sup>F NMR (470 MHz, CDCl<sub>3</sub>) δ −120.17. The undesired isomer (the more polar spot, 63.6 mg, 24%), MS (ESI) (<i>m</i>/<i>z</i>): 334.9 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.37 (dd, <i>J</i> = 6.2, 0.6 Hz, 1H), 7.11 (dd, <i>J</i> = 10.7, 0.6 Hz, 1H), 4.29 (s, 3H), 3.98 (s, 3H). <sup>19</sup>F NMR (470 MHz, CDCl<sub>3</sub>) δ −120.00. The regiochemistry was proved by NOE studies.</div></div><div id="sec5_9_129" class="NLM_sec NLM_sec_level_3"><div id="ac_i161" class="anchor-spacer"></div><h4 class="article-section__title" id="_i161"> Methyl 5-Fluoro-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indazole-6-carboxylate (<b>121a</b>)</h4><div class="NLM_p last">Prepared from <b>120</b> using the procedures described for <b>106</b> as a white solid (25.8 mg, 91%). MS (ESI) (<i>m</i>/<i>z</i>): 353.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (d, <i>J</i> = 5.5 Hz, 1H), 8.03 (d, <i>J</i> = 8.1 Hz, 2H), 7.77 (d, <i>J</i> = 8.1 Hz, 2H), 7.71 (d, <i>J</i> = 10.9 Hz, 1H), 4.21 (s, 3H), 4.03 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.57, −120.36.</div></div><div id="sec5_9_130" class="NLM_sec NLM_sec_level_3"><div id="ac_i162" class="anchor-spacer"></div><h4 class="article-section__title" id="_i162"> Methyl 5-Fluoro-3-(6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indazole-6-carboxylate (<b>121b</b>)</h4><div class="NLM_p last">Prepared from <b>120</b> using the procedures described for <b>87a</b> (70.4 mg, 97%) as a white solid. MS (ESI) (<i>m</i>/<i>z</i>): 358.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (d, <i>J</i> = 2.4 Hz, 1H), 8.09 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 8.05 (d, <i>J</i> = 5.5 Hz, 1H), 7.64 (d, <i>J</i> = 10.9 Hz, 1H), 6.89 (d, <i>J</i> = 8.6 Hz, 1H), 4.18–4.14 (m, 5H), 4.01 (s, 3H), 2.14 (dp, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.06 (d, <i>J</i> = 6.7 Hz, 6H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −121.10.</div></div><div id="sec5_9_131" class="NLM_sec NLM_sec_level_3"><div id="ac_i163" class="anchor-spacer"></div><h4 class="article-section__title" id="_i163"> 5-Fluoro-1-methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-indazole-6-carboxylic Acid (<b>122a</b>)</h4><div class="NLM_p last">Prepared from <b>121a</b> using the procedures described for <b>78a</b> (24.8 mg, 100%) as a white solid, MS (ESI) (<i>m</i>/<i>z</i>): 339.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_132" class="NLM_sec NLM_sec_level_3"><div id="ac_i164" class="anchor-spacer"></div><h4 class="article-section__title" id="_i164"> 5-Fluoro-3-(6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-indazole-6-carboxylic Acid (<b>122b</b>)</h4><div class="NLM_p last">Prepared from <b>121b</b> using the procedures described for <b>78a</b> (64.7 mg, 96%) as a white solid. MS (ESI) (<i>m</i>/<i>z</i>): 344.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_133" class="NLM_sec NLM_sec_level_3"><div id="ac_i165" class="anchor-spacer"></div><h4 class="article-section__title" id="_i165"> Methyl 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylate (<b>124</b>)</h4><div class="NLM_p last">The mixture of 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylic acid (<b>123</b>, 0.340 g, 2.097 mmol) and sulfuric acid (0.112 mL, 2.097 mmol) in MeOH (7 mL) was heated at 70 °C for 22 h. The solvent was removed via vacuum, and the crude was used as is. A small portion was further purified by p-HPLC. MS (ESI) (<i>m</i>/<i>z</i>): 177.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.07 (br s, 1H), 8.10–8.06 (m, 1H), 8.02–7.98 (m, 1H), 7.83–7.79 (m, 1H), 6.61 (dd, <i>J</i> = 3.5, 2.0 Hz, 1H), 4.09 (s, 3H).</div></div><div id="sec5_9_134" class="NLM_sec NLM_sec_level_3"><div id="ac_i166" class="anchor-spacer"></div><h4 class="article-section__title" id="_i166"> Methyl 3-Iodo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylate (<b>125</b>)</h4><div class="NLM_p last">Potassium hydroxide (0.588 g, 10.49 mmol) and methyl 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylate (<b>124</b>, 0.369 g, 2.097 mmol) in DMF (7.0 mL) was stirred at rt for 1 h. Iodine (0.639 g, 2.52 mmol) was added to the reaction mixture, and the reaction was stirred for another 3 h at rt. The reaction was diluted with water, filtered, and washed with water. The solid was air-dried to give the desired product (478 mg, 75%) as a brown solid. MS (ESI) (<i>m</i>/<i>z</i>): 301.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04 (d, <i>J</i> = 8.3 Hz, 1H), 7.94 (s, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 4.09 (s, 3H).</div></div><div id="sec5_9_135" class="NLM_sec NLM_sec_level_3"><div id="ac_i167" class="anchor-spacer"></div><h4 class="article-section__title" id="_i167"> Methyl 3-Iodo-1-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylate (<b>126</b>)</h4><div class="NLM_p last">Potassium carbonate (0.194 g, 1.401 mmol) was added to the DMF (3 mL) solution of methyl 3-iodo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylate (<b>125</b>, 0.353 g, 1.168 mmol) at rt. The mixture was stirred at rt for 30 min. Methyl iodide (0.15 mL, 2.399 mmol) was added to the reaction mixture, and the reaction was stirred for 18 h at rt. The reaction was diluted with water and extracted with diethyl ether three times. The diethyl ether layer was combined, washed with brine, and dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The product was purified by flash column eluted with EtOAc in hexane from 0 to 50% to afford the desired product (322 mg, 87%) as an off-white solid. MS (ESI) (<i>m</i>/<i>z</i>): 317.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (d, <i>J</i> = 8.3 Hz, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.49 (s, 1H), 4.04 (s, 3H), 4.00 (s, 3H).</div></div><div id="sec5_9_136" class="NLM_sec NLM_sec_level_3"><div id="ac_i168" class="anchor-spacer"></div><h4 class="article-section__title" id="_i168"> Methyl 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylate (<b>127a</b>)</h4><div class="NLM_p last">Prepared from <b>126</b> using the procedures described for <b>87a</b> (45.0 mg, 39%). MS (ESI) (<i>m</i>/<i>z</i>): 374.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.50 (d, <i>J</i> = 2.1 Hz, 1H), 8.48 (d, <i>J</i> = 8.2 Hz, 1H), 8.29 (s, 1H), 8.23 (d, <i>J</i> = 2.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.2 Hz, 1H), 4.17 (d, <i>J</i> = 6.7 Hz, 2H), 3.93 (s, 3H), 3.93 (s, 3H), 2.10 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.01 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_9_137" class="NLM_sec NLM_sec_level_3"><div id="ac_i169" class="anchor-spacer"></div><h4 class="article-section__title" id="_i169"> Methyl 1-Methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylate (<b>127b</b>)</h4><div class="NLM_p last">Prepared from <b>126</b> using the procedures described for <b>106</b> (27.0 mg, 55%). MS (ESI) (<i>m</i>/<i>z</i>): 335.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (d, <i>J</i> = 8.3 Hz, 1H), 8.06 (d, <i>J</i> = 8.0 Hz, 1H), 7.73 (d, <i>J</i> = 2.5 Hz, 4H), 7.66 (s, 1H), 4.07 (s, 3H), 4.06 (s, 3H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.38 (s, 3F).</div></div><div id="sec5_9_138" class="NLM_sec NLM_sec_level_3"><div id="ac_i170" class="anchor-spacer"></div><h4 class="article-section__title" id="_i170"> 3-(5-Chloro-6-isobutoxypyridin-3-yl)-1-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylic Acid (<b>128a</b>)</h4><div class="NLM_p last">Prepared from <b>127a</b> using the procedures described for <b>78a</b> (29.8 mg, 83%). MS (ESI) (<i>m</i>/<i>z</i>): 360.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_139" class="NLM_sec NLM_sec_level_3"><div id="ac_i171" class="anchor-spacer"></div><h4 class="article-section__title" id="_i171"> 1-Methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-6-carboxylic Acid (<b>128b</b>)</h4><div class="NLM_p last">Prepared from <b>127b</b> using the procedures described for <b>78a</b> (25.7 mg, 99%). MS (ESI) (<i>m</i>/<i>z</i>): 321.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_9_140" class="NLM_sec NLM_sec_level_3"><div id="ac_i172" class="anchor-spacer"></div><h4 class="article-section__title" id="_i172"> 6-Bromo-3-iodo-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine (<b>130</b>)</h4><div class="NLM_p last">The mixture of KOH (0.569 g, 10.13 mmol) and 6-bromo-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine (<b>129</b>, 1.551 g, 7.87 mmol) in DMF (15 mL) was stirred at rt for 1 h. Iodine (2.00 g, 7.87 mmol) in DMF (7 mL) was added to the reaction mixture at rt. The reaction was continue to stir for 18 h. The reaction was poured into 200 mL of ice–water, and the solid was filtered and washed with water. The solid was dissolved in EtOAc and dried with Na<sub>2</sub>SO<sub>4</sub>. The EtOAc layer was filtered and concentrated to give the crude product (2.43 g, 96%) as a brown solid. MS (ESI) (<i>m</i>/<i>z</i>): 322.8 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (br s, 1H), 8.43 (d, <i>J</i> = 2.0 Hz, 1H), 8.04 (d, <i>J</i> = 2.0 Hz, 1H), 7.86 (s, 1H).</div></div><div id="sec5_9_141" class="NLM_sec NLM_sec_level_3"><div id="ac_i173" class="anchor-spacer"></div><h4 class="article-section__title" id="_i173"> 6-Bromo-3-iodo-1-methyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine (<b>131</b>)</h4><div class="NLM_p last">Potassium carbonate (1.198 g, 8.67 mmol) was added to the DMF (20 mL) solution of 6-bromo-3-iodo-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine (<b>130</b>, 2.333 g, 7.22 mmol) at rt. The mixture was stirred at rt for 30 min. Methyl iodide (0.542 mL, 8.67 mmol) was added to the reaction mixture, and the reaction was stirred at rt overnight for 18 h. The reaction was diluted with water and filtered. The solid was washed by water and air-dried to afford the desired product (2.33 g, 96%) as a brown solid. MS (ESI) (<i>m</i>/<i>z</i>): 336.8 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.61 (d, <i>J</i> = 1.8 Hz, 1H), 7.34 (d, <i>J</i> = 1.8 Hz, 1H), 6.85 (s, 1H), 3.06 (s, 3H).</div></div><div id="sec5_9_142" class="NLM_sec NLM_sec_level_3"><div id="ac_i174" class="anchor-spacer"></div><h4 class="article-section__title" id="_i174"> Methyl 3-Iodo-1-methyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-6-carboxylate (<b>133</b>)</h4><div class="NLM_p last">The mixture of KOH (1.097 g, 19.56 mmol) and methyl 1-methyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-6-carboxylate (<b>132</b>, 1.24 g, 6.52 mmol) in DMF (15 mL) was stirred at rt. Iodine (3.31 g, 13.04 mmol) in DMF (5 mL) was added to the reaction mixture at rt. The reaction was continue to stir overnight for 16 h. Sodium sulfite solution was added to quench excess iodine, and water was added. Solids were filtered, rinsed with water, and further dried overnight to afford the desired product (1.218 g, 59%) as a tan solid. MS (ESI) (<i>m</i>/<i>z</i>): 316.6 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.79 (s, 1H), 8.21 (s, 1H), 7.35 (s, 1H), 4.07 (s, 3H), 3.93 (s, 3H).</div></div><div id="sec5_9_143" class="NLM_sec NLM_sec_level_3"><div id="ac_i175" class="anchor-spacer"></div><h4 class="article-section__title" id="_i175"> Methyl 1-Methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-6-carboxylate (<b>134</b>)</h4><div class="NLM_p last">Prepared from <b>133</b> using the procedures described for <b>106</b> (5.0 mg, 11%) as a white solid. MS (ESI) (<i>m</i>/<i>z</i>): 335.2 (M + H)<sup>+</sup>. <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>) δ 9.28 (d, <i>J</i> = 0.9 Hz, 1H), 8.31 (d, <i>J</i> = 1.0 Hz, 1H), 7.77 (s, 4H), 7.51 (s, 1H), 4.09 (s, 3H), 3.99 (s, 3H). <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ −62.44.</div></div><div id="sec5_9_144" class="NLM_sec NLM_sec_level_3"><div id="ac_i176" class="anchor-spacer"></div><h4 class="article-section__title" id="_i176"> 1-Methyl-3-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-6-carboxylic Acid (<b>135</b>)</h4><div class="NLM_p last">Prepared from <b>134</b> using the procedures described for <b>78a</b> (25.7 mg, 99%). MS (ESI) (<i>m</i>/<i>z</i>): 321.2 (M + H)<sup>+</sup>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i177"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01550" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01550" class="ext-link">10.1021/acs.jmedchem.8b01550</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01550/suppl_file/jm8b01550_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01550/suppl_file/jm8b01550_si_001.csv">jm8b01550_si_001.csv (4.44 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01550" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guanglin Luo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9465-3330" title="Orcid link">http://orcid.org/0000-0002-9465-3330</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#553220343b32393c3b7b39203a153738267b363a38"><span class="__cf_email__" data-cfemail="7c1b091d121b101512521009133c1e110f521f1311">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ling Chen</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Easton</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Newton</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clotilde Bourin</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Shields</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Mosure</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew G. Soars</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald J. Knox</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele Matchett</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rick L. Pieschl</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debra J. Post-Munson</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuya Wang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Herrington</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Graef</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Newberry</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Digavalli V. Sivarao</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arun Senapati</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda J. Bristow</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas A. Meanwell</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8857-1515" title="Orcid link">http://orcid.org/0000-0002-8857-1515</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorin A. Thompson</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolyn Dzierba</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and
Development, PO Box 4000, Princeton, New Jersey 08543-4000, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i178">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Mr Rick Rampulla and members of the Department of Discovery Synthesis of the Biocon Bristol-Myers Squibb Research Center (BBRC) for scaling up the synthesis of compound <b>89b</b>, which was used in the later large scale synthesis of compound <b>29</b>, and Spectrix chemists for all the final compound purification and characterization.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">EP</td><td class="NLM_def"><p class="first last">electrophysiology</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion</p></td></tr><tr><td class="NLM_term">TGG</td><td class="NLM_def"><p class="first last">trigeminal ganglion</p></td></tr><tr><td class="NLM_term">TTX</td><td class="NLM_def"><p class="first last">tetrodotoxin</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450 enzymes</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">oral administration</p></td></tr><tr><td class="NLM_term">SC</td><td class="NLM_def"><p class="first last">subcutaneous injection</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamic</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">FCC</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i180">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaskin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, P.</span></span> <span> </span><span class="NLM_article-title">The Economic Costs of Pain in the United States</span>. <i>J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1016/j.jpain.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.jpain.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=22607834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BC38nksFahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=715-724&author=D.+J.+Gaskinauthor=P.+Richard&title=The+Economic+Costs+of+Pain+in+the+United+States&doi=10.1016%2Fj.jpain.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The economic costs of pain in the United States</span></div><div class="casAuthors">Gaskin Darrell J; Richard Patrick</div><div class="citationInfo"><span class="NLM_cas:title">The journal of pain : official journal of the American Pain Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">715-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  In 2008, according to the Medical Expenditure Panel Survey (MEPS), about 100 million adults in the United States were affected by chronic pain, including joint pain or arthritis.  Pain is costly to the nation because it requires medical treatment and complicates treatment for other ailments.  Also, pain lowers worker productivity.  Using the 2008 MEPS, we estimated 1) the portion of total U.S. health care costs attributable to pain; and 2) the annual costs of pain associated with lower worker productivity.  We found that the total costs ranged from $560 to $635 billion in 2010 dollars.  The additional health care costs due to pain ranged from $261 to $300 billion.  This represents an increase in annual per person health care costs ranging from $261 to $300 compared to a base of about $4,250 for persons without pain.  The value of lost productivity due to pain ranged from $299 to $335 billion.  We found that the annual cost of pain was greater than the annual costs of heart disease ($309 billion), cancer ($243 billion), and diabetes ($188 billion).  Our estimates are conservative because they do not include costs associated with pain for nursing home residents, children, military personnel, and persons who are incarcerated.  PERSPECTIVE:  This study estimates that the national cost of pain ranges from $560 to $635 billion, larger than the cost of the nation's priority health conditions.  Because of its economic toll on society, the nation should invest in research, education, and training to advocate the successful treatment, management, and prevention of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKaeWU0MjkVr0AGQpJZWpJfW6udTcc2ebU792Lk6qK87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nksFahtw%253D%253D&md5=d42f1179dd6f7c5e7900a6a260bc4747</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DGaskin%26aufirst%3DD.%2BJ.%26aulast%3DRichard%26aufirst%3DP.%26atitle%3DThe%2520Economic%2520Costs%2520of%2520Pain%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Pain%26date%3D2012%26volume%3D13%26spage%3D715%26epage%3D724%26doi%3D10.1016%2Fj.jpain.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodcock, J. A. A.</span></span> <span> </span><span class="NLM_article-title">Difficult Balance – Pain Management, Drug Safety, and the FDA</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">2105</span>– <span class="NLM_lpage">2107</span>, <span class="refDoi"> DOI: 10.1056/NEJMp0908913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1056%2FNEJMp0908913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=19940297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWgsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=2105-2107&author=J.+A.+A.+Woodcock&title=Difficult+Balance+%E2%80%93+Pain+Management%2C+Drug+Safety%2C+and+the+FDA&doi=10.1056%2FNEJMp0908913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A difficult balance - pain management, drug safety, and the FDA</span></div><div class="casAuthors">Woodcock, Janet</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2105-2107</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdlXl7NZQaEbVg90H21EOLACvtfcHk0lh_kjvK_p3syw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWgsrnI&md5=3264557a26df008287c146e642046ca1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMp0908913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp0908913%26sid%3Dliteratum%253Aachs%26aulast%3DWoodcock%26aufirst%3DJ.%2BA.%2BA.%26atitle%3DDifficult%2520Balance%2520%25E2%2580%2593%2520Pain%2520Management%252C%2520Drug%2520Safety%252C%2520and%2520the%2520FDA%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D2105%26epage%3D2107%26doi%3D10.1056%2FNEJMp0908913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melnikova, I.</span></span> <span> </span><span class="NLM_article-title">Pain Market</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1038/nrd3226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fnrd3226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=20651743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1aru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=589-590&author=I.+Melnikova&title=Pain+Market&doi=10.1038%2Fnrd3226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pain market</span></div><div class="casAuthors">Melnikova, Irena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">589-590</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouH6uQeS0Q5bVg90H21EOLACvtfcHk0lg3-vnH12U9XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1aru7g%253D&md5=c67862cb8d31cc999c42c0ebf5f388eb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd3226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3226%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DI.%26atitle%3DPain%2520Market%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D589%26epage%3D590%26doi%3D10.1038%2Fnrd3226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span> <span> </span><span class="NLM_article-title">No Gain, No Pain: Na<sub>V</sub>1.7 as an Analgesic Target</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1021/cn500171p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500171p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaisLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=749-751&author=G.+F.+Kingauthor=I.+Vetter&title=No+Gain%2C+No+Pain%3A+NaV1.7+as+an+Analgesic+Target&doi=10.1021%2Fcn500171p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">No Gain, No Pain: NaV1.7 as an Analgesic Target</span></div><div class="casAuthors">King, Glenn F.; Vetter, Irina</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">749-751</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chronic pain is one of the most complex and difficult to manage clin. problems, with the therapeutic utility of current-generation analgesics restricted by problems such as dose-limiting side effects, tolerance, and the potential for addiction.  The voltage-gated sodium channel NaV1.7 plays a key role in setting the threshold for action potential generation in primary sensory neurons, and humans that lack this channel are completely insensitive to pain.  In this Viewpoint, the authors examine the potential of NaV1.7 as an analgesic target a well as the challenges involved in developing therapeutically useful subtype-selective inhibitors of this ion channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod_ZPZACayg7Vg90H21EOLACvtfcHk0lg3-vnH12U9XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaisLjF&md5=423db2f1ef715675e104531e1018a007</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcn500171p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500171p%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DG.%2BF.%26aulast%3DVetter%26aufirst%3DI.%26atitle%3DNo%2520Gain%252C%2520No%2520Pain%253A%2520NaV1.7%2520as%2520an%2520Analgesic%2520Target%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D749%26epage%3D751%26doi%3D10.1021%2Fcn500171p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in Sodium Channel Modulators for Pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3690</span>– <span class="NLM_lpage">3699</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2014.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=25060923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3690-3699&author=S.+K.+Bagalauthor=M.+L.+Chapmanauthor=B.+E.+Marronauthor=R.+Primeauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Recent+Progress+in+Sodium+Channel+Modulators+for+Pain&doi=10.1016%2Fj.bmcl.2014.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in sodium channel modulators for pain</span></div><div class="casAuthors">Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.; Prime, Rebecca; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3690-3699</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field.  Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda, Synchropatch and Qube.  Moreover, emerging clin. data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biol. pave the way for a future of fruitful prospective Nav drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbT6en4xkVxLVg90H21EOLACvtfcHk0lg3-vnH12U9XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL&md5=c8bae40b70509e2aa3dce106e2c41677</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPrime%26aufirst%3DR.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DRecent%2520Progress%2520in%2520Sodium%2520Channel%2520Modulators%2520for%2520Pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3690%26epage%3D3699%26doi%3D10.1016%2Fj.bmcl.2014.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de%0ALera+Ruizauthor=R.+L.+Kraus&title=Voltage-Gated+Sodium+Channels%3A+Structure%2C+Function%2C+Pharmacology%2C+and+Clinical+Indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0lgKxxMiHxYNGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-Gated%2520Sodium%2520Channels%253A%2520Structure%252C%2520Function%252C%2520Pharmacology%252C%2520and%2520Clinical%2520Indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuliani, V.</span></span> <span> </span><span class="NLM_article-title">Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1517/13543784.2016.1121992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1517%2F13543784.2016.1121992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=26576738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSrt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=215-226&author=M.+Rivaraauthor=V.+Zuliani&title=Novel+Sodium+Channel+Antagonists+in+the+Treatment+of+Neuropathic+Pain&doi=10.1517%2F13543784.2016.1121992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Novel sodium channel antagonists in the treatment of neuropathic pain</span></div><div class="casAuthors">Rivara, Mirko; Zuliani, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-226</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Effective and safe drugs for the treatment of neuropathic pain are still an unmet clin. need.  Neuropathic pain, caused by a lesion or disease that affects the somatosensory system, is a debilitating and hampering condition that has a great economic cost and, above all, a tremendous impact on the quality of life.  Sodium channels are one of the major players in generating and propagating action potentials.  They represent an appealing target for researchers involved in the development of new and safer drugs useful in the treatment of neuropathic pain.  The actual goal for researchers is to target sodium channels selectively to stop the abnormal signaling that characterizes neuropathic pain while leaving normal somatosensory functions intact.: This review covers the most recent publications regarding sodium channel blockers and their development as new treatments for neuropathic pain.  The main areas discussed are the natural sources of new blockers, such as venom exts. and the recent efforts from many pharmaceutical companies in the field.: There have been serious efforts by both the pharmaceutical industry and academia to develop new and safer therapeutic options for neuropathic pain.  A no. of different strategies have been undertaken; the main efforts directed towards the identification of selective blockers starting from both natural products or screening chem. libraries.  At this time, researchers have identified and characterized selective compds. against NaV1.7 or NaV1.8 voltage-gated sodium channels but only time will tell if they reach the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl3PzyBSNxFbVg90H21EOLACvtfcHk0lgKxxMiHxYNGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSrt7rK&md5=f0280383c1361e07d6c5378b0dda6373</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F13543784.2016.1121992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2016.1121992%26sid%3Dliteratum%253Aachs%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DZuliani%26aufirst%3DV.%26atitle%3DNovel%2520Sodium%2520Channel%2520Antagonists%2520in%2520the%2520Treatment%2520of%2520Neuropathic%2520Pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2016%26volume%3D25%26spage%3D215%26epage%3D226%26doi%3D10.1517%2F13543784.2016.1121992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">The Na<sub>V</sub>1.7 Sodium Channel: From Molecule to Man</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.+D.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+NaV1.7+Sodium+Channel%3A+From+Molecule+to+Man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0lgKxxMiHxYNGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520NaV1.7%2520Sodium%2520Channel%253A%2520From%2520Molecule%2520to%2520Man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Aral, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koszowski, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisenand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silos-Santiago, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halegoua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, G.</span></span> <span> </span><span class="NLM_article-title">Identification of PN1, A Predominant Voltage-Dependent Sodium Channel Expressed Principally in Peripheral Neurons</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1532</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.4.1527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1073%2Fpnas.94.4.1527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=9037087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADyaK2sXhtl2ms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=1527-1532&author=J.+J.+Toledo-Aralauthor=B.+L.+Mossauthor=Z.+Heauthor=A.+G.+Koszowskiauthor=T.+Whisenandauthor=S.+R.+Levinsonauthor=J.+J.+Wolfauthor=I.+Silos-Santiagoauthor=S.+Halegouaauthor=G.+Mandel&title=Identification+of+PN1%2C+A+Predominant+Voltage-Dependent+Sodium+Channel+Expressed+Principally+in+Peripheral+Neurons&doi=10.1073%2Fpnas.94.4.1527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons</span></div><div class="casAuthors">Toledo Aral, Juan J.; Moss, Brenda L.; He, Zhi Jun; Koszowski, Adam G.; Whisenand, Teri; Levinson, Simon R.; Wolf, John J.; Silos Santiago, Inmaculada; Halegoua, Simon; Mandel, Gail</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1527-1532</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Membrane excitability in different tissues is due, in large part, to the selective expression of distinct genes encoding the voltage-dependent sodium channel.  Although the predominant sodium channels in brain, skeletal muscle, and cardiac muscle have been identified, the major sodium channel types responsible for excitability within the peripheral nervous system have remained elusive.  We now describe the deduced primary structure of a sodium channel, peripheral nerve type 1 (PN1), which is expressed at high levels throughout the peripheral nervous system and is targeted to nerve terminals of cultured dorsal root ganglion neurons.  Studies using cultured PC12 cells indicate that both expression and targeting of PN1 is induced by treatment of the cells with nerve growth factor.  The preferential localization suggests that the PN1 sodium channel plays a specific role in neve excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTpQugGHLderVg90H21EOLACvtfcHk0ljK7e-QlpPGYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtl2ms7s%253D&md5=6329c810c620463f1a3df96c7e637cee</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.4.1527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.4.1527%26sid%3Dliteratum%253Aachs%26aulast%3DToledo-Aral%26aufirst%3DJ.%2BJ.%26aulast%3DMoss%26aufirst%3DB.%2BL.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DKoszowski%26aufirst%3DA.%2BG.%26aulast%3DWhisenand%26aufirst%3DT.%26aulast%3DLevinson%26aufirst%3DS.%2BR.%26aulast%3DWolf%26aufirst%3DJ.%2BJ.%26aulast%3DSilos-Santiago%26aufirst%3DI.%26aulast%3DHalegoua%26aufirst%3DS.%26aulast%3DMandel%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520PN1%252C%2520A%2520Predominant%2520Voltage-Dependent%2520Sodium%2520Channel%2520Expressed%2520Principally%2520in%2520Peripheral%2520Neurons%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D1527%26epage%3D1532%26doi%3D10.1073%2Fpnas.94.4.1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raashid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gazali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span> <span> </span><span class="NLM_article-title">An SCN9A Channelopathy Causes Congenital Inability to Experience Pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicholasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=C.+G.+Woods&title=An+SCN9A+Channelopathy+Causes+Congenital+Inability+to+Experience+Pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0ljK7e-QlpPGYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicholas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26atitle%3DAn%2520SCN9A%2520Channelopathy%2520Causes%2520Congenital%2520Inability%2520to%2520Experience%2520Pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahllund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellgren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meury, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morinville, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynoschek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouleau, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupp, J. J.</span></span> <span> </span><span class="NLM_article-title">A Stop Codon Mutation in SCN9A Causes Lack of Pain Sensation</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2114</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddm160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1093%2Fhmg%2Fddm160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=17597096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=2114-2121&author=S.+Ahmadauthor=L.+Dahllundauthor=A.+B.+Erikssonauthor=D.+Hellgrenauthor=U.+Karlssonauthor=P.+Lundauthor=I.+A.+Meijerauthor=L.+Meuryauthor=T.+Millsauthor=A.+Moodyauthor=A.+Morinvilleauthor=J.+Mortenauthor=D.+O%E2%80%99Donnellauthor=C.+Raynoschekauthor=H.+Salterauthor=G.+A.+Rouleauauthor=J.+J.+Krupp&title=A+Stop+Codon+Mutation+in+SCN9A+Causes+Lack+of+Pain+Sensation&doi=10.1093%2Fhmg%2Fddm160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A stop codon mutation in SCN9A causes lack of pain sensation</span></div><div class="casAuthors">Ahmad, Sultan; Dahllund, Leif; Eriksson, Anders B.; Hellgren, Dennis; Karlsson, Urban; Lund, Per-Eric; Meijer, Inge A.; Meury, Luc; Mills, Tracy; Moody, Adrian; Morinville, Anne; Morten, John; O'Donnell, Dajan; Raynoschek, Carina; Salter, Hugh; Rouleau, Guy A.; Krupp, Johannes J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2114-2121</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The general lack of pain experience is a rare occurrence in humans, and the mol. causes for this phenotype are not well understood.  Here we have studied a Canadian family from Newfoundland with members who exhibit a congenital inability to experience pain.  We have mapped the locus to a 13.7 Mb region on chromosome 2q (2q24.3-2q31.1).  Screening of candidate genes in this region identified a protein-truncating mutation in SCN9A, which encodes for the voltage-gated sodium channel Nav1.7.  The mutation is a C-A transversion at nucleotide 984 transforming the codon for tyrosine 328 to a stop codon.  The predicted product lacks all pore-forming regions of Nav1.7.  Indeed, expression of this altered gene in a cell line did not produce functional responses, nor did it cause compensatory effects on endogenous voltage-gated sodium currents when expressed in ND7/23 cells.  Because a homozygous knockout of Nav1.7 in mice has been shown to be lethal, we explored why a deficiency of Nav1.7 is non-lethal in humans.  Expression studies in monkey, human, mouse and rat tissue indicated species-differences in the Nav1.7 expression profile.  Whereas in rodents the channel was strongly expressed in hypothalamic nuclei, only weak mRNA levels were detected in this area in primates.  Furthermore, primate pituitary and adrenal glands were devoid of signal, whereas these two glands were mRNA-pos. in rodents.  This species difference may explain the non-lethality of the obsd. mutation in humans.  Our data further establish Nav1.7 as a crit. element of peripheral nociception in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-UExUOmeYrVg90H21EOLACvtfcHk0ljK7e-QlpPGYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVWqt7o%253D&md5=4800e0aee1230c46ada3e29e551b1833</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddm160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddm160%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDahllund%26aufirst%3DL.%26aulast%3DEriksson%26aufirst%3DA.%2BB.%26aulast%3DHellgren%26aufirst%3DD.%26aulast%3DKarlsson%26aufirst%3DU.%26aulast%3DLund%26aufirst%3DP.%26aulast%3DMeijer%26aufirst%3DI.%2BA.%26aulast%3DMeury%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DT.%26aulast%3DMoody%26aufirst%3DA.%26aulast%3DMorinville%26aufirst%3DA.%26aulast%3DMorten%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DD.%26aulast%3DRaynoschek%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DH.%26aulast%3DRouleau%26aufirst%3DG.%2BA.%26aulast%3DKrupp%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520Stop%2520Codon%2520Mutation%2520in%2520SCN9A%2520Causes%2520Lack%2520of%2520Pain%2520Sensation%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2007%26volume%3D16%26spage%3D2114%26epage%3D2121%26doi%3D10.1093%2Fhmg%2Fddm160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattice, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radomski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younghusband, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinspan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdraon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowsher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Loss-of-Function Mutations in the Na<sub>V</sub>1.7 Gene Underlie Congenital Indifference to Pain in Multiple Human Populations</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ivesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Boltshauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-Function+Mutations+in+the+NaV1.7+Gene+Underlie+Congenital+Indifference+to+Pain+in+Multiple+Human+Populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2eZHDeHCSa6ZtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DIves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBoltshauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-Function%2520Mutations%2520in%2520the%2520NaV1.7%2520Gene%2520Underlie%2520Congenital%2520Indifference%2520to%2520Pain%2520in%2520Multiple%2520Human%2520Populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Mutations in SCN9A, Encoding a Sodium Channel Alpha Subunit, in Patients with Primary Erythermalgia</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1136/jmg.2003.012153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1136%2Fjmg.2003.012153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=14985375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=171-174&author=Y.+Yangauthor=Y.+Wangauthor=S.+Liauthor=Z.+Xuauthor=H.+Liauthor=L.+Maauthor=J.+Fanauthor=D.+Buauthor=B.+Liuauthor=Z.+Fanauthor=G.+Wuauthor=J.+Jinauthor=B.+Dingauthor=X.+Zhuauthor=Y.+Shen&title=Mutations+in+SCN9A%2C+Encoding+a+Sodium+Channel+Alpha+Subunit%2C+in+Patients+with+Primary+Erythermalgia&doi=10.1136%2Fjmg.2003.012153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span></div><div class="casAuthors">Yang, Y.; Wang, Y.; Li, S.; Xu, Z.; Li, H.; Ma, L.; Fan, J.; Bu, D.; Liu, B.; Fan, Z.; Wu, G.; Jin, J.; Ding, B.; Zhu, X.; Shen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning pain with redness and heat in the extremities.  A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified.  We performed linkage anal. in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient.  Linkage anal. yielded a max. lod score of 2.11 for both markers D2S2370 and D2S2330.  Based on crit. recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345.  We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C).  Our data suggest that mutations in SCN9A cause primary erythermalgia.  SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurons, may play an important role in nociception and vasomotor regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBMPc9seMturVg90H21EOLACvtfcHk0lhpny2KGzN-6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D&md5=bf4ca6710278dd25a4de4ac5d8fdab2f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2003.012153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2003.012153%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DMutations%2520in%2520SCN9A%252C%2520Encoding%2520a%2520Sodium%2520Channel%2520Alpha%2520Subunit%252C%2520in%2520Patients%2520with%2520Primary%2520Erythermalgia%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2004%26volume%3D41%26spage%3D171%26epage%3D174%26doi%3D10.1136%2Fjmg.2003.012153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyrski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bufe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willnecker, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zizzari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gossage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinders-Zufall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zufall, F.</span></span> <span> </span><span class="NLM_article-title">Loss-of-Function Mutations in Sodium Channel Na<sub>V</sub>1.7 Cause Anosmia</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>472</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1038/nature09975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fnature09975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=21441906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2011&pages=186-190&author=J.+Weissauthor=M.+Pyrskiauthor=E.+Jacobiauthor=B.+Bufeauthor=V.+Willneckerauthor=B.+Schickauthor=P.+Zizzariauthor=S.+J.+Gossageauthor=C.+A.+Greerauthor=T.+Leinders-Zufallauthor=C.+G.+Woodsauthor=J.+N.+Woodauthor=F.+Zufall&title=Loss-of-Function+Mutations+in+Sodium+Channel+NaV1.7+Cause+Anosmia&doi=10.1038%2Fnature09975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in sodium channel Nav1.7 cause anosmia</span></div><div class="casAuthors">Weiss, Jan; Pyrski, Martina; Jacobi, Eric; Bufe, Bernd; Willnecker, Vivienne; Schick, Bernhard; Zizzari, Philippe; Gossage, Samuel J.; Greer, Charles A.; Leinders-Zufall, Trese; Woods, C. Geoffrey; Wood, John N.; Zufall, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">472</span>
        (<span class="NLM_cas:issue">7342</span>),
    <span class="NLM_cas:pages">186-190</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Loss of function of the gene SCN9A, encoding the voltage-gated sodium channel Nav1.7, causes a congenital inability to experience pain in humans.  Here we show that Nav1.7 is not only necessary for pain sensation but is also an essential requirement for odor perception in both mice and humans.  We examd. human patients with loss-of-function mutations in SCN9A and show that they are unable to sense odors.  To establish the essential role of Nav1.7 in odor perception, we generated conditional null mice in which Nav1.7 was removed from all olfactory sensory neurons.  In the absence of Nav1.7, these neurons still produce odor-evoked action potentials but fail to initiate synaptic signaling from their axon terminals at the first synapse in the olfactory system.  The mutant mice no longer display vital, odor-guided behaviors such as innate odor recognition and avoidance, short-term odor learning, and maternal pup retrieval.  Our study creates a mouse model of congenital general anosmia and provides new strategies to explore the genetic basis of the human sense of smell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlULSYZLPdCLVg90H21EOLACvtfcHk0lgSWi0O1sKO-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOitLo%253D&md5=49237d7972c38172b7c56f42d13eb68e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature09975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09975%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DJ.%26aulast%3DPyrski%26aufirst%3DM.%26aulast%3DJacobi%26aufirst%3DE.%26aulast%3DBufe%26aufirst%3DB.%26aulast%3DWillnecker%26aufirst%3DV.%26aulast%3DSchick%26aufirst%3DB.%26aulast%3DZizzari%26aufirst%3DP.%26aulast%3DGossage%26aufirst%3DS.%2BJ.%26aulast%3DGreer%26aufirst%3DC.%2BA.%26aulast%3DLeinders-Zufall%26aufirst%3DT.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DZufall%26aufirst%3DF.%26atitle%3DLoss-of-Function%2520Mutations%2520in%2520Sodium%2520Channel%2520NaV1.7%2520Cause%2520Anosmia%26jtitle%3DNature%26date%3D2011%26volume%3D472%26spage%3D186%26epage%3D190%26doi%3D10.1038%2Fnature09975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passmore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickenson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcangio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span> <span> </span><span class="NLM_article-title">Distinct Na<sub>V</sub>1.7-Dependent Pain Sensations Require Different Sets of Sensory and Sympathetic Neurons</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">799</span>, <span class="refDoi"> DOI: 10.1038/ncomms1795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fncomms1795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=22531176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BC38rnsl2mug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=791-799&author=M.+S.+Minettauthor=M.+A.+Nassarauthor=A.+K.+Clarkauthor=G.+Passmoreauthor=A.+H.+Dickensonauthor=F.+Wangauthor=M.+Malcangioauthor=J.+N.+Wood&title=Distinct+NaV1.7-Dependent+Pain+Sensations+Require+Different+Sets+of+Sensory+and+Sympathetic+Neurons&doi=10.1038%2Fncomms1795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons</span></div><div class="casAuthors">Minett Michael S; Nassar Mohammed A; Clark Anna K; Passmore Gayle; Dickenson Anthony H; Wang Fan; Malcangio Marzia; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">791</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human acute and inflammatory pain requires the expression of voltage-gated sodium channel Nav1.7 but its significance for neuropathic pain is unknown.  Here we show that Nav1.7 expression in different sets of mouse sensory and sympathetic neurons underlies distinct types of pain sensation.  Ablating Nav1.7 gene (SCN9A) expression in all sensory neurons using Advillin-Cre abolishes mechanical pain, inflammatory pain and reflex withdrawal responses to heat.  In contrast, heat-evoked pain is retained when SCN9A is deleted only in Nav1.8-positive nociceptors.  Surprisingly, responses to the hotplate test, as well as neuropathic pain, are unaffected when SCN9A is deleted in all sensory neurons.  However, deleting SCN9A in both sensory and sympathetic neurons abolishes these pain sensations and recapitulates the pain-free phenotype seen in humans with SCN9A loss-of-function mutations.  These observations demonstrate an important role for Nav1.7 in sympathetic neurons in neuropathic pain, and provide possible insights into the mechanisms that underlie gain-of-function Nav1.7-dependent pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbjQBOlkmUQoUSrryheKE6fW6udTcc2ebc4Z0H-XS-ZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnsl2mug%253D%253D&md5=86559797d628dfef8697b75a96fd5fed</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncomms1795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1795%26sid%3Dliteratum%253Aachs%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DNassar%26aufirst%3DM.%2BA.%26aulast%3DClark%26aufirst%3DA.%2BK.%26aulast%3DPassmore%26aufirst%3DG.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DMalcangio%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DDistinct%2520NaV1.7-Dependent%2520Pain%2520Sensations%2520Require%2520Different%2520Sets%2520of%2520Sensory%2520and%2520Sympathetic%2520Neurons%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D791%26epage%3D799%26doi%3D10.1038%2Fncomms1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couture, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottman, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beiler, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span> <span> </span><span class="NLM_article-title">Global Na<sub>V</sub>1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e105895</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0105895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1371%2Fjournal.pone.0105895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=25188265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105895&author=J.+Gingrasauthor=S.+Smithauthor=D.+J.+Matsonauthor=D.+Johnsonauthor=K.+Nyeauthor=L.+Coutureauthor=E.+Fericauthor=R.+Yinauthor=B.+D.+Moyerauthor=M.+L.+Petersonauthor=J.+B.+Rottmanauthor=R.+J.+Beilerauthor=A.+B.+Malmbergauthor=S.+I.+McDonough&title=Global+NaV1.7+Knockout+Mice+Recapitulate+the+Phenotype+of+Human+Congenital+Indifference+to+Pain&doi=10.1371%2Fjournal.pone.0105895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span></div><div class="casAuthors">Gingras, Jacinthe; Smith, Sarah; Matson, David J.; Johnson, Danielle; Nye, Kim; Couture, Lauren; Feric, Elma; Yin, Ruoyuan; Moyer, Bryan D.; Peterson, Matthew L.; Rottman, James B.; Beiler, Rudolph J.; Malmberg, Annika B.; McDonough, Stefan I.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e105895/1-e105895/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Clin. genetic studies have shown that loss of Nav1.7 function leads to the complete loss of acute pain perception.  The global deletion is reported lethal in mice, however, and studies of mice with promoter-specific deletions of Nav1.7 have suggested that the role of Nav1.7 in pain transduction depends on the precise form of pain.  We developed genetic and animal husbandry strategies that overcame the neonatal-lethal phenotype and enabled construction of a global Nav1.7 knockout mouse.  Knockouts were anatomically normal, reached adulthood, and had phenotype wholly analogous to human congenital indifference to pain (CIP): compared to littermates, knockouts showed no defects in mech. sensitivity or overall movement yet were completely insensitive to painful tactile, thermal, and chem. stimuli and were anosmic.  Knockouts also showed no painful behaviors resulting from peripheral injection of nonselective sodium channel activators, did not develop complete Freund's adjuvant-induced thermal hyperalgesia, and were insensitive to intra-dermal histamine injection.  Tetrodotoxin-sensitive sodium current recorded from cell bodies of isolated sensory neurons and the mech.-evoked spiking of C-fibers in a skin-nerve prepn. each were reduced but not eliminated in tissue from knockouts compared to littermates.  Results support a role for Nav1.7 that is conserved between rodents and humans and suggest several possibly translatable biomarkers for the study of Nav1.7-targeted therapeutics.  Results further suggest that Nav1.7 may retain its key role in persistent as well as acute forms of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzxB508dD1LVg90H21EOLACvtfcHk0lgSWi0O1sKO-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O&md5=6a1acb0c6e4e38ac89b1ab38d67b538e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105895%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DNye%26aufirst%3DK.%26aulast%3DCouture%26aufirst%3DL.%26aulast%3DFeric%26aufirst%3DE.%26aulast%3DYin%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRottman%26aufirst%3DJ.%2BB.%26aulast%3DBeiler%26aufirst%3DR.%2BJ.%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26atitle%3DGlobal%2520NaV1.7%2520Knockout%2520Mice%2520Recapitulate%2520the%2520Phenotype%2520of%2520Human%2520Congenital%2520Indifference%2520to%2520Pain%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105895%26doi%3D10.1371%2Fjournal.pone.0105895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werdehausen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugiero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span> <span> </span><span class="NLM_article-title">Neurological Perspectives on Voltage-Gated Sodium Channels</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">2585</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1093/brain/aws225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1093%2Fbrain%2Faws225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=22961543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=2585-2612&author=N.+Eijkelkampauthor=J.+E.+Linleyauthor=M.+D.+Bakerauthor=M.+S.+Minettauthor=R.+Creggauthor=R.+Werdehausenauthor=F.+Rugieroauthor=J.+N.+Wood&title=Neurological+Perspectives+on+Voltage-Gated+Sodium+Channels&doi=10.1093%2Fbrain%2Faws225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological perspectives on voltage-gated sodium channels</span></div><div class="casAuthors">Eijkelkamp Niels; Linley John E; Baker Mark D; Minett Michael S; Cregg Roman; Werdehausen Robert; Rugiero Francois; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">2585-612</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain.  Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders.  Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels.  This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects.  We also discuss recent advances in the development of selective sodium channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMaWmHsTCoQ3l8icjszYl0fW6udTcc2eb4KYotmeHDj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D&md5=6f9b33df722a3c5831b8860d3fad1af2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws225%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DLinley%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DCregg%26aufirst%3DR.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DRugiero%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DNeurological%2520Perspectives%2520on%2520Voltage-Gated%2520Sodium%2520Channels%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D2585%26epage%3D2612%26doi%3D10.1093%2Fbrain%2Faws225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogucki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of Na<sub>V</sub>1.7 with Efficacy in Rodent Pain Models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=277-282&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+Aryl+Sulfonamides+as+Isoform-Selective+Inhibitors+of+NaV1.7+with+Efficacy+in+Rodent+Pain+Models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models</span></div><div class="casAuthors">Focken, Thilo; Liu, Shifeng; Chahal, Navjot; Dauphinais, Maxim; Grimwood, Michael E.; Chowdhury, Sultan; Hemeon, Ivan; Bichler, Paul; Bogucki, David; Waldbrook, Matthew; Bankar, Girish; Sojo, Luis E.; Young, Clint; Lin, Sophia; Shuart, Noah; Kwan, Rainbow; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, J. P., Jr.; Dehnhardt, Christoph M.; Mansour, Tarek S.; Oballa, Renata M.; Cohen, Charles J.; Robinette, C. Lee</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7.  The optimization of these inhibitors is described.  The authors aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compd. I.  This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo.  The findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIxiu3ixqRLVg90H21EOLACvtfcHk0liDK5zfdpS80Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D&md5=ae05f2c1ef6cf51d69a67a7b1ee7f8fa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520Aryl%2520Sulfonamides%2520as%2520Isoform-Selective%2520Inhibitors%2520of%2520NaV1.7%2520with%2520Efficacy%2520in%2520Rodent%2520Pain%2520Models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D277%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable <i>in vivo</i> Target Engagement</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1062-1067&author=I.+E.+Marxauthor=T.+A.+Dineenauthor=J.+Ableauthor=C.+Bodeauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+Dimauroauthor=B.+Duauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=B.+E.+Hallauthor=L.+Huangauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=M.+J.+Linauthor=D.+Liuauthor=J.+S.+McDermottauthor=B.+D.+Moyerauthor=E.+A.+Petersonauthor=J.+T.+Robertsauthor=P.+E.+Roseauthor=J.+Wangauthor=B.+D.+Youngbloodauthor=V.+L.+Yuauthor=M.+M.+Weiss&title=Sulfonamides+as+Selective+NaV1.7+Inhibitors%3A+Optimizing+Potency+and+Pharmacokinetics+to+Enable+in+vivo+Target+Engagement&doi=10.1021%2Facsmedchemlett.6b00243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement</span></div><div class="casAuthors">Marx, Isaac E.; Dineen, Thomas A.; Able, Jessica; Bode, Christiane; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Du, Bingfan; Foti, Robert S.; Fremeau, Robert T.; Gao, Hua; Gunaydin, Hakan; Hall, Brian E.; Huang, Liyue; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Lin, Min-Hwa Jasmine; Liu, Dong; McDermott, Jeff S.; Moyer, Bryan D.; Peterson, Emily A.; Roberts, Jonathan T.; Rose, Paul; Wang, Jean; Youngblood, Beth D.; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1062-1067</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human genetic evidence has identified the voltage-gated sodium channel NaV1.7 as an attractive target for the treatment of pain.  The authors initially identified naphthalene sulfonamide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (compd. 3) as a potent and selective inhibitor of NaV1.7.  Optimization to reduce biliary clearance by balancing hydrophilicity and hydrophobicity (Log D) while maintaining NaV1.7 potency led to the identification of quinazoline 16 (AM-2099).  Compd. 16 demonstrated a favorable pharmacokinetic profile in rat and dog and demonstrated dose-dependent redn. of histamine-induced scratching bouts in a mouse behavioral model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNi8X2t0EULVg90H21EOLACvtfcHk0lht1POhPnmF1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE&md5=43c2ae357af90d6c6f56245c3114c016</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00243%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDimauro%26aufirst%3DE.%2BF.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRoberts%26aufirst%3DJ.%2BT.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%2BL.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520Selective%2520NaV1.7%2520Inhibitors%253A%2520Optimizing%2520Potency%2520and%2520Pharmacokinetics%2520to%2520Enable%2520in%2520vivo%2520Target%2520Engagement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1062%26epage%3D1067%26doi%3D10.1021%2Facsmedchemlett.6b00243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gum, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fricano, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgaard, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kouhen, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neelands, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulenko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daanen, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreishi-Haack, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kort, M. E.</span></span> <span> </span><span class="NLM_article-title">Substituted Indazoles as Na<sub>V</sub>1.7 Blockers for the Treatment of Pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3373</span>– <span class="NLM_lpage">3391</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00063</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00063" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3373-3391&author=J.+M.+Frostauthor=D.+A.+DeGoeyauthor=L.+Shiauthor=R.+J.+Gumauthor=M.+M.+Fricanoauthor=G.+L.+Lundgaardauthor=O.+F.+El-Kouhenauthor=G.+C.+Hsiehauthor=T.+Neelandsauthor=M.+A.+Matulenkoauthor=J.+F.+Daanenauthor=M.+Paiauthor=N.+Ghoreishi-Haackauthor=C.+Zhanauthor=X.-F.+Zhangauthor=M.+E.+Kort&title=Substituted+Indazoles+as+NaV1.7+Blockers+for+the+Treatment+of+Pain&doi=10.1021%2Facs.jmedchem.6b00063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00063%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DGum%26aufirst%3DR.%2BJ.%26aulast%3DFricano%26aufirst%3DM.%2BM.%26aulast%3DLundgaard%26aufirst%3DG.%2BL.%26aulast%3DEl-Kouhen%26aufirst%3DO.%2BF.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DNeelands%26aufirst%3DT.%26aulast%3DMatulenko%26aufirst%3DM.%2BA.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%26aulast%3DZhan%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.-F.%26aulast%3DKort%26aufirst%3DM.%2BE.%26atitle%3DSubstituted%2520Indazoles%2520as%2520NaV1.7%2520Blockers%2520for%2520the%2520Treatment%2520of%2520Pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3373%26epage%3D3391%26doi%3D10.1021%2Facs.jmedchem.6b00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric
Bojic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5969</span>– <span class="NLM_lpage">5989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5969-5989&author=M.+M.+Weissauthor=T.+A.+Dineenauthor=I.+E.+Marxauthor=S.+Altmannauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=E.+Feric%0ABojicauthor=R.+S.+Fotiauthor=H.+Gaoauthor=R.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=H.+Huangauthor=L.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=J.+Liguttiauthor=D.+S.+Laauthor=M.+J.+Linauthor=D.+Liuauthor=B.+D.+Moyerauthor=H.+Nguyenauthor=E.+A.+Petersonauthor=P.+E.+Roseauthor=K.+Tabornauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=R.+T.+Fremeau&title=Sulfonamides+as+Selective+NaV1.7+Inhibitors%3A+Optimizing+Potency+and+Pharmacokinetics+While+Mitigating+Metabolic+Liabilities&doi=10.1021%2Facs.jmedchem.6b01851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span></div><div class="casAuthors">Weiss, Matthew M.; Dineen, Thomas A.; Marx, Isaac E.; Altmann, Steven; Boezio, Alessandro; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Feric Bojic, Elma; Foti, Robert S.; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Huang, Hongbing; Huang, Liyue; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; Ligutti, Joseph; La, Daniel S.; Lin, Min-Hwa Jasmine; Liu, Dong; Moyer, Bryan D.; Nguyen, Hanh N.; Peterson, Emily A.; Rose, Paul E.; Taborn, Kristin; Youngblood, Beth D.; Yu, Violeta; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5969-5989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several reports have recently emerged regarding the identification of heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  The optimization of a series of internal NaV1.7 leads that address a no. of metabolic liabilities including bioactivation, PXR activation, as well as CYP3A4 induction and inhibition led to the identification of potent and selective inhibitors that demonstrated favorable pharmacokinetic profiles and were devoid of the aforementioned liabilities.  The key to achieving this within a series prone to transporter-mediated clearance was the identification of a small range of optimal cLogD values and the discovery of subtle PXR SAR that was not lipophilicity dependent.  This enabled the identification of compd. 20, which was advanced into a target engagement pharmacodynamic model where it exhibited robust reversal of histamine-induced scratching bouts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovsPC2UZpxsbVg90H21EOLACvtfcHk0lht1POhPnmF1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D&md5=6333a6b936e48f9d18cf9df10ea12853</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DFeric%2BBojic%26aufirst%3DE.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DSulfonamides%2520as%2520Selective%2520NaV1.7%2520Inhibitors%253A%2520Optimizing%2520Potency%2520and%2520Pharmacokinetics%2520While%2520Mitigating%2520Metabolic%2520Liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5969%26epage%3D5989%26doi%3D10.1021%2Facs.jmedchem.6b01851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric
Bojic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) That Affords Robust <i>in vivo</i> Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=T.+Feric%0ABojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.-H.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+Selective+NaV1.7+Inhibitors%3A+Optimizing+Potency%2C+Pharmacokinetics%2C+and+Metabolic+Properties+to+Obtain+Atropisomeric+Quinolinone+%28AM-0466%29+That+Affords+Robust+in+vivo+Activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0li8Zxtejd7U7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DFeric%2BBojic%26aufirst%3DT.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520Selective%2520NaV1.7%2520Inhibitors%253A%2520Optimizing%2520Potency%252C%2520Pharmacokinetics%252C%2520and%2520Metabolic%2520Properties%2520to%2520Obtain%2520Atropisomeric%2520Quinolinone%2520%2528AM-0466%2529%2520That%2520Affords%2520Robust%2520in%2520vivo%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egbertson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koser, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Selective, Orally Bioavailable, <i>N</i>-Linked Arylsulfonamide Na<sub>V</sub>1.7 Inhibitors with Pain Efficacy in Mice</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=28389149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2087-2093&author=A.+J.+Roeckerauthor=M.+Egbertsonauthor=K.+L.+G.+Jonesauthor=R.+Gomezauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+J.+Koserauthor=M.+O.+Urbanauthor=R.+Kleinauthor=M.+Clementsauthor=J.+Panigelauthor=C.+Daleyauthor=J.+Wangauthor=E.+N.+Fingerauthor=J.+Majercakauthor=V.+Santarelliauthor=I.+Greganauthor=M.+Catoauthor=T.+Filzenauthor=A.+Jovanovskaauthor=Y.+H.+Wangauthor=D.+Wangauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=X.+Pengauthor=X.+Wangauthor=H.+Sunauthor=P.+J.+Colemanauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Discovery+of+Selective%2C+Orally+Bioavailable%2C+N-Linked+Arylsulfonamide+NaV1.7+Inhibitors+with+Pain+Efficacy+in+Mice&doi=10.1016%2Fj.bmcl.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice</span></div><div class="casAuthors">Roecker, Anthony J.; Egbertson, Melissa; Jones, Kristen L. G.; Gomez, Robert; Kraus, Richard L.; Li, Yuxing; Koser, Amy Jo; Urban, Mark O.; Klein, Rebecca; Clements, Michelle; Panigel, Jacqueline; Daley, Christopher; Wang, Jixin; Finger, Eleftheria N.; Majercak, John; Santarelli, Vincent; Gregan, Irene; Cato, Matthew; Filzen, Tracey; Jovanovska, Aneta; Wang, Ying-Hong; Wang, Deping; Joyce, Leo A.; Sherer, Edward C.; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Coleman, Paul J.; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel Nav1.7 is a genetically validated target for the treatment of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss-of-function mutations affording insensitivity to pain.  Unfortunately, drugs thought to garner efficacy via Nav1 inhibition have undesirable side effect profiles due to their lack of selectivity over channel isoforms.  Herein we report the discovery of a novel series of orally bioavailable arylsulfonamide Nav1.7 inhibitors with high levels of selectivity over Nav1.5, the Nav isoform responsible for cardiovascular side effects, through judicious use of parallel medicinal chem. and physicochem. property optimization.  This effort produced inhibitors such as compd. 5 with excellent potency, selectivity, behavioral efficacy in a rodent pain model, and efficacy in a mouse itch model suggestive of target modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDA0s8NB86LVg90H21EOLACvtfcHk0li8Zxtejd7U7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D&md5=5729efef8e3df4afe3f89c25472c9268</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKoser%26aufirst%3DA.%2BJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DSantarelli%26aufirst%3DV.%26aulast%3DGregan%26aufirst%3DI.%26aulast%3DCato%26aufirst%3DM.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520Selective%252C%2520Orally%2520Bioavailable%252C%2520N-Linked%2520Arylsulfonamide%2520NaV1.7%2520Inhibitors%2520with%2520Pain%2520Efficacy%2520in%2520Mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2087%26epage%3D2093%26doi%3D10.1016%2Fj.bmcl.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulhearn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henze, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolinone Aryl Sulfonamides as Potent, Selective Na<sub>V</sub>1.7 Inhibitors with <i>in vivo</i> Efficacy in a Preclinical Pain Model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2017.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=28465103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2683-2688&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=H.+D.+G.+F.+Lehmanauthor=M.+J.+Kellyauthor=J.+J.+Mulhearnauthor=S.+E.+Wolkenbergauthor=M.+J.+Catoauthor=M.+K.+Clementsauthor=C.+J.+Daleyauthor=T.+Filzenauthor=E.+N.+Fingerauthor=Y.+Greganauthor=D.+A.+Henzeauthor=A.+Jovanovskaauthor=R.+Kleinauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+Liangauthor=J.+M.+Majercakauthor=J.+Panigelauthor=M.+O.+Urbanauthor=J.+Wangauthor=Y.-H.+Wangauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Benzoxazolinone+Aryl+Sulfonamides+as+Potent%2C+Selective+NaV1.7+Inhibitors+with+in+vivo+Efficacy+in+a+Preclinical+Pain+Model&doi=10.1016%2Fj.bmcl.2017.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model</span></div><div class="casAuthors">Pero, Joseph E.; Rossi, Michael A.; Lehman, Hannah D. G. F.; Kelly, Michael J., III; Mulhearn, James J.; Wolkenberg, Scott E.; Cato, Matthew J.; Clements, Michelle K.; Daley, Christopher J.; Filzen, Tracey; Finger, Eleftheria N.; Gregan, Yun; Henze, Darrell A.; Jovanovska, Aneta; Klein, Rebecca; Kraus, Richard L.; Li, Yuxing; Liang, Annie; Majercak, John M.; Panigel, Jacqueline; Urban, Mark O.; Wang, Jixin; Wang, Ying-Hong; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2683-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies on human genetics have suggested that inhibitors of the Nav1.7 voltage-gated sodium channel hold considerable promise as therapies for the treatment of chronic pain syndromes.  Herein, we report novel, peripherally-restricted benzoxazolinone aryl sulfonamides as potent Nav1.7 inhibitors with excellent selectivity against the Nav1.5 isoform, which is expressed in the heart muscle.  Elaboration of initial lead compd. 3d afforded exemplar 13, which featured attractive physicochem. properties, outstanding lipophilic ligand efficiency and pharmacol. selectivity against Nav1.5 exceeding 1000-fold.  Key structure-activity relationships assocd. with oral bioavailability were leveraged to discover compd. 17, which exhibited a comparable potency/selectivity profile as well as full efficacy following oral administration in a preclin. model indicative of antinociceptive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCg6OCYoM57Vg90H21EOLACvtfcHk0ljOABS3KTMglw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D&md5=9ea2c021a2c76ffe0bb8c623d1eb7427</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DLehman%26aufirst%3DH.%2BD.%2BG.%2BF.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DCato%26aufirst%3DM.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DDaley%26aufirst%3DC.%2BJ.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DGregan%26aufirst%3DY.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMajercak%26aufirst%3DJ.%2BM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DBenzoxazolinone%2520Aryl%2520Sulfonamides%2520as%2520Potent%252C%2520Selective%2520NaV1.7%2520Inhibitors%2520with%2520in%2520vivo%2520Efficacy%2520in%2520a%2520Preclinical%2520Pain%2520Model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2683%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2017.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span> <span> </span><span class="NLM_article-title">The Discovery of Tetrahydropyridine Analogs as hNa<sub>V</sub>1.7 Selective Inhibitors for Analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2017.03.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=28385504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2210-2215&author=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=M.+Tengauthor=J.+Qinauthor=Z.+Huauthor=L.+Houauthor=L.+Shenauthor=H.+Dongauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=J.+Zhangauthor=L.+Ye&title=The+Discovery+of+Tetrahydropyridine+Analogs+as+hNaV1.7+Selective+Inhibitors+for+Analgesia&doi=10.1016%2Fj.bmcl.2017.03.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia</span></div><div class="casAuthors">Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Teng, Mingxing; Qin, Jian; Hu, Zhijing; Hou, Lijuan; Shen, Liang; Dong, Haiheng; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Zhang, Jianzhao; Ye, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2210-2215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 small mol. inhibitors have attracted lots of attention by its unique analgesic effect.  Herein, the design and synthesis of a novel series of tetrahydropyridine analogs as hNav1.7 inhibitors for analgesia is reported.  Detail structural-activity relationship (SAR) studies were undertaken towards improving hNav1.7 activity, in vitro ADME, and in vivo PK profiles.  These efforts resulted in the identification of compd. (-)-I, a highly potent and selective hNav1.7 inhibitor with good ADME and PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP6xx5fd4NYrVg90H21EOLACvtfcHk0ljOABS3KTMglw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D&md5=ed0b99fa7611354124394c07bbf259ac</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.043%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26atitle%3DThe%2520Discovery%2520of%2520Tetrahydropyridine%2520Analogs%2520as%2520hNaV1.7%2520Selective%2520Inhibitors%2520for%2520Analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2210%26epage%3D2215%26doi%3D10.1016%2Fj.bmcl.2017.03.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">De Groot, M. J.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Pacheco, M. P.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span>; <span class="NLM_string-name">Gaulier, S. M.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. US. Patent Appl.<span class="NLM_patent">US 2012/0010183</span>, Jan 12th, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=M.+J.+De+Groot&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=D.+S.+Millan&author=M.+P.+Pacheco&author=D.+J.+Rawson&author=N.+Sciammetta&author=R.+I.+Storer&author=N.+A.+Swain&author=S.+M.+Gaulier&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">De Groot, M. J.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Indazole Derivatives as Sodium Channel Inhibitors and Their Preparation and Use in the Treatment of Pain</span>. PCT Int. Appl. <span class="NLM_patent">WO 2012/095781</span>, July 19th, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=M.+J.+De+Groot&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=N.+Sciammetta&author=R.+I.+Storer&author=N.+A.+Swain&title=Indazole+Derivatives+as+Sodium+Channel+Inhibitors+and+Their+Preparation+and+Use+in+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DIndazole%2520Derivatives%2520as%2520Sodium%2520Channel%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Pain%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.–J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Development of New Benzenesulfonamides as Potent and Selective Na<sub>V</sub>1.7 Inhibitors for the Treatment of Pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2513-2525&author=Y.%E2%80%93J.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=J.+Dittaauthor=K.+J.+Robbinsauthor=R.+Rajamaniauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Development+of+New+Benzenesulfonamides+as+Potent+and+Selective+NaV1.7+Inhibitors+for+the+Treatment+of+Pain&doi=10.1021%2Facs.jmedchem.6b01918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Shi, Jianliang; Ditta, Jonathan; Robbins, Kevin J.; Rajamani, Ramkumar; Easton, Amy; Newton, Amy; Bourin, Clotilde; Mosure, Kathleen; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of certain features in piperidine (I), the authors developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Nav1.7 inhibitors.  However, 4-((((1S,4S)-4-aminocydohexyl)methyl)amino)-5-chloro-2-fluoro-N-(thiazol-2-yl)benzenesulfonamide (24), one of the early analogs, failed to reduce phase 2 flinching in the mouse formalin test even at a dose of 100 mpk PO due to insufficient DRG exposure attributed to poor membrane permeability.  Two analogs with improved membrane permeability showed much increased DRG concns. at doses of 30 mpk PO but, confoundingly, only one of these was effective in the formalin test.  More data are needed to understand the disconnect between efficacy and exposure relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVESOC2ks88bVg90H21EOLACvtfcHk0ljgmeAoX7ITOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D&md5=d320dedb1d61794445680d94dc2c7e48</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01918%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%25E2%2580%2593J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DDitta%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520New%2520Benzenesulfonamides%2520as%2520Potent%2520and%2520Selective%2520NaV1.7%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2513%26epage%3D2525%26doi%3D10.1021%2Facs.jmedchem.6b01918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. – J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaby, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarao, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Non-Zwitterionic Aryl Sulfonamides as Na<sub>V</sub>1.7 Inhibitors with Efficacy in Preclinical Behavioral Models and Translational Measures of Nociceptive Neuron Activation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5490</span>– <span class="NLM_lpage">5505</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmc.2017.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=28818462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5490-5505&author=Y.+%E2%80%93+J.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=G.+Luoauthor=R.+Rajamaniauthor=A.+Ngauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=D.+Parkerauthor=K.+Mosureauthor=O.+Barnabyauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+Pieschlauthor=J.+Herringtonauthor=P.+Chenauthor=D.+V.+Sivaraoauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=J.+Bronsonauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+Non-Zwitterionic+Aryl+Sulfonamides+as+NaV1.7+Inhibitors+with+Efficacy+in+Preclinical+Behavioral+Models+and+Translational+Measures+of+Nociceptive+Neuron+Activation&doi=10.1016%2Fj.bmc.2017.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Luo, Guanglin; Rajamani, Ramkumar; Ng, Alicia; Easton, Amy; Newton, Amy; Bourin, Clotilde; Parker, Dawn; Mosure, Kathleen; Barnaby, Omar; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick; Herrington, James; Chen, Ping; Sivarao, D. V.; Bristow, Linda J.; Meanwell, Nicholas A.; Bronson, Joanne; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5490-5505</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since zwitterionic benzenesulfonamide Nav1.7 inhibitors suffer from poor membrane permeability, the authors sought to eliminate this characteristic by replacing the basic moiety with non-basic bicyclic acetals and monocyclic ethers.  These efforts led to the discovery of the non-zwitterionic aryl sulfonamide 49 ((R)-5-chloro-2-fluoro-4-(((tetrahydro-2H-pyran-3-yl)methyl)amino)-N-(thiazol-2-yl)benzenesulfonamide) as a selective Nav1.7 inhibitor with improved membrane permeability.  Despite its moderate cellular activity, 49 exhibited robust efficacy in mouse models of neuropathic and inflammatory pain and modulated translational electromyogram measures assocd. with activation of nociceptive neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfNtc0Dv967Vg90H21EOLACvtfcHk0ljgmeAoX7ITOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE&md5=d8426c3423ce37ddfb45f1ea31f89d16</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2B%25E2%2580%2593%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DBarnaby%26aufirst%3DO.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520Non-Zwitterionic%2520Aryl%2520Sulfonamides%2520as%2520NaV1.7%2520Inhibitors%2520with%2520Efficacy%2520in%2520Preclinical%2520Behavioral%2520Models%2520and%2520Translational%2520Measures%2520of%2520Nociceptive%2520Neuron%2520Activation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5490%26epage%3D5505%26doi%3D10.1016%2Fj.bmc.2017.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. – J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Morpholine-Based Aryl Sulfonamides as Na<sub>V</sub>1.7 Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.01.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2018.01.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=29439904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=958-962&author=Y.+%E2%80%93+J.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=B.+Venablesauthor=R.+Rajamaniauthor=K.+Robbinsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=J.+Herringtonauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+Morpholine-Based+Aryl+Sulfonamides+as+NaV1.7+Inhibitors&doi=10.1016%2Fj.bmcl.2018.01.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Venables, Brian; Rajamani, Ramkumar; Robbins, Kevin J.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Herrington, James; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">958-962</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Replacement of the piperidine ring in the lead benzenesulfonamide Nav1.7 inhibitor I with a weakly basic morpholine core resulted in a significant redn. in Nav1.7 inhibitory activity, but the activity was restored by shortening the linkage from methyleneoxy to oxygen.  These efforts led to a series of morpholine-based aryl sulfonamides as isoform-selective Nav1.7 inhibitors.  This report describes the synthesis and SAR of these analogs.  Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgiZrOTuKrbVg90H21EOLACvtfcHk0lhOACE1o83I-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCmtLc%253D&md5=7d9f583e76737c61f2b7c386ed661619</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.01.035%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2B%25E2%2580%2593%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DVenables%26aufirst%3DB.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DRobbins%26aufirst%3DK.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520Morpholine-Based%2520Aryl%2520Sulfonamides%2520as%2520NaV1.7%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D958%26epage%3D962%26doi%3D10.1016%2Fj.bmcl.2018.01.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fevig, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amparo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aungst, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knab, br M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-[3-(Aminomethyl)Phenyl]-<i>N</i>-[3-Fluoro-2′-(Methylsulfonyl)-[1,1′-Biphenyl]-4-yl]-3-(Trifluoromethyl)-1<i>H</i>-Pyrazole-5-Carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/jm000409z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000409z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=566-578&author=D.+J.+P.+Pintoauthor=M.+J.+Orwatauthor=S.+Wangauthor=J.+M.+Fevigauthor=M.+L.+Quanauthor=E.+Amparoauthor=J.+Cacciolaauthor=K.+A.+Rossiauthor=R.+S.+Alexanderauthor=A.+M.+Smallwoodauthor=J.+M.+Luettgenauthor=L.+Liangauthor=B.+J.+Aungstauthor=M.+R.+Wrightauthor=br+M.+Knabauthor=P.+C.+Wongauthor=R.+R.+Wexlerauthor=P.+Y.+S.+Lam&title=Discovery+of+1-%5B3-%28Aminomethyl%29Phenyl%5D-N-%5B3-Fluoro-2%E2%80%B2-%28Methylsulfonyl%29-%5B1%2C1%E2%80%B2-Biphenyl%5D-4-yl%5D-3-%28Trifluoromethyl%29-1H-Pyrazole-5-Carboxamide+%28DPC423%29%2C+a+Highly+Potent%2C+Selective%2C+and+Orally+Bioavailable+Inhibitor+of+Blood+Coagulation+Factor+Xa&doi=10.1021%2Fjm000409z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm000409z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000409z%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFevig%26aufirst%3DJ.%2BM.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DAmparo%26aufirst%3DE.%26aulast%3DCacciola%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DAungst%26aufirst%3DB.%2BJ.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DKnab%26aufirst%3Dbr%2BM.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26atitle%3DDiscovery%2520of%25201-%255B3-%2528Aminomethyl%2529Phenyl%255D-N-%255B3-Fluoro-2%25E2%2580%25B2-%2528Methylsulfonyl%2529-%255B1%252C1%25E2%2580%25B2-Biphenyl%255D-4-yl%255D-3-%2528Trifluoromethyl%2529-1H-Pyrazole-5-Carboxamide%2520%2528DPC423%2529%252C%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520Blood%2520Coagulation%2520Factor%2520Xa%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D566%26epage%3D578%26doi%3D10.1021%2Fjm000409z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span>; <span class="NLM_string-name">Venables, B.</span>; <span class="NLM_string-name">Guernon, J.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Sit, S.-Y.</span>; <span class="NLM_string-name">Rajamani, R.</span>; <span class="NLM_string-name">Knox, R. J.</span>; <span class="NLM_string-name">Matchett, M.</span>; <span class="NLM_string-name">Pieschl, R. L.</span>; <span class="NLM_string-name">Herrington, J.</span>; <span class="NLM_string-name">Bristow, L. J.</span>; <span class="NLM_string-name">Meanwell, N. A.</span>; <span class="NLM_string-name">Thompson, L. A.</span>; <span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of New Indole-based Acylsulfonamide Nav1.7 Inhibitors</span>.  <i>Bioorg. Med. Chem. Lett.</i>, <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume">29</span>, DOI: <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.013</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2018.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&author=Y.-J.+Wu&author=B.+Venables&author=J.+Guernon&author=J.+Chen&author=S.-Y.+Sit&author=R.+Rajamani&author=R.+J.+Knox&author=M.+Matchett&author=R.+L.+Pieschl&author=J.+Herrington&author=L.+J.+Bristow&author=N.+A.+Meanwell&author=L.+A.+Thompson&author=C.+Dzierba&title=Discovery+of+New+Indole-based+Acylsulfonamide+Nav1.7+Inhibitors&doi=10.1016%2Fj.bmcl.2018.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26atitle%3DDiscovery%2520of%2520New%2520Indole-based%2520Acylsulfonamide%2520Nav1.7%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D29%26doi%3D10.1016%2Fj.bmcl.2018.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubuisson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, S. G.</span></span> <span> </span><span class="NLM_article-title">The Formalin Test: A Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(77)90130-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2F0304-3959%2877%2990130-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-174&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+Formalin+Test%3A+A+Quantitative+Study+of+the+Analgesic+Effects+of+Morphine%2C+Meperidine%2C+and+Brain+Stem+Stimulation+in+Rats+and+Cats&doi=10.1016%2F0304-3959%2877%2990130-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test:  a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span></div><div class="casAuthors">Dubuisson, David; Dennis, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-74</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In a procedure to evaluate the analgesic strengths of morphine sulfate  [64-31-3] and meperidine-HCl  [50-13-5], cats or rats, which were pretreated with an appropriate analgesic dose of either drug, were injected with a soln. of formalin  [50-00-0] in the paws and the pain-related behavior was obsd. and compared with that obsd. in the control animals which received formalin but no analgesic.  Pretreatment with either of the 2 analgesics or brain stem stimulation significantly decreased the effect of the pain stimuli.  Morphine and brain stem stimulation provided similar and greater analgesia than meperidine.  The behavioral patterns of the animals seemed to be similar following morphine or the brain stem stimultion.  Thus, formalin injection can be used effectively to evaluate the potencies of analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0ErPKDkXGbVg90H21EOLACvtfcHk0lhOACE1o83I-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D&md5=bd26bbc3c46b9c964d0b3aa011580980</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2877%2990130-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252877%252990130-0%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Formalin%2520Test%253A%2520A%2520Quantitative%2520Study%2520of%2520the%2520Analgesic%2520Effects%2520of%2520Morphine%252C%2520Meperidine%252C%2520and%2520Brain%2520Stem%2520Stimulation%2520in%2520Rats%2520and%2520Cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D174%26doi%3D10.1016%2F0304-3959%2877%2990130-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingledine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaradhi, R.</span></span> <span> </span><span class="NLM_article-title">Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5809</span>– <span class="NLM_lpage">5817</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.8b00764</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.8b00764" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2rurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=5809-5817&author=T.+Ganeshauthor=A.+Banikauthor=R.+Dingledineauthor=W.+Wangauthor=R.+Amaradhi&title=Peripherally+Restricted%2C+Highly+Potent%2C+Selective%2C+Aqueous-Soluble+EP2+Antagonist+with+Anti-Inflammatory+Properties&doi=10.1021%2Facs.molpharmaceut.8b00764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties</span></div><div class="casAuthors">Ganesh, Thota; Banik, Avijit; Dingledine, Ray; Wang, Wenyi; Amaradhi, Radhika</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5809-5817</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prostaglandin E2 receptor, EP2, plays an important role in physiol. and in a variety of pathol. conditions.  Studies indicate that EP2 is pro-inflammatory in chronic peripheral and central nervous system disease and cancer models.  Thus, targeting the EP2 receptor with small mols. could be a therapeutic strategy for treating inflammatory diseases and cancer.  The authors recently reported a novel class of competitive antagonists of the EP2 receptor.  However, earlier leads displayed low selectivity against the DP1 prostanoid receptor, moderate plasma half-life, and low aq. soly., which renders them suboptimal for testing in animal models of disease.  The authors now report a novel compd. TG8-69, which has suitable drug-like properties.  The authors present synthesis, lead-optimization studies, pharmacol. characterization, and anti-inflammatory properties of this compd. that support its use in chronic peripheral inflammatory diseases, including rheumatoid arthritis, endometriosis, and cancer, in which EP2 appears to play a pathogenic role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQoFDKN4q9LLVg90H21EOLACvtfcHk0ljUrjXXhv6d3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2rurbF&md5=aef1113b2a028176e383364b37a2618b</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.8b00764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.8b00764%26sid%3Dliteratum%253Aachs%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DBanik%26aufirst%3DA.%26aulast%3DDingledine%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DAmaradhi%26aufirst%3DR.%26atitle%3DPeripherally%2520Restricted%252C%2520Highly%2520Potent%252C%2520Selective%252C%2520Aqueous-Soluble%2520EP2%2520Antagonist%2520with%2520Anti-Inflammatory%2520Properties%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2018%26volume%3D15%26spage%3D5809%26epage%3D5817%26doi%3D10.1021%2Facs.molpharmaceut.8b00764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernier, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorusso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westlin, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evindar, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of Clinical Candidate GSK1842799 as a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">942</span>– <span class="NLM_lpage">947</span>, <span class="refDoi"> DOI: 10.1021/ml400194r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400194r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=942-947&author=H.+Dengauthor=S.+G.+Bernierauthor=E.+Doyleauthor=J.+Lorussoauthor=B.+A.+Morganauthor=W.+F.+Westlinauthor=G.+Evindar&title=Discovery+of+Clinical+Candidate+GSK1842799+as+a+Selective+S1P1+Receptor+Agonist+%28Prodrug%29+for+Multiple+Sclerosis&doi=10.1021%2Fml400194r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1021%2Fml400194r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400194r%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DBernier%26aufirst%3DS.%2BG.%26aulast%3DDoyle%26aufirst%3DE.%26aulast%3DLorusso%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DWestlin%26aufirst%3DW.%2BF.%26aulast%3DEvindar%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520Clinical%2520Candidate%2520GSK1842799%2520as%2520a%2520Selective%2520S1P1%2520Receptor%2520Agonist%2520%2528Prodrug%2529%2520for%2520Multiple%2520Sclerosis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D942%26epage%3D947%26doi%3D10.1021%2Fml400194r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit34c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodchild, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelkenbrecher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimi Tari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span> <span> </span><span class="NLM_article-title">Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of <i>N</i>-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methanesulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4810</span>– <span class="NLM_lpage">4831</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01826</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01826" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4810-4831&author=T.+Fockenauthor=S.+Chowdhuryauthor=A.+Zenovaauthor=M.+E.+Grimwoodauthor=C.+Chabotauthor=T.+Shengauthor=I.+Hemeonauthor=S.+M.+Deckerauthor=M.+Wilsonauthor=P.+Bichlerauthor=Q.+Jiaauthor=S.+Sunauthor=C.+Youngauthor=S.+Linauthor=S.+J.+Goodchildauthor=N.+G.+Shuartauthor=E.+Changauthor=Z.+Xieauthor=B.+Liauthor=K.+Khakhauthor=G.+Bankarauthor=M.+Waldbrookauthor=R.+Kwanauthor=K.+Nelkenbrecherauthor=P.+Karimi+Tariauthor=N.+Chahalauthor=L.+Sojoauthor=C.+L.+Robinetteauthor=A.+D.+Whiteauthor=C.-A.+Chenauthor=Y.+Zhangauthor=J.+Pangauthor=J.+H.+Changauthor=D.+H.+Hackosauthor=J.+P.+Johnsonauthor=C.+J.+Cohenauthor=D.+F.+Ortwineauthor=D.+P.+Sutherlinauthor=C.+M.+Dehnhardtauthor=B.+S.+Safina&title=Design+of+Conformationally+Constrained+Acyl+Sulfonamide+Isosteres%3A+Identification+of+N-%28%5B1%2C2%2C4%5DTriazolo%5B4%2C3-a%5Dpyridin-3-yl%29methanesulfonamides+as+Potent+and+Selective+hNaV1.7+Inhibitors+for+the+Treatment+of+Pain&doi=10.1021%2Facs.jmedchem.7b01826"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01826%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DZenova%26aufirst%3DA.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DDecker%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DGoodchild%26aufirst%3DS.%2BJ.%26aulast%3DShuart%26aufirst%3DN.%2BG.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DNelkenbrecher%26aufirst%3DK.%26aulast%3DKarimi%2BTari%26aufirst%3DP.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DSojo%26aufirst%3DL.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26aulast%3DWhite%26aufirst%3DA.%2BD.%26aulast%3DChen%26aufirst%3DC.-A.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26atitle%3DDesign%2520of%2520Conformationally%2520Constrained%2520Acyl%2520Sulfonamide%2520Isosteres%253A%2520Identification%2520of%2520N-%2528%255B1%252C2%252C4%255DTriazolo%255B4%252C3-a%255Dpyridin-3-yl%2529methanesulfonamides%2520as%2520Potent%2520and%2520Selective%2520hNaV1.7%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4810%26epage%3D4831%26doi%3D10.1021%2Facs.jmedchem.7b01826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzygiel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segelbacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flanaganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+Micro-Dose+Studies+to+Explore+the+Human+Pharmacokinetics+of+Four+Selective+Inhibitors+of+Human+Nav1.7+Voltage-Dependent+Sodium+Channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0ljOKfIghsEKjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanagan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520Micro-Dose%2520Studies%2520to%2520Explore%2520the%2520Human%2520Pharmacokinetics%2520of%2520Four%2520Selective%2520Inhibitors%2520of%2520Human%2520Nav1.7%2520Voltage-Dependent%2520Sodium%2520Channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N.</span></span> <span> </span><span class="NLM_article-title">Design of Subtype Selective Nav1.7 Inhibitors for the Treatment of Pain</span>.  <i>Abstracts of Papers, 249th ACS National Meeting & Exposition, Denver, CO, March 22-26, 2015</i>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2015</span>,  <span class="NLM_fpage">MEDI-172</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=MEDI-172&author=N.+Swain&title=Abstracts+of+Papers%2C+249th+ACS+National+Meeting+%26+Exposition%2C+Denver%2C+CO%2C+March+22-26%2C+2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%26atitle%3DDesign%2520of%2520Subtype%2520Selective%2520Nav1.7%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pain%26btitle%3DAbstracts%2520of%2520Papers%252C%2520249th%2520ACS%2520National%2520Meeting%2520%2526%2520Exposition%252C%2520Denver%252C%2520CO%252C%2520March%252022-26%252C%25202015%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2015%26spage%3DMEDI-172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamoto, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilenkin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, D. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund’s Adjuvant Models of Pain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0138140</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0138140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1371%2Fjournal.pone.0138140" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0138140&author=D.+J.+Matsonauthor=D.+T.+Hamamotoauthor=H.+Bregmanauthor=M.+Cookeauthor=D.+F.+DiMauroauthor=L.+Huangauthor=D.+Johnsonauthor=X.+Liauthor=J.+McDermottauthor=C.+Morganauthor=B.+Wilenkinauthor=A.+B.+Malmbergauthor=S.+I.+McDonoughauthor=D.+A.+Simone&title=Inhibition+of+Inactive+States+of+Tetrodotoxin-Sensitive+Sodium+Channels+Reduces+Spontaneous+Firing+of+C-Fiber+Nociceptors+and+Produces+Analgesia+in+Formalin+and+Complete+Freund%E2%80%99s+Adjuvant+Models+of+Pain&doi=10.1371%2Fjournal.pone.0138140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0138140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0138140%26sid%3Dliteratum%253Aachs%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DHamamoto%26aufirst%3DD.%2BT.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DD.%2BF.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMcDermott%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DC.%26aulast%3DWilenkin%26aufirst%3DB.%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DSimone%26aufirst%3DD.%2BA.%26atitle%3DInhibition%2520of%2520Inactive%2520States%2520of%2520Tetrodotoxin-Sensitive%2520Sodium%2520Channels%2520Reduces%2520Spontaneous%2520Firing%2520of%2520C-Fiber%2520Nociceptors%2520and%2520Produces%2520Analgesia%2520in%2520Formalin%2520and%2520Complete%2520Freund%25E2%2580%2599s%2520Adjuvant%2520Models%2520of%2520Pain%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0138140%26doi%3D10.1371%2Fjournal.pone.0138140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubner, R.</span></span> <span> </span><span class="NLM_article-title">Inflammatory Models of Pain and Hyperalgesia</span>. <i>ILAR J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1093/ilar.40.3.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1093%2Filar.40.3.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=11406689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BC2srjs1Gmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=111-118&author=K.+Renauthor=R.+Dubner&title=Inflammatory+Models+of+Pain+and+Hyperalgesia&doi=10.1093%2Filar.40.3.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory Models of Pain and Hyperalgesia</span></div><div class="casAuthors">Ren Ke; Dubner Ronald</div><div class="citationInfo"><span class="NLM_cas:title">ILAR journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">111-118</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article addresses important pain research models in nonhuman animals.  These models attempt to mimic human persistent pain conditions.  Models of persistent pain employ inflammatory agents that produce discomfort and hyperalgesia (i.e., an enhanced response to a noxious stimulus).  The models are associated with skin, subcutaneous tissue, and joint inflammation (somatic structures).  Studies employing such models have led to significantly improved understanding of mechanisms of somatic pain.  It is important that investigators assess the level of pain produced in these animals and provide analgesic agents whenever it does not interfere with the purpose of the experiment.  Pain can be inferred from ongoing behavioral variables such as feeding and drinking, sleep-waking cycle, grooming, and social behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTp4mVi1DOWUUwlCcfExbvbfW6udTcc2ebWoi96logOM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjs1Gmsg%253D%253D&md5=f297e3756d02c459c75e2ef76849a74c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Filar.40.3.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Filar.40.3.111%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DK.%26aulast%3DDubner%26aufirst%3DR.%26atitle%3DInflammatory%2520Models%2520of%2520Pain%2520and%2520Hyperalgesia%26jtitle%3DILAR%2520J.%26date%3D1999%26volume%3D40%26spage%3D111%26epage%3D118%26doi%3D10.1093%2Filar.40.3.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jasmin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franssen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, J. R.</span></span> <span> </span><span class="NLM_article-title">The Cold Plate as a Test of Nociceptive Behaviors: Description and Application to the Study of Chronic Neuropathic and Inflammatory Pain Models</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1016/S0304-3959(98)00017-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2FS0304-3959%2898%2900017-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1998&pages=367-382&author=L.+Jasminauthor=L.+Kohanauthor=M.+Franssenauthor=G.+Janniauthor=J.+R.+Goff&title=The+Cold+Plate+as+a+Test+of+Nociceptive+Behaviors%3A+Description+and+Application+to+the+Study+of+Chronic+Neuropathic+and+Inflammatory+Pain+Models&doi=10.1016%2FS0304-3959%2898%2900017-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2898%2900017-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252898%252900017-7%26sid%3Dliteratum%253Aachs%26aulast%3DJasmin%26aufirst%3DL.%26aulast%3DKohan%26aufirst%3DL.%26aulast%3DFranssen%26aufirst%3DM.%26aulast%3DJanni%26aufirst%3DG.%26aulast%3DGoff%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Cold%2520Plate%2520as%2520a%2520Test%2520of%2520Nociceptive%2520Behaviors%253A%2520Description%2520and%2520Application%2520to%2520the%2520Study%2520of%2520Chronic%2520Neuropathic%2520and%2520Inflammatory%2520Pain%2520Models%26jtitle%3DPain%26date%3D1998%26volume%3D75%26spage%3D367%26epage%3D382%26doi%3D10.1016%2FS0304-3959%2898%2900017-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koltzenburg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stucky, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, G. R.</span></span> <span> </span><span class="NLM_article-title">Receptive Properties of Mouse Sensory Neurons Innervating Hairy Skin</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1841</span>– <span class="NLM_lpage">1850</span>, <span class="refDoi"> DOI: 10.1152/jn.1997.78.4.1841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1152%2Fjn.1997.78.4.1841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=9325353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADyaK2svmslajuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1997&pages=1841-1850&author=M.+Koltzenburgauthor=C.+L.+Stuckyauthor=G.+R.+Lewin&title=Receptive+Properties+of+Mouse+Sensory+Neurons+Innervating+Hairy+Skin&doi=10.1152%2Fjn.1997.78.4.1841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Receptive properties of mouse sensory neurons innervating hairy skin</span></div><div class="casAuthors">Koltzenburg M; Stucky C L; Lewin G R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurophysiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1841-50</span>
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    </div><div class="casAbstract">Using an in vitro nerve skin preparation and controlled mechanical or thermal stimuli, we analyzed the receptive properties of 277 mechanosensitive single primary afferents with myelinated (n = 251) or unmyelinated (n = 26) axons innervating the hairy skin in adult or 2-wk-old mice.  Afferents were recorded from small filaments of either sural or saphenous nerves in an outbred mice strain or in the inbred Balb/c strain.  On the basis of their receptive properties and conduction velocity, several receptor types could be distinguished.  In adult animals (>6 wk old), 54% of the large myelinated fibers (Abeta, n = 83) showed rapidly adapting (RA) discharges to constant force stimuli and probably innervated hair follicles, whereas 46% displayed a slowly adapting (SA) response and probably innervated Merkel cells in touch domes.  Among thin myelinated fibers (Adelta, n = 91), 34% were sensitive D hair receptors and 66% were high-threshold mechanoreceptors (AM fibers).  Unmyelinated fibers had high mechanical thresholds and nociceptive functions.  All receptor types had characteristic stimulus-response functions to suprathreshold force stimuli.  Noxious heat stimuli (15-s ramp from 32 to 47 degrees C measured at the corium side of the skin) excited 26% (5 of 19) of AM fibers with a threshold of 42.5 +/- 1.4 degrees C (mean +/- SE) and an average discharge of 15.8 +/- 9.7 action potentials and 41% (7 of 17) C fibers with a mean threshold of 37.6 +/- 1.9 degrees C and an average discharge of 22.0 +/- 6.0 action potentials.  Noxious cold stimuli activated 1 of 10 AM fibers and 3 of 10 C fibers.  One of 10 C units responded to both heat and cold stimuli.  All types of afferent fibers present in adult mice could readily be recognized in mice at postnatal day 14.  However, fibers had reduced conduction velocities and the stimulus-response function to mechanical stimuli was more shallow in all fibers except for the D hairs.  In juvenile mice, 22% of RA units also displayed an SA response at high stimulus intensities; these units were termed RA/SA units.  We conclude that all types of cutaneous afferent fibers are already committed to their phenotype 2 wk after birth but undergo some maturation over the following weeks.  This preparation has great potential for the study of transgenic mice with targeted mutations of genes that code factors that are involved in the specification of sensory neuron phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRX3Zr3olesLPtos8R3JUhXfW6udTcc2eYP34R7jirisbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svmslajuw%253D%253D&md5=3884440a177af6eccac988fa92919969</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1152%2Fjn.1997.78.4.1841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.1997.78.4.1841%26sid%3Dliteratum%253Aachs%26aulast%3DKoltzenburg%26aufirst%3DM.%26aulast%3DStucky%26aufirst%3DC.%2BL.%26aulast%3DLewin%26aufirst%3DG.%2BR.%26atitle%3DReceptive%2520Properties%2520of%2520Mouse%2520Sensory%2520Neurons%2520Innervating%2520Hairy%2520Skin%26jtitle%3DJ.%2520Neurophysiol.%26date%3D1997%26volume%3D78%26spage%3D1841%26epage%3D1850%26doi%3D10.1152%2Fjn.1997.78.4.1841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span> <span> </span><span class="NLM_article-title">Facile Synthesis of Acyl sulfonamides from Carboxylic Acids Using the Mukaiyama Reagent</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2018.12.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.tetlet.2018.12.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2019&pages=268-271&author=L.+Chenauthor=G.+Luo&title=Facile+Synthesis+of+Acyl+sulfonamides+from+Carboxylic+Acids+Using+the+Mukaiyama+Reagent&doi=10.1016%2Fj.tetlet.2018.12.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2018.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2018.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DG.%26atitle%3DFacile%2520Synthesis%2520of%2520Acyl%2520sulfonamides%2520from%2520Carboxylic%2520Acids%2520Using%2520the%2520Mukaiyama%2520Reagent%26jtitle%3DTetrahedron%2520Lett.%26date%3D2019%26volume%3D60%26spage%3D268%26epage%3D271%26doi%3D10.1016%2Fj.tetlet.2018.12.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mothes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavielle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karoyan, P.</span></span> <span> </span><span class="NLM_article-title">Amino-Zinc-Ene-Enolate Cyclization: A Short Access to cis-3-Substituted Prolino-Homotryptophane Derivatives</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">6706</span>– <span class="NLM_lpage">6710</span>, <span class="refDoi"> DOI: 10.1021/jo801006a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo801006a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVGjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=6706-6710&author=C.+Mothesauthor=S.+Lavielleauthor=P.+Karoyan&title=Amino-Zinc-Ene-Enolate+Cyclization%3A+A+Short+Access+to+cis-3-Substituted+Prolino-Homotryptophane+Derivatives&doi=10.1021%2Fjo801006a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-zinc-ene-enolate cyclization: A short access to cis-3-substituted prolino-homotryptophane derivatives</span></div><div class="casAuthors">Mothes, Celine; Lavielle, Solange; Karoyan, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6706-6710</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proline chimeras are useful tools for medicinal chem. and/or biol. applications.  The asym. synthesis of cis-3-substituted prolines can be easily achieved via amino-zinc-ene-enolate cyclization followed by transmetalation of the cyclic zinc intermediate for further functionalization.  Syntheses of prolino-homotryptophane derivs. were achieved through Negishi cross-coupling of the zinc intermediate with indole rings.  The use of Pd catalyst derived from Fu's [(t-Bu3)PH]-BF4 was required to avoid the undesired β-hydride elimination.  Optically pure and orthogonally protected compds. were obtained readily usable for peptide synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo5KvhXDhBVbVg90H21EOLACvtfcHk0lgfAelZEjfRVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVGjs7o%253D&md5=c039bdf833efbab59b2984fd6e8ab88e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo801006a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801006a%26sid%3Dliteratum%253Aachs%26aulast%3DMothes%26aufirst%3DC.%26aulast%3DLavielle%26aufirst%3DS.%26aulast%3DKaroyan%26aufirst%3DP.%26atitle%3DAmino-Zinc-Ene-Enolate%2520Cyclization%253A%2520A%2520Short%2520Access%2520to%2520cis-3-Substituted%2520Prolino-Homotryptophane%2520Derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D6706%26epage%3D6710%26doi%3D10.1021%2Fjo801006a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merkul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T. J.</span></span> <span> </span><span class="NLM_article-title">Rapid Synthesis of Bis(Hetero)Aryls by One-Pot Masuda Borylation-Suzuki Coupling Sequence and Its Application to Concise Total Synthesis of Meridianins A and G</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3139</span>– <span class="NLM_lpage">3141</span>, <span class="refDoi"> DOI: 10.1039/c1ob05310h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1039%2Fc1ob05310h" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=3139-3141&author=E.+Merkulauthor=E.+Schaferauthor=T.+J.+Muller&title=Rapid+Synthesis+of+Bis%28Hetero%29Aryls+by+One-Pot+Masuda+Borylation-Suzuki+Coupling+Sequence+and+Its+Application+to+Concise+Total+Synthesis+of+Meridianins+A+and+G&doi=10.1039%2Fc1ob05310h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2Fc1ob05310h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1ob05310h%26sid%3Dliteratum%253Aachs%26aulast%3DMerkul%26aufirst%3DE.%26aulast%3DSchafer%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DT.%2BJ.%26atitle%3DRapid%2520Synthesis%2520of%2520Bis%2528Hetero%2529Aryls%2520by%2520One-Pot%2520Masuda%2520Borylation-Suzuki%2520Coupling%2520Sequence%2520and%2520Its%2520Application%2520to%2520Concise%2520Total%2520Synthesis%2520of%2520Meridianins%2520A%2520and%2520G%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D3139%26epage%3D3141%26doi%3D10.1039%2Fc1ob05310h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. B.</span>; <span class="NLM_string-name">Paek, S. Y.</span>; <span class="NLM_string-name">Yoon, S. K.</span>; <span class="NLM_string-name">Yoon, S. H.</span>; <span class="NLM_string-name">Choi, J. S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Heterocyclyl Substituted (hetero)aryl Carboxylic Acids as GPR40 Receptor Agonists</span>. PCT Int. Appl. <span class="NLM_patent">WO 201473904</span>, May 15th, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+B.+Lee&author=S.+Y.+Paek&author=S.+K.+Yoon&author=S.+H.+Yoon&author=J.+S.+Choi&title=Preparation+of+Heterocyclyl+Substituted+%28hetero%29aryl+Carboxylic+Acids+as+GPR40+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BB.%26atitle%3DPreparation%2520of%2520Heterocyclyl%2520Substituted%2520%2528hetero%2529aryl%2520Carboxylic%2520Acids%2520as%2520GPR40%2520Receptor%2520Agonists%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Littke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumeillant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaltenbach, R. F.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarby, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiau, S.</span></span> <span> </span><span class="NLM_article-title">Mild and General Methods for the Palladium-Catalyzed Cyanation of Aryl and Heteroaryl Chlorides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1714</span>, <span class="refDoi"> DOI: 10.1021/ol070372d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol070372d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVait7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1711-1714&author=A.+Littkeauthor=M.+Soumeillantauthor=R.+F.+Kaltenbachauthor=R.+J.+Cherneyauthor=C.+M.+Tarbyauthor=S.+Kiau&title=Mild+and+General+Methods+for+the+Palladium-Catalyzed+Cyanation+of+Aryl+and+Heteroaryl+Chlorides&doi=10.1021%2Fol070372d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mild and General Methods for the Palladium-Catalyzed Cyanation of Aryl and Heteroaryl Chlorides</span></div><div class="casAuthors">Littke, Adam; Soumeillant, Maxime; Kaltenbach, Robert F., III; Cherney, Robert J.; Tarby, Christine M.; Kiau, Susanne</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1711-1714</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New methods for the palladium-catalyzed cyanation of aryl and heteroaryl chlorides have been developed, featuring sterically demanding, electron-rich phosphines.  E.g., Pd(TFA)2/(binaphthyl)P(t-Bu)2/Zn catalyzed the cyanation of 4-ClC6H4NH2 by Zn(CN)2 to give 93% 4-NCC6H4NH2.  Highly challenging electron-rich aryl chlorides, in addn. to electron-neutral and electron-deficient substrates, as well as nitrogen- and sulfur-contg. heteroaryl chlorides can all undergo efficient cyanation under relatively mild conditions using readily available materials.  In terms of substrate scope and temp., these methods compare very favorably with the state-of-the-art cyanations of aryl chlorides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2pNIsHoeonLVg90H21EOLACvtfcHk0lj5pzko4ylEcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVait7k%253D&md5=e4685437e438d9d0df3cfe64b9fb3ee5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fol070372d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol070372d%26sid%3Dliteratum%253Aachs%26aulast%3DLittke%26aufirst%3DA.%26aulast%3DSoumeillant%26aufirst%3DM.%26aulast%3DKaltenbach%26aufirst%3DR.%2BF.%26aulast%3DCherney%26aufirst%3DR.%2BJ.%26aulast%3DTarby%26aufirst%3DC.%2BM.%26aulast%3DKiau%26aufirst%3DS.%26atitle%3DMild%2520and%2520General%2520Methods%2520for%2520the%2520Palladium-Catalyzed%2520Cyanation%2520of%2520Aryl%2520and%2520Heteroaryl%2520Chlorides%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D1711%26epage%3D1714%26doi%3D10.1021%2Fol070372d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT Int. Appl. <span class="NLM_patent">WO 2012007868</span>, January 19th, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraley, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brnardic, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrington, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanney, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirdivant, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drakas, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepp-Lorenzino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikuta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreatsoulas, C.</span></span> <span> </span><span class="NLM_article-title">3-(Indol-2-yl)Indazoles as Chek1 Kinase Inhibitors: Optimization of Potency and Selectivity via Substitution at C6</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6049</span>– <span class="NLM_lpage">6053</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2006.08.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=16978863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2jsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=6049-6053&author=M.+E.+Fraleyauthor=J.+T.+Steenauthor=E.+J.+Brnardicauthor=K.+L.+Arringtonauthor=K.+L.+Spencerauthor=B.+A.+Hanneyauthor=Y.+Kimauthor=G.+D.+Hartmanauthor=S.+M.+Stirdivantauthor=B.+A.+Drakasauthor=K.+Rickertauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=J.+Hardwickauthor=W.+Taoauthor=S.+C.+Beckauthor=X.+Maoauthor=R.+B.+Lobellauthor=L.+Sepp-Lorenzinoauthor=Y.+Yanauthor=M.+Ikutaauthor=S.+K.+Munshiauthor=L.+C.+Kuoauthor=C.+Kreatsoulas&title=3-%28Indol-2-yl%29Indazoles+as+Chek1+Kinase+Inhibitors%3A+Optimization+of+Potency+and+Selectivity+via+Substitution+at+C6&doi=10.1016%2Fj.bmcl.2006.08.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6</span></div><div class="casAuthors">Fraley, Mark E.; Steen, Justin T.; Brnardic, Edward J.; Arrington, Kenneth L.; Spencer, Keith L.; Hanney, Barbara A.; Kim, Yuntae; Hartman, George D.; Stirdivant, Steven M.; Drakas, Bob A.; Rickert, Keith; Walsh, Eileen S.; Hamilton, Kelly; Buser, Carolyn A.; Hardwick, James; Tao, Weikang; Beck, Stephen C.; Mao, Xianzhi; Lobell, Robert B.; Sepp-Lorenzino, Laura; Yan, Youwei; Ikuta, Mari; Munshi, Sanjeev K.; Kuo, Lawrence C.; Kreatsoulas, Constantine</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6049-6053</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of 3-(indol-2-yl)indazoles as inhibitors of Chek1 kinase is described.  Introduction of amides and heteroaryl groups at the C6 position of the indazole ring system provided sufficient Chek1 potency and selectivity over Cdk7 to permit escape from DNA damage-induced arrest in a cellular assay.  Enzyme potency against Chek1 was optimized by the incorporation of a hydroxymethyl triazole moiety in compd. 21 (I) (Chek1 IC50 = 0.30 nM) that was shown by X-ray crystallog. to displace one of three highly conserved water mols. in the HI region of the ATP-binding cleft.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1iEFdjN7eWrVg90H21EOLACvtfcHk0lj5pzko4ylEcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2jsrbO&md5=5ce4094132e1e200a96ebb75282bd4a6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.118%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DSteen%26aufirst%3DJ.%2BT.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DSpencer%26aufirst%3DK.%2BL.%26aulast%3DHanney%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DDrakas%26aufirst%3DB.%2BA.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DHardwick%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DKreatsoulas%26aufirst%3DC.%26atitle%3D3-%2528Indol-2-yl%2529Indazoles%2520as%2520Chek1%2520Kinase%2520Inhibitors%253A%2520Optimization%2520of%2520Potency%2520and%2520Selectivity%2520via%2520Substitution%2520at%2520C6%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D6049%26epage%3D6053%26doi%3D10.1016%2Fj.bmcl.2006.08.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gossas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Easy-to-Execute Carbonylations: Microwave Synthesis of Acyl Sulfonamides Using Mo(CO)<sub>6</sub> as a Solid Carbon Monoxide Source</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3094</span>– <span class="NLM_lpage">3098</span>, <span class="refDoi"> DOI: 10.1021/jo050080v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo050080v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVynurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=3094-3098&author=X.+Wuauthor=R.+Ronnauthor=T.+Gossasauthor=M.+Larhed&title=Easy-to-Execute+Carbonylations%3A+Microwave+Synthesis+of+Acyl+Sulfonamides+Using+Mo%28CO%296+as+a+Solid+Carbon+Monoxide+Source&doi=10.1021%2Fjo050080v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Easy-to-Execute Carbonylations: Microwave Synthesis of Acyl Sulfonamides Using Mo(CO)6 as a Solid Carbon Monoxide Source</span></div><div class="casAuthors">Wu, Xiongyu; Roenn, Robert; Gossas, Thomas; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3094-3098</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of a robust palladium-catalyzed amidocarbonylation protocol for the prepn. of arom. acyl sulfonamides utilizing high-d. microwave heating is described.  This synthetic approach employs Mo(CO)6 as a convenient CO-releasing reagent and allows for the direct prepn. of acyl sulfonamides from both aryl iodides and aryl bromides.  The reactions can be performed under air, employing only 15 min of microwave irradn., to produce acyl sulfonamide derivs. in good to excellent yields.  To illustrate the usefulness of this method, we reported the synthesis of a novel hepatitis C virus NS3 protease inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp281_WOJXTW7Vg90H21EOLACvtfcHk0lh3PbBkF7ccCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVynurg%253D&md5=443608fb9917b8194efc9fb778a2aede</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo050080v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050080v%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DRonn%26aufirst%3DR.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DEasy-to-Execute%2520Carbonylations%253A%2520Microwave%2520Synthesis%2520of%2520Acyl%2520Sulfonamides%2520Using%2520Mo%2528CO%25296%2520as%2520a%2520Solid%2520Carbon%2520Monoxide%2520Source%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D3094%26epage%3D3098%26doi%3D10.1021%2Fjo050080v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal-Regulating Kinase 1 Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2011097079</span>, August 11th, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Chang&title=Apoptosis+Signal-Regulating+Kinase+1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26atitle%3DApoptosis%2520Signal-Regulating%2520Kinase%25201%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b','cit34c'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tsuyoshi Shinozuka, Hiroyuki Kobayashi, Sayaka Suzuki, Kyosuke Tanaka, Narayan Karanjule, Noriyuki Hayashi, Toshifumi Tsuda, Eri Tokumaru, Masahiro Inoue, Kiyono Ueda, Hiroko Kimoto, Yuki Domon, Sakiko Takahashi, Kazufumi Kubota, Tomihisa Yokoyama, Akiko Shimizugawa, Ryuta Koishi, Chie Fujiwara, Daigo Asano, Tomoko Sakakura, Kiyoshi Takasuna, Yasuyuki Abe, Toshiyuki Watanabe, <span class="NLM_string-name hlFld-ContribAuthor">Yutaka Kitano</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of DS-1971a, a Potent, Selective NaV1.7 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10204-10220. <a href="https://doi.org/10.1021/acs.jmedchem.0c00259" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00259%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDS-1971a%25252C%252Ba%252BPotent%25252C%252BSelective%252BNaV1.7%252BInhibitor%26aulast%3DShinozuka%26aufirst%3DTsuyoshi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12022020%26date%3D26052020%26date%3D11052020%26volume%3D63%26issue%3D18%26spage%3D10204%26epage%3D10220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vidya Ramdas, Rashmi Talwar, Vijay Kanoje, Rajesh M. Loriya, Moloy Banerjee, Pradeep Patil, Advait Arun Joshi, Laxmikant Datrange, Amit Kumar Das, Deepak Sahebrao Walke, Vaibhav Kalhapure, Talha Khan, Ganesh Gote, Usha Dhayagude, Shreyas Deshpande, Javed Shaikh, Ganesh Chaure, Ravindra R. Pal, Santosh Parkale, Sachin Suravase, Smita Bhoskar, Rajesh V. Gupta, Anil Kalia, Rajesh Yeshodharan, Mahammad Azhar, Jagadeesh Daler, Vinod Mali, Geetika Sharma, Amitesh Kishore, Rupali Vyawahare, Gautam Agarwal, Himani Pareek, Sagar Budhe, Arun Nayak, Dnyaneshwar Warude, Praveen Kumar Gupta, Parag Joshi, Sneha Joshi, Sagar Darekar, Dilip Pandey, Akshaya Wagh, Prashant B. Nigade, Maneesh Mehta, Vinod Patil, Dipak Modi, Shashikant Pawar, Mahip Verma, Minakshi Singh, Sudipto Das, Jayasagar Gundu, Kumar Nemmani, Mark G. Bock, Sharad Sharma, Dhananjay Bakhle, Rajender Kumar Kamboj, <span class="NLM_string-name hlFld-ContribAuthor">Venkata P. Palle</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6107-6133. <a href="https://doi.org/10.1021/acs.jmedchem.0c00361" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BState-Dependent%252BNaV1.7%252BInhibitors%252Bwith%252BRobust%252BOral%252BEfficacy%252Bin%252BPain%252BModels%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Band%252BOptimization%252Bof%252BChroman%252Band%252BIndane%252BAryl%252BSulfonamides%26aulast%3DRamdas%26aufirst%3DVidya%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29022020%26date%3D19052020%26date%3D05052020%26volume%3D63%26issue%3D11%26spage%3D6107%26epage%3D6133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">John V. Mulcahy, Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig, J. Du Bois, <span class="NLM_string-name hlFld-ContribAuthor">John C. Hunter</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (19)
                                     , 8695-8710. <a href="https://doi.org/10.1021/acs.jmedchem.8b01906" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChallenges%252Band%252BOpportunities%252Bfor%252BTherapeutics%252BTargeting%252Bthe%252BVoltage-Gated%252BSodium%252BChannel%252BIsoform%252BNaV1.7%26aulast%3DMulcahy%26aufirst%3DJohn%2BV.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D04122018%26date%3D07052019%26date%3D23042019%26volume%3D62%26issue%3D19%26spage%3D8695%26epage%3D8710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Xi  Zhang</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Zhicun  Liu</span>, <span class="hlFld-ContribAuthor ">Zunting  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of
              
                2
                H
              
              ‐benzo[
              g
              ]furo/thieno/pyrrolo[2,3‐
              e
              ]indazoles
              via
              Intramolecular Dehydrogenation Photocyclization. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2021,</strong> <em>39 </em>
                                    (8)
                                     , 2213-2219. <a href="https://doi.org/10.1002/cjoc.202100103" title="DOI URL">https://doi.org/10.1002/cjoc.202100103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202100103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202100103%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2%252BH%252B%2525E2%252580%252590benzo%25255B%252Bg%252B%25255Dfuro%25252Fthieno%25252Fpyrrolo%25255B2%25252C3%2525E2%252580%252590%252Be%252B%25255Dindazoles%252Bvia%252BIntramolecular%252BDehydrogenation%252BPhotocyclization%26aulast%3DZhang%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D39%26issue%3D8%26spage%3D2213%26epage%3D2219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Hao  Yan</span>, <span class="hlFld-ContribAuthor ">Xuyong  Zheng</span>, <span class="hlFld-ContribAuthor ">Lili  Fu</span>, <span class="hlFld-ContribAuthor ">Yuyan  Bao</span>, <span class="hlFld-ContribAuthor ">Haibo  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Xiuhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Gaozhi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A novel indazole derivative, compound Cyy-272, attenuates LPS-induced acute lung injury by inhibiting JNK phosphorylation. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2021,</strong> <em>159 </em>, 115648. <a href="https://doi.org/10.1016/j.taap.2021.115648" title="DOI URL">https://doi.org/10.1016/j.taap.2021.115648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2021.115648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2021.115648%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DA%252Bnovel%252Bindazole%252Bderivative%25252C%252Bcompound%252BCyy-272%25252C%252Battenuates%252BLPS-induced%252Bacute%252Blung%252Binjury%252Bby%252Binhibiting%252BJNK%252Bphosphorylation%26aulast%3DLiu%26aufirst%3DQian%26date%3D2021%26volume%3D159%26spage%3D115648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Cai</span>, <span class="hlFld-ContribAuthor ">Chengjie  Feng</span>, <span class="hlFld-ContribAuthor ">Fangqi  Shen</span>, <span class="hlFld-ContribAuthor ">Kejun  Bian</span>, <span class="hlFld-ContribAuthor ">Chunlei  Wu</span>, <span class="hlFld-ContribAuthor ">Runpu  Shen</span>, <span class="hlFld-ContribAuthor ">Yuzhen  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2‐Substituted Benzothio(seleno)phenes and Indoles
              via
              Ag‐Catalyzed Cyclization/Demethylation of 2‐Alkynylthio(seleno)anisoles and 2‐Alkynyldimethylanilines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (4)
                                     , 653-656. <a href="https://doi.org/10.1002/ejoc.202001465" title="DOI URL">https://doi.org/10.1002/ejoc.202001465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001465%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2%2525E2%252580%252590Substituted%252BBenzothio%252528seleno%252529phenes%252Band%252BIndoles%252Bvia%252BAg%2525E2%252580%252590Catalyzed%252BCyclization%25252FDemethylation%252Bof%252B2%2525E2%252580%252590Alkynylthio%252528seleno%252529anisoles%252Band%252B2%2525E2%252580%252590Alkynyldimethylanilines%26aulast%3DCai%26aufirst%3DTao%26date%3D2021%26date%3D2020%26volume%3D2021%26issue%3D4%26spage%3D653%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shovan  Mondal</span>, <span class="hlFld-ContribAuthor ">Suniti  Malakar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of sulfonamide and their synthetic and therapeutic applications: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (48)
                                     , 131662. <a href="https://doi.org/10.1016/j.tet.2020.131662" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131662%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bsulfonamide%252Band%252Btheir%252Bsynthetic%252Band%252Btherapeutic%252Bapplications%25253A%252BRecent%252Badvances%26aulast%3DMondal%26aufirst%3DShovan%26date%3D2020%26volume%3D76%26issue%3D48%26spage%3D131662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-tao  Wang</span>, <span class="hlFld-ContribAuthor ">Yue-ming  Zheng</span>, <span class="hlFld-ContribAuthor ">Yue-ting  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Gu</span>, <span class="hlFld-ContribAuthor ">Zhao-bing  Gao</span>, <span class="hlFld-ContribAuthor ">Fa-jun  Nan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (3)
                                     , 293-302. <a href="https://doi.org/10.1038/s41401-019-0267-z" title="DOI URL">https://doi.org/10.1038/s41401-019-0267-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0267-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0267-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDiscovery%252Bof%252Baryl%252Bsulfonamide-selective%252BNav1.7%252Binhibitors%252Bwith%252Ba%252Bhighly%252Bhydrophobic%252Bethanoanthracene%252Bcore%26aulast%3DWang%26aufirst%3DJin-tao%26date%3D2020%26date%3D2019%26volume%3D41%26issue%3D3%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangkuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Christelle  Roudaut</span>, <span class="hlFld-ContribAuthor ">Vincent  Gandon</span>, <span class="hlFld-ContribAuthor ">Mouad  Alami</span>, <span class="hlFld-ContribAuthor ">Olivier  Provot</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-substituted indoles through cyclization and demethylation of 2-alkynyldimethylanilines by ethanol. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (15)
                                     , 4204-4210. <a href="https://doi.org/10.1039/C9GC01880H" title="DOI URL">https://doi.org/10.1039/C9GC01880H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC01880H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC01880H%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-substituted%252Bindoles%252Bthrough%252Bcyclization%252Band%252Bdemethylation%252Bof%252B2-alkynyldimethylanilines%252Bby%252Bethanol%26aulast%3DZhao%26aufirst%3DGuangkuan%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D15%26spage%3D4204%26epage%3D4210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0026.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Representative Na<sub>V</sub>1.7 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design principles leading to 3-arylindole and 3-arylindazole acylsulfonamide-based Na<sub>v</sub>1.7 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures and Na<sub>v</sub>1.7 inhibition data for indazole derivatives <b>60</b>–<b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures and Na<sub>v</sub>1.7 inhibition data for the series of azaindole derivatives <b>63</b>–<b>68</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Mouse PK profiles of compounds <b>29</b> and <b>47</b> dosed at 30 mg/kg IP and PO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>2</b> (30 mg/kg, PO) or <b>29</b> (3, 10, 30 mg/kg, IP) on phase I/II formalin-induced nociceptive behaviors. Results are presented as the mean ± SEM response (<i>n</i> = 12–15 per group) and were analyzed by ANOVA followed by Dunnett’s posthoc tests; ***<i>P</i> < 0.001 compared to vehicle/formalin group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of <b>2</b> (30 mg/kg, PO) or <b>29</b> (3, 10, 30 mg/kg, IP) or <b>47</b> (3, 10, 30 mg/kg, PO) on percentage reversal of phase II formalin-induced nociceptive behaviors. Results are presented as the mean ± SEM response (<i>n</i> = 12–15 per group) and were analyzed by ANOVA followed by Dunnett’s posthoc tests; ***<i>P</i> < 0.001 compared to vehicle/formalin group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>2</b> (60 mg/kg, PO) or <b>29</b> (3, 10, 30 mg/kg, IP) on latency of thermal hyperalgesia in CFA mice. Results are presented as the mean ± SEM response (<i>n</i> = 12–14/group) and were analyzed by ANOVA followed by Dunnett’s posthoc tests; ***<i>P</i> < 0.001 compared to vehicle/control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of compound <b>2</b> (60 mg/kg, PO) or <b>29</b> (3, 10, 30 mg/kg, IP) on latency of cold allodynia in CCI mice. Results are presented as the mean ± SEM response (<i>n</i> = 12–14 per group) and were analyzed by ANOVA followed by Dunnett’s posthoc tests; ***<i>P</i> < 0.001, *<i>p</i> < 0.05 compared to vehicle/control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of <b>29</b> and <b>47</b> (30 mg/kg) on mechanosensitivity of the mouse sural nerve when dosed IP. *indicates significant difference from vehicle (two-way ANOVA followed by Dunnett’s test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effects of <b>29</b> and <b>47</b> on mechanosensitivity of the mouse sural nerve when applied directly to the nerve. *indicates significant difference from vehicle (two-way ANOVA followed by Dunnett’s test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Approaches to Indoles <b>5</b>–<b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, DMF, rt, 2 h, 93%; (b) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 18 h, 90%; (c) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h, 92%; (d) methansulfonamide, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1.5 h, 93%; (e) R-ArB(OH)<sub>2</sub>, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 2 h.</p></p></figure><figure data-id="sch2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Approaches to the Preparation of <b>16</b>–<b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) I<sub>2</sub>, KOH, DMF, rt, 18 h, 91%; (b) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 18 h, 89%; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h, 81%; (d) 4-isobutoxyphenyl bromide, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 12 h; (e) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h, 88%; (f) DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, R<sup>1</sup>SO<sub>2</sub>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 28%; (g) PPh<sub>3</sub>, DIAD, THF, rt, 2 h, 40%; (h) Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h, then MeOH, R-Ar-Br, Cs<sub>2</sub>CO<sub>3</sub>, 80 °C, 4 h, 60–63%.</p></p></figure><figure data-id="sch3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Approaches to the Preparation of <b>24</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DMF, 100 °C, 1 h, 86%; (b) Pd/C, H<sub>2</sub>, EtOAc, rt, 2 h, 70%; (c) I<sub>2</sub>, KOH, DMF, rt, 16 h; then MeI, rt, 5 h, 85%; (d) Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h; (e) MeOH, R-Ar-Br, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 4 h; (f) LiOH, THF, H<sub>2</sub>O, rt, 18 h; (g) DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, R<sup>1</sup>SO<sub>2</sub>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h.</p></p></figure><figure data-id="sch4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Approaches to the Preparation of <b>28</b>–<b>48</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R-pyridyl bromide, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 12 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h, then MeOH, R-pyridyl bromide, Cs<sub>2</sub>CO<sub>3</sub>, 80 °C, 4 h; (c) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (d) R<sup>1</sup>SO<sub>2</sub>NH<sub>2</sub>, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (e) Cs<sub>2</sub>CO<sub>3</sub>, 2-methylpropanol, DMSO, 90 °C, 10 h, 91%; (f) (1,1′-binaphthalen)-2-yl di-<i>tert</i>-butylphosphine, Zn, Pd(O<sub>2</sub>CCF<sub>3</sub>)<sub>2</sub>, Zn(CN)<sub>2</sub>, DMAC, 95 °C, 3 h, 56%; (g) R<sup>2</sup>CH<sub>2</sub>OH, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 80 °C, 18 h; (h) (1,5-cyclooctadiene)(methoxy)iridium(i) dimer, bis(pinacolato)diboron, 4,4′-di-<i>tert</i>-butyl-2,2′-bipyridine, tBuOMe, 80 °C, 30 min; (i) PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 2 h; (j) K<sub>2</sub>CO<sub>3</sub>, 2,2-dimethyloxirane, 2-butanone, 80 °C, 18 h, 19%.</p></p></figure><figure data-id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0015.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Approaches to the <i>N</i>-Alkylated Indole Derivatives <b>49</b>–<b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>1</sup>-I, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 18 h, 44–46%; (b) 5-bromo-3-chloro-2-isobutoxypyridine, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 12 h; (c) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (d) R<sup>2</sup>SO<sub>2</sub>NH<sub>2</sub>, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h.</p></p></figure><figure data-id="sch6" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0016.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Approaches to the Preparation of Indazole Derivatives <b>52</b>, <b>55</b>–<b>57</b>, and <b>60</b>–<b>62</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, MeI, rt, 72 h, <b>104</b> (14%), <b>105</b> (48%); (b) 4-trifluoromethylphenyl bromide, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 1 h; (c) methanesulfonamide, Mo(CO)<sub>6</sub>, DBU, tri-<i>tert</i>-butylphosphonium tetrafluoroborate, <i>trans</i>-di-μ-acetatobis[2-[bis(2-methylphenyl)phosphino]benzyl]dipalladium, dioxane, 140 °C, 10 min, 61%; (d) NaH, THF, MeI, rt, 18 h, <b>108</b> (18%), <b>109</b> (34%); (e) 5-bromo-3-chloro-2-isobutoxypyridine, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 2 h; (f) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (g) RSO<sub>2</sub>N<sub>2</sub>, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h.</p></p></figure><figure data-id="sch7" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0017.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthetic Approaches to the 5-Fluoroindazole Derivatives <b>53</b>, <b>54</b>, <b>58</b>, and <b>59</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, HNO<sub>3</sub>, 0 °C, 3 h; (b) H<sub>2</sub>SO<sub>4</sub>, MeOH, 65 °C, 20 h, 92% for 2 steps; (c) Pd/C, H<sub>2</sub>, EtOAc, rt, 2 h, 95%; (d) KOAc, AcOH, isoamyl nitrite, CHCl<sub>3</sub>, rt, 3 h, 13%; (e) I<sub>2</sub>, KOH, DMF, rt, 18 h, then MeI, 20 h, 59%; (f) PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 18 h; (g) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (h) sulfonamides, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h.</p></p></figure><figure data-id="sch8" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/medium/jm-2018-015506_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0018.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Approaches to the Azaindole Derivatives <b>63</b>–<b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01550/20190116/images/large/jm-2018-015506_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01550&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, MeOH, 70 °C, 4 h; (b) I<sub>2</sub>, KOH, DMF, rt, 18 h; (c) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 18 h; (d) <b>127a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, dioxane, 80 °C, 2 h, then MeOH, R-Ar-Br, Cs<sub>2</sub>CO<sub>3</sub>, 80 °C, 4 h; (e) <b>127b</b>, AR-B(OH)<sub>2</sub>, PdCl<sub>2</sub>(dppf), Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 18 h; (f) LiOH, THF–MeOH, H<sub>2</sub>O, rt, 18 h; (g) sulfonamides, DMAP, 2-chloro-1-methylpyridin-1-ium iodide, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (h) RSO<sub>2</sub>NH<sub>2</sub>, Mo(CO)<sub>6</sub>, DBU, tri-<i>tert</i>-butylphosphonium tetrafluoroborate, <i>trans</i>-di-μ-acetatobis[2-[bis(2-methylphenyl)phosphino]benzyl]dipalladium, dioxane, 140 °C, 10 min.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i180">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12247" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12247" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaskin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, P.</span></span> <span> </span><span class="NLM_article-title">The Economic Costs of Pain in the United States</span>. <i>J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1016/j.jpain.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.jpain.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=22607834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BC38nksFahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=715-724&author=D.+J.+Gaskinauthor=P.+Richard&title=The+Economic+Costs+of+Pain+in+the+United+States&doi=10.1016%2Fj.jpain.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The economic costs of pain in the United States</span></div><div class="casAuthors">Gaskin Darrell J; Richard Patrick</div><div class="citationInfo"><span class="NLM_cas:title">The journal of pain : official journal of the American Pain Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">715-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  In 2008, according to the Medical Expenditure Panel Survey (MEPS), about 100 million adults in the United States were affected by chronic pain, including joint pain or arthritis.  Pain is costly to the nation because it requires medical treatment and complicates treatment for other ailments.  Also, pain lowers worker productivity.  Using the 2008 MEPS, we estimated 1) the portion of total U.S. health care costs attributable to pain; and 2) the annual costs of pain associated with lower worker productivity.  We found that the total costs ranged from $560 to $635 billion in 2010 dollars.  The additional health care costs due to pain ranged from $261 to $300 billion.  This represents an increase in annual per person health care costs ranging from $261 to $300 compared to a base of about $4,250 for persons without pain.  The value of lost productivity due to pain ranged from $299 to $335 billion.  We found that the annual cost of pain was greater than the annual costs of heart disease ($309 billion), cancer ($243 billion), and diabetes ($188 billion).  Our estimates are conservative because they do not include costs associated with pain for nursing home residents, children, military personnel, and persons who are incarcerated.  PERSPECTIVE:  This study estimates that the national cost of pain ranges from $560 to $635 billion, larger than the cost of the nation's priority health conditions.  Because of its economic toll on society, the nation should invest in research, education, and training to advocate the successful treatment, management, and prevention of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKaeWU0MjkVr0AGQpJZWpJfW6udTcc2ebGVhboZBCUVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nksFahtw%253D%253D&md5=d42f1179dd6f7c5e7900a6a260bc4747</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DGaskin%26aufirst%3DD.%2BJ.%26aulast%3DRichard%26aufirst%3DP.%26atitle%3DThe%2520Economic%2520Costs%2520of%2520Pain%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Pain%26date%3D2012%26volume%3D13%26spage%3D715%26epage%3D724%26doi%3D10.1016%2Fj.jpain.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodcock, J. A. A.</span></span> <span> </span><span class="NLM_article-title">Difficult Balance – Pain Management, Drug Safety, and the FDA</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">2105</span>– <span class="NLM_lpage">2107</span>, <span class="refDoi"> DOI: 10.1056/NEJMp0908913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1056%2FNEJMp0908913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=19940297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWgsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=2105-2107&author=J.+A.+A.+Woodcock&title=Difficult+Balance+%E2%80%93+Pain+Management%2C+Drug+Safety%2C+and+the+FDA&doi=10.1056%2FNEJMp0908913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A difficult balance - pain management, drug safety, and the FDA</span></div><div class="casAuthors">Woodcock, Janet</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2105-2107</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdlXl7NZQaEbVg90H21EOLACvtfcHk0lgcfS7hXUAKig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWgsrnI&md5=3264557a26df008287c146e642046ca1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMp0908913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp0908913%26sid%3Dliteratum%253Aachs%26aulast%3DWoodcock%26aufirst%3DJ.%2BA.%2BA.%26atitle%3DDifficult%2520Balance%2520%25E2%2580%2593%2520Pain%2520Management%252C%2520Drug%2520Safety%252C%2520and%2520the%2520FDA%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D2105%26epage%3D2107%26doi%3D10.1056%2FNEJMp0908913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melnikova, I.</span></span> <span> </span><span class="NLM_article-title">Pain Market</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1038/nrd3226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fnrd3226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=20651743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1aru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=589-590&author=I.+Melnikova&title=Pain+Market&doi=10.1038%2Fnrd3226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pain market</span></div><div class="casAuthors">Melnikova, Irena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">589-590</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouH6uQeS0Q5bVg90H21EOLACvtfcHk0li8iWpnRWmDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1aru7g%253D&md5=c67862cb8d31cc999c42c0ebf5f388eb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd3226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3226%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DI.%26atitle%3DPain%2520Market%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D589%26epage%3D590%26doi%3D10.1038%2Fnrd3226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span> <span> </span><span class="NLM_article-title">No Gain, No Pain: Na<sub>V</sub>1.7 as an Analgesic Target</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1021/cn500171p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500171p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaisLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=749-751&author=G.+F.+Kingauthor=I.+Vetter&title=No+Gain%2C+No+Pain%3A+NaV1.7+as+an+Analgesic+Target&doi=10.1021%2Fcn500171p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">No Gain, No Pain: NaV1.7 as an Analgesic Target</span></div><div class="casAuthors">King, Glenn F.; Vetter, Irina</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">749-751</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chronic pain is one of the most complex and difficult to manage clin. problems, with the therapeutic utility of current-generation analgesics restricted by problems such as dose-limiting side effects, tolerance, and the potential for addiction.  The voltage-gated sodium channel NaV1.7 plays a key role in setting the threshold for action potential generation in primary sensory neurons, and humans that lack this channel are completely insensitive to pain.  In this Viewpoint, the authors examine the potential of NaV1.7 as an analgesic target a well as the challenges involved in developing therapeutically useful subtype-selective inhibitors of this ion channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod_ZPZACayg7Vg90H21EOLACvtfcHk0li8iWpnRWmDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaisLjF&md5=423db2f1ef715675e104531e1018a007</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcn500171p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500171p%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DG.%2BF.%26aulast%3DVetter%26aufirst%3DI.%26atitle%3DNo%2520Gain%252C%2520No%2520Pain%253A%2520NaV1.7%2520as%2520an%2520Analgesic%2520Target%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D749%26epage%3D751%26doi%3D10.1021%2Fcn500171p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in Sodium Channel Modulators for Pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3690</span>– <span class="NLM_lpage">3699</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2014.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=25060923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3690-3699&author=S.+K.+Bagalauthor=M.+L.+Chapmanauthor=B.+E.+Marronauthor=R.+Primeauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Recent+Progress+in+Sodium+Channel+Modulators+for+Pain&doi=10.1016%2Fj.bmcl.2014.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in sodium channel modulators for pain</span></div><div class="casAuthors">Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.; Prime, Rebecca; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3690-3699</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field.  Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda, Synchropatch and Qube.  Moreover, emerging clin. data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biol. pave the way for a future of fruitful prospective Nav drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbT6en4xkVxLVg90H21EOLACvtfcHk0li8iWpnRWmDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL&md5=c8bae40b70509e2aa3dce106e2c41677</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPrime%26aufirst%3DR.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DRecent%2520Progress%2520in%2520Sodium%2520Channel%2520Modulators%2520for%2520Pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3690%26epage%3D3699%26doi%3D10.1016%2Fj.bmcl.2014.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de%0ALera+Ruizauthor=R.+L.+Kraus&title=Voltage-Gated+Sodium+Channels%3A+Structure%2C+Function%2C+Pharmacology%2C+and+Clinical+Indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0li8iWpnRWmDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-Gated%2520Sodium%2520Channels%253A%2520Structure%252C%2520Function%252C%2520Pharmacology%252C%2520and%2520Clinical%2520Indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuliani, V.</span></span> <span> </span><span class="NLM_article-title">Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1517/13543784.2016.1121992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1517%2F13543784.2016.1121992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=26576738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSrt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=215-226&author=M.+Rivaraauthor=V.+Zuliani&title=Novel+Sodium+Channel+Antagonists+in+the+Treatment+of+Neuropathic+Pain&doi=10.1517%2F13543784.2016.1121992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Novel sodium channel antagonists in the treatment of neuropathic pain</span></div><div class="casAuthors">Rivara, Mirko; Zuliani, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-226</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Effective and safe drugs for the treatment of neuropathic pain are still an unmet clin. need.  Neuropathic pain, caused by a lesion or disease that affects the somatosensory system, is a debilitating and hampering condition that has a great economic cost and, above all, a tremendous impact on the quality of life.  Sodium channels are one of the major players in generating and propagating action potentials.  They represent an appealing target for researchers involved in the development of new and safer drugs useful in the treatment of neuropathic pain.  The actual goal for researchers is to target sodium channels selectively to stop the abnormal signaling that characterizes neuropathic pain while leaving normal somatosensory functions intact.: This review covers the most recent publications regarding sodium channel blockers and their development as new treatments for neuropathic pain.  The main areas discussed are the natural sources of new blockers, such as venom exts. and the recent efforts from many pharmaceutical companies in the field.: There have been serious efforts by both the pharmaceutical industry and academia to develop new and safer therapeutic options for neuropathic pain.  A no. of different strategies have been undertaken; the main efforts directed towards the identification of selective blockers starting from both natural products or screening chem. libraries.  At this time, researchers have identified and characterized selective compds. against NaV1.7 or NaV1.8 voltage-gated sodium channels but only time will tell if they reach the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl3PzyBSNxFbVg90H21EOLACvtfcHk0liqG9B_9p-DAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSrt7rK&md5=f0280383c1361e07d6c5378b0dda6373</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F13543784.2016.1121992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2016.1121992%26sid%3Dliteratum%253Aachs%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DZuliani%26aufirst%3DV.%26atitle%3DNovel%2520Sodium%2520Channel%2520Antagonists%2520in%2520the%2520Treatment%2520of%2520Neuropathic%2520Pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2016%26volume%3D25%26spage%3D215%26epage%3D226%26doi%3D10.1517%2F13543784.2016.1121992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">The Na<sub>V</sub>1.7 Sodium Channel: From Molecule to Man</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.+D.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+NaV1.7+Sodium+Channel%3A+From+Molecule+to+Man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0liqG9B_9p-DAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520NaV1.7%2520Sodium%2520Channel%253A%2520From%2520Molecule%2520to%2520Man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Aral, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koszowski, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisenand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silos-Santiago, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halegoua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, G.</span></span> <span> </span><span class="NLM_article-title">Identification of PN1, A Predominant Voltage-Dependent Sodium Channel Expressed Principally in Peripheral Neurons</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1532</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.4.1527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1073%2Fpnas.94.4.1527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=9037087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADyaK2sXhtl2ms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=1527-1532&author=J.+J.+Toledo-Aralauthor=B.+L.+Mossauthor=Z.+Heauthor=A.+G.+Koszowskiauthor=T.+Whisenandauthor=S.+R.+Levinsonauthor=J.+J.+Wolfauthor=I.+Silos-Santiagoauthor=S.+Halegouaauthor=G.+Mandel&title=Identification+of+PN1%2C+A+Predominant+Voltage-Dependent+Sodium+Channel+Expressed+Principally+in+Peripheral+Neurons&doi=10.1073%2Fpnas.94.4.1527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons</span></div><div class="casAuthors">Toledo Aral, Juan J.; Moss, Brenda L.; He, Zhi Jun; Koszowski, Adam G.; Whisenand, Teri; Levinson, Simon R.; Wolf, John J.; Silos Santiago, Inmaculada; Halegoua, Simon; Mandel, Gail</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1527-1532</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Membrane excitability in different tissues is due, in large part, to the selective expression of distinct genes encoding the voltage-dependent sodium channel.  Although the predominant sodium channels in brain, skeletal muscle, and cardiac muscle have been identified, the major sodium channel types responsible for excitability within the peripheral nervous system have remained elusive.  We now describe the deduced primary structure of a sodium channel, peripheral nerve type 1 (PN1), which is expressed at high levels throughout the peripheral nervous system and is targeted to nerve terminals of cultured dorsal root ganglion neurons.  Studies using cultured PC12 cells indicate that both expression and targeting of PN1 is induced by treatment of the cells with nerve growth factor.  The preferential localization suggests that the PN1 sodium channel plays a specific role in neve excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTpQugGHLderVg90H21EOLACvtfcHk0liqG9B_9p-DAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtl2ms7s%253D&md5=6329c810c620463f1a3df96c7e637cee</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.4.1527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.4.1527%26sid%3Dliteratum%253Aachs%26aulast%3DToledo-Aral%26aufirst%3DJ.%2BJ.%26aulast%3DMoss%26aufirst%3DB.%2BL.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DKoszowski%26aufirst%3DA.%2BG.%26aulast%3DWhisenand%26aufirst%3DT.%26aulast%3DLevinson%26aufirst%3DS.%2BR.%26aulast%3DWolf%26aufirst%3DJ.%2BJ.%26aulast%3DSilos-Santiago%26aufirst%3DI.%26aulast%3DHalegoua%26aufirst%3DS.%26aulast%3DMandel%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520PN1%252C%2520A%2520Predominant%2520Voltage-Dependent%2520Sodium%2520Channel%2520Expressed%2520Principally%2520in%2520Peripheral%2520Neurons%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D1527%26epage%3D1532%26doi%3D10.1073%2Fpnas.94.4.1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raashid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gazali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span> <span> </span><span class="NLM_article-title">An SCN9A Channelopathy Causes Congenital Inability to Experience Pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicholasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=C.+G.+Woods&title=An+SCN9A+Channelopathy+Causes+Congenital+Inability+to+Experience+Pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0lj2pPhPlo2MzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicholas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26atitle%3DAn%2520SCN9A%2520Channelopathy%2520Causes%2520Congenital%2520Inability%2520to%2520Experience%2520Pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahllund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellgren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meury, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morinville, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynoschek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouleau, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupp, J. J.</span></span> <span> </span><span class="NLM_article-title">A Stop Codon Mutation in SCN9A Causes Lack of Pain Sensation</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2114</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddm160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1093%2Fhmg%2Fddm160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=17597096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=2114-2121&author=S.+Ahmadauthor=L.+Dahllundauthor=A.+B.+Erikssonauthor=D.+Hellgrenauthor=U.+Karlssonauthor=P.+Lundauthor=I.+A.+Meijerauthor=L.+Meuryauthor=T.+Millsauthor=A.+Moodyauthor=A.+Morinvilleauthor=J.+Mortenauthor=D.+O%E2%80%99Donnellauthor=C.+Raynoschekauthor=H.+Salterauthor=G.+A.+Rouleauauthor=J.+J.+Krupp&title=A+Stop+Codon+Mutation+in+SCN9A+Causes+Lack+of+Pain+Sensation&doi=10.1093%2Fhmg%2Fddm160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A stop codon mutation in SCN9A causes lack of pain sensation</span></div><div class="casAuthors">Ahmad, Sultan; Dahllund, Leif; Eriksson, Anders B.; Hellgren, Dennis; Karlsson, Urban; Lund, Per-Eric; Meijer, Inge A.; Meury, Luc; Mills, Tracy; Moody, Adrian; Morinville, Anne; Morten, John; O'Donnell, Dajan; Raynoschek, Carina; Salter, Hugh; Rouleau, Guy A.; Krupp, Johannes J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2114-2121</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The general lack of pain experience is a rare occurrence in humans, and the mol. causes for this phenotype are not well understood.  Here we have studied a Canadian family from Newfoundland with members who exhibit a congenital inability to experience pain.  We have mapped the locus to a 13.7 Mb region on chromosome 2q (2q24.3-2q31.1).  Screening of candidate genes in this region identified a protein-truncating mutation in SCN9A, which encodes for the voltage-gated sodium channel Nav1.7.  The mutation is a C-A transversion at nucleotide 984 transforming the codon for tyrosine 328 to a stop codon.  The predicted product lacks all pore-forming regions of Nav1.7.  Indeed, expression of this altered gene in a cell line did not produce functional responses, nor did it cause compensatory effects on endogenous voltage-gated sodium currents when expressed in ND7/23 cells.  Because a homozygous knockout of Nav1.7 in mice has been shown to be lethal, we explored why a deficiency of Nav1.7 is non-lethal in humans.  Expression studies in monkey, human, mouse and rat tissue indicated species-differences in the Nav1.7 expression profile.  Whereas in rodents the channel was strongly expressed in hypothalamic nuclei, only weak mRNA levels were detected in this area in primates.  Furthermore, primate pituitary and adrenal glands were devoid of signal, whereas these two glands were mRNA-pos. in rodents.  This species difference may explain the non-lethality of the obsd. mutation in humans.  Our data further establish Nav1.7 as a crit. element of peripheral nociception in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-UExUOmeYrVg90H21EOLACvtfcHk0lj2pPhPlo2MzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVWqt7o%253D&md5=4800e0aee1230c46ada3e29e551b1833</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddm160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddm160%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDahllund%26aufirst%3DL.%26aulast%3DEriksson%26aufirst%3DA.%2BB.%26aulast%3DHellgren%26aufirst%3DD.%26aulast%3DKarlsson%26aufirst%3DU.%26aulast%3DLund%26aufirst%3DP.%26aulast%3DMeijer%26aufirst%3DI.%2BA.%26aulast%3DMeury%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DT.%26aulast%3DMoody%26aufirst%3DA.%26aulast%3DMorinville%26aufirst%3DA.%26aulast%3DMorten%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DD.%26aulast%3DRaynoschek%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DH.%26aulast%3DRouleau%26aufirst%3DG.%2BA.%26aulast%3DKrupp%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520Stop%2520Codon%2520Mutation%2520in%2520SCN9A%2520Causes%2520Lack%2520of%2520Pain%2520Sensation%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2007%26volume%3D16%26spage%3D2114%26epage%3D2121%26doi%3D10.1093%2Fhmg%2Fddm160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattice, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radomski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younghusband, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinspan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdraon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowsher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Loss-of-Function Mutations in the Na<sub>V</sub>1.7 Gene Underlie Congenital Indifference to Pain in Multiple Human Populations</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ivesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Boltshauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-Function+Mutations+in+the+NaV1.7+Gene+Underlie+Congenital+Indifference+to+Pain+in+Multiple+Human+Populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2eZeFm-Gt64mPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DIves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBoltshauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-Function%2520Mutations%2520in%2520the%2520NaV1.7%2520Gene%2520Underlie%2520Congenital%2520Indifference%2520to%2520Pain%2520in%2520Multiple%2520Human%2520Populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Mutations in SCN9A, Encoding a Sodium Channel Alpha Subunit, in Patients with Primary Erythermalgia</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1136/jmg.2003.012153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1136%2Fjmg.2003.012153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=14985375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=171-174&author=Y.+Yangauthor=Y.+Wangauthor=S.+Liauthor=Z.+Xuauthor=H.+Liauthor=L.+Maauthor=J.+Fanauthor=D.+Buauthor=B.+Liuauthor=Z.+Fanauthor=G.+Wuauthor=J.+Jinauthor=B.+Dingauthor=X.+Zhuauthor=Y.+Shen&title=Mutations+in+SCN9A%2C+Encoding+a+Sodium+Channel+Alpha+Subunit%2C+in+Patients+with+Primary+Erythermalgia&doi=10.1136%2Fjmg.2003.012153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span></div><div class="casAuthors">Yang, Y.; Wang, Y.; Li, S.; Xu, Z.; Li, H.; Ma, L.; Fan, J.; Bu, D.; Liu, B.; Fan, Z.; Wu, G.; Jin, J.; Ding, B.; Zhu, X.; Shen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning pain with redness and heat in the extremities.  A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified.  We performed linkage anal. in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient.  Linkage anal. yielded a max. lod score of 2.11 for both markers D2S2370 and D2S2330.  Based on crit. recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345.  We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C).  Our data suggest that mutations in SCN9A cause primary erythermalgia.  SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurons, may play an important role in nociception and vasomotor regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBMPc9seMturVg90H21EOLACvtfcHk0lgJPZDstlclpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D&md5=bf4ca6710278dd25a4de4ac5d8fdab2f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2003.012153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2003.012153%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DMutations%2520in%2520SCN9A%252C%2520Encoding%2520a%2520Sodium%2520Channel%2520Alpha%2520Subunit%252C%2520in%2520Patients%2520with%2520Primary%2520Erythermalgia%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2004%26volume%3D41%26spage%3D171%26epage%3D174%26doi%3D10.1136%2Fjmg.2003.012153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyrski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bufe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willnecker, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zizzari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gossage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinders-Zufall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zufall, F.</span></span> <span> </span><span class="NLM_article-title">Loss-of-Function Mutations in Sodium Channel Na<sub>V</sub>1.7 Cause Anosmia</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>472</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1038/nature09975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fnature09975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=21441906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2011&pages=186-190&author=J.+Weissauthor=M.+Pyrskiauthor=E.+Jacobiauthor=B.+Bufeauthor=V.+Willneckerauthor=B.+Schickauthor=P.+Zizzariauthor=S.+J.+Gossageauthor=C.+A.+Greerauthor=T.+Leinders-Zufallauthor=C.+G.+Woodsauthor=J.+N.+Woodauthor=F.+Zufall&title=Loss-of-Function+Mutations+in+Sodium+Channel+NaV1.7+Cause+Anosmia&doi=10.1038%2Fnature09975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in sodium channel Nav1.7 cause anosmia</span></div><div class="casAuthors">Weiss, Jan; Pyrski, Martina; Jacobi, Eric; Bufe, Bernd; Willnecker, Vivienne; Schick, Bernhard; Zizzari, Philippe; Gossage, Samuel J.; Greer, Charles A.; Leinders-Zufall, Trese; Woods, C. Geoffrey; Wood, John N.; Zufall, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">472</span>
        (<span class="NLM_cas:issue">7342</span>),
    <span class="NLM_cas:pages">186-190</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Loss of function of the gene SCN9A, encoding the voltage-gated sodium channel Nav1.7, causes a congenital inability to experience pain in humans.  Here we show that Nav1.7 is not only necessary for pain sensation but is also an essential requirement for odor perception in both mice and humans.  We examd. human patients with loss-of-function mutations in SCN9A and show that they are unable to sense odors.  To establish the essential role of Nav1.7 in odor perception, we generated conditional null mice in which Nav1.7 was removed from all olfactory sensory neurons.  In the absence of Nav1.7, these neurons still produce odor-evoked action potentials but fail to initiate synaptic signaling from their axon terminals at the first synapse in the olfactory system.  The mutant mice no longer display vital, odor-guided behaviors such as innate odor recognition and avoidance, short-term odor learning, and maternal pup retrieval.  Our study creates a mouse model of congenital general anosmia and provides new strategies to explore the genetic basis of the human sense of smell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlULSYZLPdCLVg90H21EOLACvtfcHk0lgJPZDstlclpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOitLo%253D&md5=49237d7972c38172b7c56f42d13eb68e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature09975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09975%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DJ.%26aulast%3DPyrski%26aufirst%3DM.%26aulast%3DJacobi%26aufirst%3DE.%26aulast%3DBufe%26aufirst%3DB.%26aulast%3DWillnecker%26aufirst%3DV.%26aulast%3DSchick%26aufirst%3DB.%26aulast%3DZizzari%26aufirst%3DP.%26aulast%3DGossage%26aufirst%3DS.%2BJ.%26aulast%3DGreer%26aufirst%3DC.%2BA.%26aulast%3DLeinders-Zufall%26aufirst%3DT.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DZufall%26aufirst%3DF.%26atitle%3DLoss-of-Function%2520Mutations%2520in%2520Sodium%2520Channel%2520NaV1.7%2520Cause%2520Anosmia%26jtitle%3DNature%26date%3D2011%26volume%3D472%26spage%3D186%26epage%3D190%26doi%3D10.1038%2Fnature09975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passmore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickenson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcangio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span> <span> </span><span class="NLM_article-title">Distinct Na<sub>V</sub>1.7-Dependent Pain Sensations Require Different Sets of Sensory and Sympathetic Neurons</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">799</span>, <span class="refDoi"> DOI: 10.1038/ncomms1795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1038%2Fncomms1795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=22531176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BC38rnsl2mug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=791-799&author=M.+S.+Minettauthor=M.+A.+Nassarauthor=A.+K.+Clarkauthor=G.+Passmoreauthor=A.+H.+Dickensonauthor=F.+Wangauthor=M.+Malcangioauthor=J.+N.+Wood&title=Distinct+NaV1.7-Dependent+Pain+Sensations+Require+Different+Sets+of+Sensory+and+Sympathetic+Neurons&doi=10.1038%2Fncomms1795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons</span></div><div class="casAuthors">Minett Michael S; Nassar Mohammed A; Clark Anna K; Passmore Gayle; Dickenson Anthony H; Wang Fan; Malcangio Marzia; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">791</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human acute and inflammatory pain requires the expression of voltage-gated sodium channel Nav1.7 but its significance for neuropathic pain is unknown.  Here we show that Nav1.7 expression in different sets of mouse sensory and sympathetic neurons underlies distinct types of pain sensation.  Ablating Nav1.7 gene (SCN9A) expression in all sensory neurons using Advillin-Cre abolishes mechanical pain, inflammatory pain and reflex withdrawal responses to heat.  In contrast, heat-evoked pain is retained when SCN9A is deleted only in Nav1.8-positive nociceptors.  Surprisingly, responses to the hotplate test, as well as neuropathic pain, are unaffected when SCN9A is deleted in all sensory neurons.  However, deleting SCN9A in both sensory and sympathetic neurons abolishes these pain sensations and recapitulates the pain-free phenotype seen in humans with SCN9A loss-of-function mutations.  These observations demonstrate an important role for Nav1.7 in sympathetic neurons in neuropathic pain, and provide possible insights into the mechanisms that underlie gain-of-function Nav1.7-dependent pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbjQBOlkmUQoUSrryheKE6fW6udTcc2eZtSfLf2lif07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnsl2mug%253D%253D&md5=86559797d628dfef8697b75a96fd5fed</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncomms1795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1795%26sid%3Dliteratum%253Aachs%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DNassar%26aufirst%3DM.%2BA.%26aulast%3DClark%26aufirst%3DA.%2BK.%26aulast%3DPassmore%26aufirst%3DG.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DMalcangio%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DDistinct%2520NaV1.7-Dependent%2520Pain%2520Sensations%2520Require%2520Different%2520Sets%2520of%2520Sensory%2520and%2520Sympathetic%2520Neurons%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D791%26epage%3D799%26doi%3D10.1038%2Fncomms1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couture, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottman, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beiler, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span> <span> </span><span class="NLM_article-title">Global Na<sub>V</sub>1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e105895</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0105895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1371%2Fjournal.pone.0105895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=25188265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105895&author=J.+Gingrasauthor=S.+Smithauthor=D.+J.+Matsonauthor=D.+Johnsonauthor=K.+Nyeauthor=L.+Coutureauthor=E.+Fericauthor=R.+Yinauthor=B.+D.+Moyerauthor=M.+L.+Petersonauthor=J.+B.+Rottmanauthor=R.+J.+Beilerauthor=A.+B.+Malmbergauthor=S.+I.+McDonough&title=Global+NaV1.7+Knockout+Mice+Recapitulate+the+Phenotype+of+Human+Congenital+Indifference+to+Pain&doi=10.1371%2Fjournal.pone.0105895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span></div><div class="casAuthors">Gingras, Jacinthe; Smith, Sarah; Matson, David J.; Johnson, Danielle; Nye, Kim; Couture, Lauren; Feric, Elma; Yin, Ruoyuan; Moyer, Bryan D.; Peterson, Matthew L.; Rottman, James B.; Beiler, Rudolph J.; Malmberg, Annika B.; McDonough, Stefan I.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e105895/1-e105895/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Clin. genetic studies have shown that loss of Nav1.7 function leads to the complete loss of acute pain perception.  The global deletion is reported lethal in mice, however, and studies of mice with promoter-specific deletions of Nav1.7 have suggested that the role of Nav1.7 in pain transduction depends on the precise form of pain.  We developed genetic and animal husbandry strategies that overcame the neonatal-lethal phenotype and enabled construction of a global Nav1.7 knockout mouse.  Knockouts were anatomically normal, reached adulthood, and had phenotype wholly analogous to human congenital indifference to pain (CIP): compared to littermates, knockouts showed no defects in mech. sensitivity or overall movement yet were completely insensitive to painful tactile, thermal, and chem. stimuli and were anosmic.  Knockouts also showed no painful behaviors resulting from peripheral injection of nonselective sodium channel activators, did not develop complete Freund's adjuvant-induced thermal hyperalgesia, and were insensitive to intra-dermal histamine injection.  Tetrodotoxin-sensitive sodium current recorded from cell bodies of isolated sensory neurons and the mech.-evoked spiking of C-fibers in a skin-nerve prepn. each were reduced but not eliminated in tissue from knockouts compared to littermates.  Results support a role for Nav1.7 that is conserved between rodents and humans and suggest several possibly translatable biomarkers for the study of Nav1.7-targeted therapeutics.  Results further suggest that Nav1.7 may retain its key role in persistent as well as acute forms of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzxB508dD1LVg90H21EOLACvtfcHk0ljB-vGpgV1OZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O&md5=6a1acb0c6e4e38ac89b1ab38d67b538e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105895%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DNye%26aufirst%3DK.%26aulast%3DCouture%26aufirst%3DL.%26aulast%3DFeric%26aufirst%3DE.%26aulast%3DYin%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRottman%26aufirst%3DJ.%2BB.%26aulast%3DBeiler%26aufirst%3DR.%2BJ.%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26atitle%3DGlobal%2520NaV1.7%2520Knockout%2520Mice%2520Recapitulate%2520the%2520Phenotype%2520of%2520Human%2520Congenital%2520Indifference%2520to%2520Pain%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105895%26doi%3D10.1371%2Fjournal.pone.0105895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werdehausen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugiero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span> <span> </span><span class="NLM_article-title">Neurological Perspectives on Voltage-Gated Sodium Channels</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">2585</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1093/brain/aws225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1093%2Fbrain%2Faws225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=22961543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=2585-2612&author=N.+Eijkelkampauthor=J.+E.+Linleyauthor=M.+D.+Bakerauthor=M.+S.+Minettauthor=R.+Creggauthor=R.+Werdehausenauthor=F.+Rugieroauthor=J.+N.+Wood&title=Neurological+Perspectives+on+Voltage-Gated+Sodium+Channels&doi=10.1093%2Fbrain%2Faws225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological perspectives on voltage-gated sodium channels</span></div><div class="casAuthors">Eijkelkamp Niels; Linley John E; Baker Mark D; Minett Michael S; Cregg Roman; Werdehausen Robert; Rugiero Francois; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">2585-612</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain.  Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders.  Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels.  This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects.  We also discuss recent advances in the development of selective sodium channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMaWmHsTCoQ3l8icjszYl0fW6udTcc2eZtSfLf2lif07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D&md5=6f9b33df722a3c5831b8860d3fad1af2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws225%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DLinley%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DCregg%26aufirst%3DR.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DRugiero%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DNeurological%2520Perspectives%2520on%2520Voltage-Gated%2520Sodium%2520Channels%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D2585%26epage%3D2612%26doi%3D10.1093%2Fbrain%2Faws225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogucki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of Na<sub>V</sub>1.7 with Efficacy in Rodent Pain Models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=277-282&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+Aryl+Sulfonamides+as+Isoform-Selective+Inhibitors+of+NaV1.7+with+Efficacy+in+Rodent+Pain+Models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models</span></div><div class="casAuthors">Focken, Thilo; Liu, Shifeng; Chahal, Navjot; Dauphinais, Maxim; Grimwood, Michael E.; Chowdhury, Sultan; Hemeon, Ivan; Bichler, Paul; Bogucki, David; Waldbrook, Matthew; Bankar, Girish; Sojo, Luis E.; Young, Clint; Lin, Sophia; Shuart, Noah; Kwan, Rainbow; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, J. P., Jr.; Dehnhardt, Christoph M.; Mansour, Tarek S.; Oballa, Renata M.; Cohen, Charles J.; Robinette, C. Lee</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7.  The optimization of these inhibitors is described.  The authors aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compd. I.  This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo.  The findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIxiu3ixqRLVg90H21EOLACvtfcHk0liA0ZCE72BC3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D&md5=ae05f2c1ef6cf51d69a67a7b1ee7f8fa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520Aryl%2520Sulfonamides%2520as%2520Isoform-Selective%2520Inhibitors%2520of%2520NaV1.7%2520with%2520Efficacy%2520in%2520Rodent%2520Pain%2520Models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D277%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable <i>in vivo</i> Target Engagement</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1062-1067&author=I.+E.+Marxauthor=T.+A.+Dineenauthor=J.+Ableauthor=C.+Bodeauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+Dimauroauthor=B.+Duauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=B.+E.+Hallauthor=L.+Huangauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=M.+J.+Linauthor=D.+Liuauthor=J.+S.+McDermottauthor=B.+D.+Moyerauthor=E.+A.+Petersonauthor=J.+T.+Robertsauthor=P.+E.+Roseauthor=J.+Wangauthor=B.+D.+Youngbloodauthor=V.+L.+Yuauthor=M.+M.+Weiss&title=Sulfonamides+as+Selective+NaV1.7+Inhibitors%3A+Optimizing+Potency+and+Pharmacokinetics+to+Enable+in+vivo+Target+Engagement&doi=10.1021%2Facsmedchemlett.6b00243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement</span></div><div class="casAuthors">Marx, Isaac E.; Dineen, Thomas A.; Able, Jessica; Bode, Christiane; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Du, Bingfan; Foti, Robert S.; Fremeau, Robert T.; Gao, Hua; Gunaydin, Hakan; Hall, Brian E.; Huang, Liyue; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Lin, Min-Hwa Jasmine; Liu, Dong; McDermott, Jeff S.; Moyer, Bryan D.; Peterson, Emily A.; Roberts, Jonathan T.; Rose, Paul; Wang, Jean; Youngblood, Beth D.; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1062-1067</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human genetic evidence has identified the voltage-gated sodium channel NaV1.7 as an attractive target for the treatment of pain.  The authors initially identified naphthalene sulfonamide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (compd. 3) as a potent and selective inhibitor of NaV1.7.  Optimization to reduce biliary clearance by balancing hydrophilicity and hydrophobicity (Log D) while maintaining NaV1.7 potency led to the identification of quinazoline 16 (AM-2099).  Compd. 16 demonstrated a favorable pharmacokinetic profile in rat and dog and demonstrated dose-dependent redn. of histamine-induced scratching bouts in a mouse behavioral model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNi8X2t0EULVg90H21EOLACvtfcHk0liA0ZCE72BC3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE&md5=43c2ae357af90d6c6f56245c3114c016</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00243%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDimauro%26aufirst%3DE.%2BF.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRoberts%26aufirst%3DJ.%2BT.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%2BL.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520Selective%2520NaV1.7%2520Inhibitors%253A%2520Optimizing%2520Potency%2520and%2520Pharmacokinetics%2520to%2520Enable%2520in%2520vivo%2520Target%2520Engagement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1062%26epage%3D1067%26doi%3D10.1021%2Facsmedchemlett.6b00243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gum, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fricano, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgaard, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kouhen, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neelands, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulenko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daanen, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreishi-Haack, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kort, M. E.</span></span> <span> </span><span class="NLM_article-title">Substituted Indazoles as Na<sub>V</sub>1.7 Blockers for the Treatment of Pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3373</span>– <span class="NLM_lpage">3391</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00063</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00063" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3373-3391&author=J.+M.+Frostauthor=D.+A.+DeGoeyauthor=L.+Shiauthor=R.+J.+Gumauthor=M.+M.+Fricanoauthor=G.+L.+Lundgaardauthor=O.+F.+El-Kouhenauthor=G.+C.+Hsiehauthor=T.+Neelandsauthor=M.+A.+Matulenkoauthor=J.+F.+Daanenauthor=M.+Paiauthor=N.+Ghoreishi-Haackauthor=C.+Zhanauthor=X.-F.+Zhangauthor=M.+E.+Kort&title=Substituted+Indazoles+as+NaV1.7+Blockers+for+the+Treatment+of+Pain&doi=10.1021%2Facs.jmedchem.6b00063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00063%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DGum%26aufirst%3DR.%2BJ.%26aulast%3DFricano%26aufirst%3DM.%2BM.%26aulast%3DLundgaard%26aufirst%3DG.%2BL.%26aulast%3DEl-Kouhen%26aufirst%3DO.%2BF.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DNeelands%26aufirst%3DT.%26aulast%3DMatulenko%26aufirst%3DM.%2BA.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%26aulast%3DZhan%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.-F.%26aulast%3DKort%26aufirst%3DM.%2BE.%26atitle%3DSubstituted%2520Indazoles%2520as%2520NaV1.7%2520Blockers%2520for%2520the%2520Treatment%2520of%2520Pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3373%26epage%3D3391%26doi%3D10.1021%2Facs.jmedchem.6b00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric
Bojic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5969</span>– <span class="NLM_lpage">5989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5969-5989&author=M.+M.+Weissauthor=T.+A.+Dineenauthor=I.+E.+Marxauthor=S.+Altmannauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=E.+Feric%0ABojicauthor=R.+S.+Fotiauthor=H.+Gaoauthor=R.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=H.+Huangauthor=L.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=J.+Liguttiauthor=D.+S.+Laauthor=M.+J.+Linauthor=D.+Liuauthor=B.+D.+Moyerauthor=H.+Nguyenauthor=E.+A.+Petersonauthor=P.+E.+Roseauthor=K.+Tabornauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=R.+T.+Fremeau&title=Sulfonamides+as+Selective+NaV1.7+Inhibitors%3A+Optimizing+Potency+and+Pharmacokinetics+While+Mitigating+Metabolic+Liabilities&doi=10.1021%2Facs.jmedchem.6b01851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span></div><div class="casAuthors">Weiss, Matthew M.; Dineen, Thomas A.; Marx, Isaac E.; Altmann, Steven; Boezio, Alessandro; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Feric Bojic, Elma; Foti, Robert S.; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Huang, Hongbing; Huang, Liyue; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; Ligutti, Joseph; La, Daniel S.; Lin, Min-Hwa Jasmine; Liu, Dong; Moyer, Bryan D.; Nguyen, Hanh N.; Peterson, Emily A.; Rose, Paul E.; Taborn, Kristin; Youngblood, Beth D.; Yu, Violeta; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5969-5989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several reports have recently emerged regarding the identification of heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  The optimization of a series of internal NaV1.7 leads that address a no. of metabolic liabilities including bioactivation, PXR activation, as well as CYP3A4 induction and inhibition led to the identification of potent and selective inhibitors that demonstrated favorable pharmacokinetic profiles and were devoid of the aforementioned liabilities.  The key to achieving this within a series prone to transporter-mediated clearance was the identification of a small range of optimal cLogD values and the discovery of subtle PXR SAR that was not lipophilicity dependent.  This enabled the identification of compd. 20, which was advanced into a target engagement pharmacodynamic model where it exhibited robust reversal of histamine-induced scratching bouts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovsPC2UZpxsbVg90H21EOLACvtfcHk0lj1nKkI-7Ed5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D&md5=6333a6b936e48f9d18cf9df10ea12853</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DFeric%2BBojic%26aufirst%3DE.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DSulfonamides%2520as%2520Selective%2520NaV1.7%2520Inhibitors%253A%2520Optimizing%2520Potency%2520and%2520Pharmacokinetics%2520While%2520Mitigating%2520Metabolic%2520Liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5969%26epage%3D5989%26doi%3D10.1021%2Facs.jmedchem.6b01851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric
Bojic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) That Affords Robust <i>in vivo</i> Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=T.+Feric%0ABojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.-H.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+Selective+NaV1.7+Inhibitors%3A+Optimizing+Potency%2C+Pharmacokinetics%2C+and+Metabolic+Properties+to+Obtain+Atropisomeric+Quinolinone+%28AM-0466%29+That+Affords+Robust+in+vivo+Activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0lgsmvogHUwgzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DFeric%2BBojic%26aufirst%3DT.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520Selective%2520NaV1.7%2520Inhibitors%253A%2520Optimizing%2520Potency%252C%2520Pharmacokinetics%252C%2520and%2520Metabolic%2520Properties%2520to%2520Obtain%2520Atropisomeric%2520Quinolinone%2520%2528AM-0466%2529%2520That%2520Affords%2520Robust%2520in%2520vivo%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egbertson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koser, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Selective, Orally Bioavailable, <i>N</i>-Linked Arylsulfonamide Na<sub>V</sub>1.7 Inhibitors with Pain Efficacy in Mice</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=28389149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2087-2093&author=A.+J.+Roeckerauthor=M.+Egbertsonauthor=K.+L.+G.+Jonesauthor=R.+Gomezauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+J.+Koserauthor=M.+O.+Urbanauthor=R.+Kleinauthor=M.+Clementsauthor=J.+Panigelauthor=C.+Daleyauthor=J.+Wangauthor=E.+N.+Fingerauthor=J.+Majercakauthor=V.+Santarelliauthor=I.+Greganauthor=M.+Catoauthor=T.+Filzenauthor=A.+Jovanovskaauthor=Y.+H.+Wangauthor=D.+Wangauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=X.+Pengauthor=X.+Wangauthor=H.+Sunauthor=P.+J.+Colemanauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Discovery+of+Selective%2C+Orally+Bioavailable%2C+N-Linked+Arylsulfonamide+NaV1.7+Inhibitors+with+Pain+Efficacy+in+Mice&doi=10.1016%2Fj.bmcl.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice</span></div><div class="casAuthors">Roecker, Anthony J.; Egbertson, Melissa; Jones, Kristen L. G.; Gomez, Robert; Kraus, Richard L.; Li, Yuxing; Koser, Amy Jo; Urban, Mark O.; Klein, Rebecca; Clements, Michelle; Panigel, Jacqueline; Daley, Christopher; Wang, Jixin; Finger, Eleftheria N.; Majercak, John; Santarelli, Vincent; Gregan, Irene; Cato, Matthew; Filzen, Tracey; Jovanovska, Aneta; Wang, Ying-Hong; Wang, Deping; Joyce, Leo A.; Sherer, Edward C.; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Coleman, Paul J.; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel Nav1.7 is a genetically validated target for the treatment of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss-of-function mutations affording insensitivity to pain.  Unfortunately, drugs thought to garner efficacy via Nav1 inhibition have undesirable side effect profiles due to their lack of selectivity over channel isoforms.  Herein we report the discovery of a novel series of orally bioavailable arylsulfonamide Nav1.7 inhibitors with high levels of selectivity over Nav1.5, the Nav isoform responsible for cardiovascular side effects, through judicious use of parallel medicinal chem. and physicochem. property optimization.  This effort produced inhibitors such as compd. 5 with excellent potency, selectivity, behavioral efficacy in a rodent pain model, and efficacy in a mouse itch model suggestive of target modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDA0s8NB86LVg90H21EOLACvtfcHk0lgsmvogHUwgzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D&md5=5729efef8e3df4afe3f89c25472c9268</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKoser%26aufirst%3DA.%2BJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DSantarelli%26aufirst%3DV.%26aulast%3DGregan%26aufirst%3DI.%26aulast%3DCato%26aufirst%3DM.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520Selective%252C%2520Orally%2520Bioavailable%252C%2520N-Linked%2520Arylsulfonamide%2520NaV1.7%2520Inhibitors%2520with%2520Pain%2520Efficacy%2520in%2520Mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2087%26epage%3D2093%26doi%3D10.1016%2Fj.bmcl.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulhearn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henze, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolinone Aryl Sulfonamides as Potent, Selective Na<sub>V</sub>1.7 Inhibitors with <i>in vivo</i> Efficacy in a Preclinical Pain Model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2017.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=28465103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2683-2688&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=H.+D.+G.+F.+Lehmanauthor=M.+J.+Kellyauthor=J.+J.+Mulhearnauthor=S.+E.+Wolkenbergauthor=M.+J.+Catoauthor=M.+K.+Clementsauthor=C.+J.+Daleyauthor=T.+Filzenauthor=E.+N.+Fingerauthor=Y.+Greganauthor=D.+A.+Henzeauthor=A.+Jovanovskaauthor=R.+Kleinauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+Liangauthor=J.+M.+Majercakauthor=J.+Panigelauthor=M.+O.+Urbanauthor=J.+Wangauthor=Y.-H.+Wangauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Benzoxazolinone+Aryl+Sulfonamides+as+Potent%2C+Selective+NaV1.7+Inhibitors+with+in+vivo+Efficacy+in+a+Preclinical+Pain+Model&doi=10.1016%2Fj.bmcl.2017.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model</span></div><div class="casAuthors">Pero, Joseph E.; Rossi, Michael A.; Lehman, Hannah D. G. F.; Kelly, Michael J., III; Mulhearn, James J.; Wolkenberg, Scott E.; Cato, Matthew J.; Clements, Michelle K.; Daley, Christopher J.; Filzen, Tracey; Finger, Eleftheria N.; Gregan, Yun; Henze, Darrell A.; Jovanovska, Aneta; Klein, Rebecca; Kraus, Richard L.; Li, Yuxing; Liang, Annie; Majercak, John M.; Panigel, Jacqueline; Urban, Mark O.; Wang, Jixin; Wang, Ying-Hong; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2683-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies on human genetics have suggested that inhibitors of the Nav1.7 voltage-gated sodium channel hold considerable promise as therapies for the treatment of chronic pain syndromes.  Herein, we report novel, peripherally-restricted benzoxazolinone aryl sulfonamides as potent Nav1.7 inhibitors with excellent selectivity against the Nav1.5 isoform, which is expressed in the heart muscle.  Elaboration of initial lead compd. 3d afforded exemplar 13, which featured attractive physicochem. properties, outstanding lipophilic ligand efficiency and pharmacol. selectivity against Nav1.5 exceeding 1000-fold.  Key structure-activity relationships assocd. with oral bioavailability were leveraged to discover compd. 17, which exhibited a comparable potency/selectivity profile as well as full efficacy following oral administration in a preclin. model indicative of antinociceptive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCg6OCYoM57Vg90H21EOLACvtfcHk0ljWdLzBuhsptA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D&md5=9ea2c021a2c76ffe0bb8c623d1eb7427</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DLehman%26aufirst%3DH.%2BD.%2BG.%2BF.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DCato%26aufirst%3DM.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DDaley%26aufirst%3DC.%2BJ.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DGregan%26aufirst%3DY.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMajercak%26aufirst%3DJ.%2BM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DBenzoxazolinone%2520Aryl%2520Sulfonamides%2520as%2520Potent%252C%2520Selective%2520NaV1.7%2520Inhibitors%2520with%2520in%2520vivo%2520Efficacy%2520in%2520a%2520Preclinical%2520Pain%2520Model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2683%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2017.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span> <span> </span><span class="NLM_article-title">The Discovery of Tetrahydropyridine Analogs as hNa<sub>V</sub>1.7 Selective Inhibitors for Analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2017.03.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=28385504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2210-2215&author=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=M.+Tengauthor=J.+Qinauthor=Z.+Huauthor=L.+Houauthor=L.+Shenauthor=H.+Dongauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=J.+Zhangauthor=L.+Ye&title=The+Discovery+of+Tetrahydropyridine+Analogs+as+hNaV1.7+Selective+Inhibitors+for+Analgesia&doi=10.1016%2Fj.bmcl.2017.03.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia</span></div><div class="casAuthors">Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Teng, Mingxing; Qin, Jian; Hu, Zhijing; Hou, Lijuan; Shen, Liang; Dong, Haiheng; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Zhang, Jianzhao; Ye, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2210-2215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 small mol. inhibitors have attracted lots of attention by its unique analgesic effect.  Herein, the design and synthesis of a novel series of tetrahydropyridine analogs as hNav1.7 inhibitors for analgesia is reported.  Detail structural-activity relationship (SAR) studies were undertaken towards improving hNav1.7 activity, in vitro ADME, and in vivo PK profiles.  These efforts resulted in the identification of compd. (-)-I, a highly potent and selective hNav1.7 inhibitor with good ADME and PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP6xx5fd4NYrVg90H21EOLACvtfcHk0ljWdLzBuhsptA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D&md5=ed0b99fa7611354124394c07bbf259ac</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.043%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26atitle%3DThe%2520Discovery%2520of%2520Tetrahydropyridine%2520Analogs%2520as%2520hNaV1.7%2520Selective%2520Inhibitors%2520for%2520Analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2210%26epage%3D2215%26doi%3D10.1016%2Fj.bmcl.2017.03.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">De Groot, M. J.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Pacheco, M. P.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span>; <span class="NLM_string-name">Gaulier, S. M.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. US. Patent Appl.<span class="NLM_patent">US 2012/0010183</span>, Jan 12th, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=M.+J.+De+Groot&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=D.+S.+Millan&author=M.+P.+Pacheco&author=D.+J.+Rawson&author=N.+Sciammetta&author=R.+I.+Storer&author=N.+A.+Swain&author=S.+M.+Gaulier&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">De Groot, M. J.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Indazole Derivatives as Sodium Channel Inhibitors and Their Preparation and Use in the Treatment of Pain</span>. PCT Int. Appl. <span class="NLM_patent">WO 2012/095781</span>, July 19th, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=M.+J.+De+Groot&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=N.+Sciammetta&author=R.+I.+Storer&author=N.+A.+Swain&title=Indazole+Derivatives+as+Sodium+Channel+Inhibitors+and+Their+Preparation+and+Use+in+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DIndazole%2520Derivatives%2520as%2520Sodium%2520Channel%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Pain%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.–J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Development of New Benzenesulfonamides as Potent and Selective Na<sub>V</sub>1.7 Inhibitors for the Treatment of Pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2513-2525&author=Y.%E2%80%93J.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=J.+Dittaauthor=K.+J.+Robbinsauthor=R.+Rajamaniauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Development+of+New+Benzenesulfonamides+as+Potent+and+Selective+NaV1.7+Inhibitors+for+the+Treatment+of+Pain&doi=10.1021%2Facs.jmedchem.6b01918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Shi, Jianliang; Ditta, Jonathan; Robbins, Kevin J.; Rajamani, Ramkumar; Easton, Amy; Newton, Amy; Bourin, Clotilde; Mosure, Kathleen; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of certain features in piperidine (I), the authors developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Nav1.7 inhibitors.  However, 4-((((1S,4S)-4-aminocydohexyl)methyl)amino)-5-chloro-2-fluoro-N-(thiazol-2-yl)benzenesulfonamide (24), one of the early analogs, failed to reduce phase 2 flinching in the mouse formalin test even at a dose of 100 mpk PO due to insufficient DRG exposure attributed to poor membrane permeability.  Two analogs with improved membrane permeability showed much increased DRG concns. at doses of 30 mpk PO but, confoundingly, only one of these was effective in the formalin test.  More data are needed to understand the disconnect between efficacy and exposure relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVESOC2ks88bVg90H21EOLACvtfcHk0lhG4gPB5stVnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D&md5=d320dedb1d61794445680d94dc2c7e48</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01918%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%25E2%2580%2593J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DDitta%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520New%2520Benzenesulfonamides%2520as%2520Potent%2520and%2520Selective%2520NaV1.7%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2513%26epage%3D2525%26doi%3D10.1021%2Facs.jmedchem.6b01918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. – J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaby, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarao, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Non-Zwitterionic Aryl Sulfonamides as Na<sub>V</sub>1.7 Inhibitors with Efficacy in Preclinical Behavioral Models and Translational Measures of Nociceptive Neuron Activation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5490</span>– <span class="NLM_lpage">5505</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmc.2017.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=28818462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5490-5505&author=Y.+%E2%80%93+J.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=G.+Luoauthor=R.+Rajamaniauthor=A.+Ngauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=D.+Parkerauthor=K.+Mosureauthor=O.+Barnabyauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+Pieschlauthor=J.+Herringtonauthor=P.+Chenauthor=D.+V.+Sivaraoauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=J.+Bronsonauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+Non-Zwitterionic+Aryl+Sulfonamides+as+NaV1.7+Inhibitors+with+Efficacy+in+Preclinical+Behavioral+Models+and+Translational+Measures+of+Nociceptive+Neuron+Activation&doi=10.1016%2Fj.bmc.2017.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Luo, Guanglin; Rajamani, Ramkumar; Ng, Alicia; Easton, Amy; Newton, Amy; Bourin, Clotilde; Parker, Dawn; Mosure, Kathleen; Barnaby, Omar; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick; Herrington, James; Chen, Ping; Sivarao, D. V.; Bristow, Linda J.; Meanwell, Nicholas A.; Bronson, Joanne; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5490-5505</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since zwitterionic benzenesulfonamide Nav1.7 inhibitors suffer from poor membrane permeability, the authors sought to eliminate this characteristic by replacing the basic moiety with non-basic bicyclic acetals and monocyclic ethers.  These efforts led to the discovery of the non-zwitterionic aryl sulfonamide 49 ((R)-5-chloro-2-fluoro-4-(((tetrahydro-2H-pyran-3-yl)methyl)amino)-N-(thiazol-2-yl)benzenesulfonamide) as a selective Nav1.7 inhibitor with improved membrane permeability.  Despite its moderate cellular activity, 49 exhibited robust efficacy in mouse models of neuropathic and inflammatory pain and modulated translational electromyogram measures assocd. with activation of nociceptive neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfNtc0Dv967Vg90H21EOLACvtfcHk0lhG4gPB5stVnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE&md5=d8426c3423ce37ddfb45f1ea31f89d16</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2B%25E2%2580%2593%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DBarnaby%26aufirst%3DO.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520Non-Zwitterionic%2520Aryl%2520Sulfonamides%2520as%2520NaV1.7%2520Inhibitors%2520with%2520Efficacy%2520in%2520Preclinical%2520Behavioral%2520Models%2520and%2520Translational%2520Measures%2520of%2520Nociceptive%2520Neuron%2520Activation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5490%26epage%3D5505%26doi%3D10.1016%2Fj.bmc.2017.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. – J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Morpholine-Based Aryl Sulfonamides as Na<sub>V</sub>1.7 Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.01.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2018.01.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=29439904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=958-962&author=Y.+%E2%80%93+J.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=B.+Venablesauthor=R.+Rajamaniauthor=K.+Robbinsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=J.+Herringtonauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+Morpholine-Based+Aryl+Sulfonamides+as+NaV1.7+Inhibitors&doi=10.1016%2Fj.bmcl.2018.01.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Venables, Brian; Rajamani, Ramkumar; Robbins, Kevin J.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Herrington, James; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">958-962</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Replacement of the piperidine ring in the lead benzenesulfonamide Nav1.7 inhibitor I with a weakly basic morpholine core resulted in a significant redn. in Nav1.7 inhibitory activity, but the activity was restored by shortening the linkage from methyleneoxy to oxygen.  These efforts led to a series of morpholine-based aryl sulfonamides as isoform-selective Nav1.7 inhibitors.  This report describes the synthesis and SAR of these analogs.  Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgiZrOTuKrbVg90H21EOLACvtfcHk0lhmRF5vSP2zkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCmtLc%253D&md5=7d9f583e76737c61f2b7c386ed661619</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.01.035%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2B%25E2%2580%2593%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DVenables%26aufirst%3DB.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DRobbins%26aufirst%3DK.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520Morpholine-Based%2520Aryl%2520Sulfonamides%2520as%2520NaV1.7%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D958%26epage%3D962%26doi%3D10.1016%2Fj.bmcl.2018.01.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fevig, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amparo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacciola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aungst, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knab, br M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-[3-(Aminomethyl)Phenyl]-<i>N</i>-[3-Fluoro-2′-(Methylsulfonyl)-[1,1′-Biphenyl]-4-yl]-3-(Trifluoromethyl)-1<i>H</i>-Pyrazole-5-Carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/jm000409z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000409z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=566-578&author=D.+J.+P.+Pintoauthor=M.+J.+Orwatauthor=S.+Wangauthor=J.+M.+Fevigauthor=M.+L.+Quanauthor=E.+Amparoauthor=J.+Cacciolaauthor=K.+A.+Rossiauthor=R.+S.+Alexanderauthor=A.+M.+Smallwoodauthor=J.+M.+Luettgenauthor=L.+Liangauthor=B.+J.+Aungstauthor=M.+R.+Wrightauthor=br+M.+Knabauthor=P.+C.+Wongauthor=R.+R.+Wexlerauthor=P.+Y.+S.+Lam&title=Discovery+of+1-%5B3-%28Aminomethyl%29Phenyl%5D-N-%5B3-Fluoro-2%E2%80%B2-%28Methylsulfonyl%29-%5B1%2C1%E2%80%B2-Biphenyl%5D-4-yl%5D-3-%28Trifluoromethyl%29-1H-Pyrazole-5-Carboxamide+%28DPC423%29%2C+a+Highly+Potent%2C+Selective%2C+and+Orally+Bioavailable+Inhibitor+of+Blood+Coagulation+Factor+Xa&doi=10.1021%2Fjm000409z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm000409z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000409z%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFevig%26aufirst%3DJ.%2BM.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DAmparo%26aufirst%3DE.%26aulast%3DCacciola%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DAungst%26aufirst%3DB.%2BJ.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DKnab%26aufirst%3Dbr%2BM.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26atitle%3DDiscovery%2520of%25201-%255B3-%2528Aminomethyl%2529Phenyl%255D-N-%255B3-Fluoro-2%25E2%2580%25B2-%2528Methylsulfonyl%2529-%255B1%252C1%25E2%2580%25B2-Biphenyl%255D-4-yl%255D-3-%2528Trifluoromethyl%2529-1H-Pyrazole-5-Carboxamide%2520%2528DPC423%2529%252C%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520Blood%2520Coagulation%2520Factor%2520Xa%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D566%26epage%3D578%26doi%3D10.1021%2Fjm000409z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span>; <span class="NLM_string-name">Venables, B.</span>; <span class="NLM_string-name">Guernon, J.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Sit, S.-Y.</span>; <span class="NLM_string-name">Rajamani, R.</span>; <span class="NLM_string-name">Knox, R. J.</span>; <span class="NLM_string-name">Matchett, M.</span>; <span class="NLM_string-name">Pieschl, R. L.</span>; <span class="NLM_string-name">Herrington, J.</span>; <span class="NLM_string-name">Bristow, L. J.</span>; <span class="NLM_string-name">Meanwell, N. A.</span>; <span class="NLM_string-name">Thompson, L. A.</span>; <span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of New Indole-based Acylsulfonamide Nav1.7 Inhibitors</span>.  <i>Bioorg. Med. Chem. Lett.</i>, <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume">29</span>, DOI: <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.013</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2018.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&author=Y.-J.+Wu&author=B.+Venables&author=J.+Guernon&author=J.+Chen&author=S.-Y.+Sit&author=R.+Rajamani&author=R.+J.+Knox&author=M.+Matchett&author=R.+L.+Pieschl&author=J.+Herrington&author=L.+J.+Bristow&author=N.+A.+Meanwell&author=L.+A.+Thompson&author=C.+Dzierba&title=Discovery+of+New+Indole-based+Acylsulfonamide+Nav1.7+Inhibitors&doi=10.1016%2Fj.bmcl.2018.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26atitle%3DDiscovery%2520of%2520New%2520Indole-based%2520Acylsulfonamide%2520Nav1.7%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D29%26doi%3D10.1016%2Fj.bmcl.2018.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubuisson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, S. G.</span></span> <span> </span><span class="NLM_article-title">The Formalin Test: A Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(77)90130-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2F0304-3959%2877%2990130-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-174&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+Formalin+Test%3A+A+Quantitative+Study+of+the+Analgesic+Effects+of+Morphine%2C+Meperidine%2C+and+Brain+Stem+Stimulation+in+Rats+and+Cats&doi=10.1016%2F0304-3959%2877%2990130-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test:  a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span></div><div class="casAuthors">Dubuisson, David; Dennis, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-74</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In a procedure to evaluate the analgesic strengths of morphine sulfate  [64-31-3] and meperidine-HCl  [50-13-5], cats or rats, which were pretreated with an appropriate analgesic dose of either drug, were injected with a soln. of formalin  [50-00-0] in the paws and the pain-related behavior was obsd. and compared with that obsd. in the control animals which received formalin but no analgesic.  Pretreatment with either of the 2 analgesics or brain stem stimulation significantly decreased the effect of the pain stimuli.  Morphine and brain stem stimulation provided similar and greater analgesia than meperidine.  The behavioral patterns of the animals seemed to be similar following morphine or the brain stem stimultion.  Thus, formalin injection can be used effectively to evaluate the potencies of analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0ErPKDkXGbVg90H21EOLACvtfcHk0lhmRF5vSP2zkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D&md5=bd26bbc3c46b9c964d0b3aa011580980</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2877%2990130-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252877%252990130-0%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Formalin%2520Test%253A%2520A%2520Quantitative%2520Study%2520of%2520the%2520Analgesic%2520Effects%2520of%2520Morphine%252C%2520Meperidine%252C%2520and%2520Brain%2520Stem%2520Stimulation%2520in%2520Rats%2520and%2520Cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D174%26doi%3D10.1016%2F0304-3959%2877%2990130-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingledine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaradhi, R.</span></span> <span> </span><span class="NLM_article-title">Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5809</span>– <span class="NLM_lpage">5817</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.8b00764</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.8b00764" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2rurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=5809-5817&author=T.+Ganeshauthor=A.+Banikauthor=R.+Dingledineauthor=W.+Wangauthor=R.+Amaradhi&title=Peripherally+Restricted%2C+Highly+Potent%2C+Selective%2C+Aqueous-Soluble+EP2+Antagonist+with+Anti-Inflammatory+Properties&doi=10.1021%2Facs.molpharmaceut.8b00764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties</span></div><div class="casAuthors">Ganesh, Thota; Banik, Avijit; Dingledine, Ray; Wang, Wenyi; Amaradhi, Radhika</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5809-5817</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prostaglandin E2 receptor, EP2, plays an important role in physiol. and in a variety of pathol. conditions.  Studies indicate that EP2 is pro-inflammatory in chronic peripheral and central nervous system disease and cancer models.  Thus, targeting the EP2 receptor with small mols. could be a therapeutic strategy for treating inflammatory diseases and cancer.  The authors recently reported a novel class of competitive antagonists of the EP2 receptor.  However, earlier leads displayed low selectivity against the DP1 prostanoid receptor, moderate plasma half-life, and low aq. soly., which renders them suboptimal for testing in animal models of disease.  The authors now report a novel compd. TG8-69, which has suitable drug-like properties.  The authors present synthesis, lead-optimization studies, pharmacol. characterization, and anti-inflammatory properties of this compd. that support its use in chronic peripheral inflammatory diseases, including rheumatoid arthritis, endometriosis, and cancer, in which EP2 appears to play a pathogenic role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQoFDKN4q9LLVg90H21EOLACvtfcHk0lgBpzA14i0beg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2rurbF&md5=aef1113b2a028176e383364b37a2618b</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.8b00764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.8b00764%26sid%3Dliteratum%253Aachs%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DBanik%26aufirst%3DA.%26aulast%3DDingledine%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DAmaradhi%26aufirst%3DR.%26atitle%3DPeripherally%2520Restricted%252C%2520Highly%2520Potent%252C%2520Selective%252C%2520Aqueous-Soluble%2520EP2%2520Antagonist%2520with%2520Anti-Inflammatory%2520Properties%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2018%26volume%3D15%26spage%3D5809%26epage%3D5817%26doi%3D10.1021%2Facs.molpharmaceut.8b00764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernier, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorusso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westlin, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evindar, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of Clinical Candidate GSK1842799 as a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">942</span>– <span class="NLM_lpage">947</span>, <span class="refDoi"> DOI: 10.1021/ml400194r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400194r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=942-947&author=H.+Dengauthor=S.+G.+Bernierauthor=E.+Doyleauthor=J.+Lorussoauthor=B.+A.+Morganauthor=W.+F.+Westlinauthor=G.+Evindar&title=Discovery+of+Clinical+Candidate+GSK1842799+as+a+Selective+S1P1+Receptor+Agonist+%28Prodrug%29+for+Multiple+Sclerosis&doi=10.1021%2Fml400194r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1021%2Fml400194r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400194r%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DBernier%26aufirst%3DS.%2BG.%26aulast%3DDoyle%26aufirst%3DE.%26aulast%3DLorusso%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DWestlin%26aufirst%3DW.%2BF.%26aulast%3DEvindar%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520Clinical%2520Candidate%2520GSK1842799%2520as%2520a%2520Selective%2520S1P1%2520Receptor%2520Agonist%2520%2528Prodrug%2529%2520for%2520Multiple%2520Sclerosis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D942%26epage%3D947%26doi%3D10.1021%2Fml400194r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit34c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodchild, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelkenbrecher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimi Tari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span> <span> </span><span class="NLM_article-title">Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of <i>N</i>-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methanesulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4810</span>– <span class="NLM_lpage">4831</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01826</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01826" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4810-4831&author=T.+Fockenauthor=S.+Chowdhuryauthor=A.+Zenovaauthor=M.+E.+Grimwoodauthor=C.+Chabotauthor=T.+Shengauthor=I.+Hemeonauthor=S.+M.+Deckerauthor=M.+Wilsonauthor=P.+Bichlerauthor=Q.+Jiaauthor=S.+Sunauthor=C.+Youngauthor=S.+Linauthor=S.+J.+Goodchildauthor=N.+G.+Shuartauthor=E.+Changauthor=Z.+Xieauthor=B.+Liauthor=K.+Khakhauthor=G.+Bankarauthor=M.+Waldbrookauthor=R.+Kwanauthor=K.+Nelkenbrecherauthor=P.+Karimi+Tariauthor=N.+Chahalauthor=L.+Sojoauthor=C.+L.+Robinetteauthor=A.+D.+Whiteauthor=C.-A.+Chenauthor=Y.+Zhangauthor=J.+Pangauthor=J.+H.+Changauthor=D.+H.+Hackosauthor=J.+P.+Johnsonauthor=C.+J.+Cohenauthor=D.+F.+Ortwineauthor=D.+P.+Sutherlinauthor=C.+M.+Dehnhardtauthor=B.+S.+Safina&title=Design+of+Conformationally+Constrained+Acyl+Sulfonamide+Isosteres%3A+Identification+of+N-%28%5B1%2C2%2C4%5DTriazolo%5B4%2C3-a%5Dpyridin-3-yl%29methanesulfonamides+as+Potent+and+Selective+hNaV1.7+Inhibitors+for+the+Treatment+of+Pain&doi=10.1021%2Facs.jmedchem.7b01826"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01826%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DZenova%26aufirst%3DA.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DDecker%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DGoodchild%26aufirst%3DS.%2BJ.%26aulast%3DShuart%26aufirst%3DN.%2BG.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DNelkenbrecher%26aufirst%3DK.%26aulast%3DKarimi%2BTari%26aufirst%3DP.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DSojo%26aufirst%3DL.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26aulast%3DWhite%26aufirst%3DA.%2BD.%26aulast%3DChen%26aufirst%3DC.-A.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26atitle%3DDesign%2520of%2520Conformationally%2520Constrained%2520Acyl%2520Sulfonamide%2520Isosteres%253A%2520Identification%2520of%2520N-%2528%255B1%252C2%252C4%255DTriazolo%255B4%252C3-a%255Dpyridin-3-yl%2529methanesulfonamides%2520as%2520Potent%2520and%2520Selective%2520hNaV1.7%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4810%26epage%3D4831%26doi%3D10.1021%2Facs.jmedchem.7b01826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzygiel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segelbacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flanaganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+Micro-Dose+Studies+to+Explore+the+Human+Pharmacokinetics+of+Four+Selective+Inhibitors+of+Human+Nav1.7+Voltage-Dependent+Sodium+Channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0lgqoTdfTUSfCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanagan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520Micro-Dose%2520Studies%2520to%2520Explore%2520the%2520Human%2520Pharmacokinetics%2520of%2520Four%2520Selective%2520Inhibitors%2520of%2520Human%2520Nav1.7%2520Voltage-Dependent%2520Sodium%2520Channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N.</span></span> <span> </span><span class="NLM_article-title">Design of Subtype Selective Nav1.7 Inhibitors for the Treatment of Pain</span>.  <i>Abstracts of Papers, 249th ACS National Meeting & Exposition, Denver, CO, March 22-26, 2015</i>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2015</span>,  <span class="NLM_fpage">MEDI-172</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=MEDI-172&author=N.+Swain&title=Abstracts+of+Papers%2C+249th+ACS+National+Meeting+%26+Exposition%2C+Denver%2C+CO%2C+March+22-26%2C+2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%26atitle%3DDesign%2520of%2520Subtype%2520Selective%2520Nav1.7%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pain%26btitle%3DAbstracts%2520of%2520Papers%252C%2520249th%2520ACS%2520National%2520Meeting%2520%2526%2520Exposition%252C%2520Denver%252C%2520CO%252C%2520March%252022-26%252C%25202015%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2015%26spage%3DMEDI-172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamoto, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilenkin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, D. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund’s Adjuvant Models of Pain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0138140</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0138140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1371%2Fjournal.pone.0138140" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0138140&author=D.+J.+Matsonauthor=D.+T.+Hamamotoauthor=H.+Bregmanauthor=M.+Cookeauthor=D.+F.+DiMauroauthor=L.+Huangauthor=D.+Johnsonauthor=X.+Liauthor=J.+McDermottauthor=C.+Morganauthor=B.+Wilenkinauthor=A.+B.+Malmbergauthor=S.+I.+McDonoughauthor=D.+A.+Simone&title=Inhibition+of+Inactive+States+of+Tetrodotoxin-Sensitive+Sodium+Channels+Reduces+Spontaneous+Firing+of+C-Fiber+Nociceptors+and+Produces+Analgesia+in+Formalin+and+Complete+Freund%E2%80%99s+Adjuvant+Models+of+Pain&doi=10.1371%2Fjournal.pone.0138140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0138140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0138140%26sid%3Dliteratum%253Aachs%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DHamamoto%26aufirst%3DD.%2BT.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DD.%2BF.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMcDermott%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DC.%26aulast%3DWilenkin%26aufirst%3DB.%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DSimone%26aufirst%3DD.%2BA.%26atitle%3DInhibition%2520of%2520Inactive%2520States%2520of%2520Tetrodotoxin-Sensitive%2520Sodium%2520Channels%2520Reduces%2520Spontaneous%2520Firing%2520of%2520C-Fiber%2520Nociceptors%2520and%2520Produces%2520Analgesia%2520in%2520Formalin%2520and%2520Complete%2520Freund%25E2%2580%2599s%2520Adjuvant%2520Models%2520of%2520Pain%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0138140%26doi%3D10.1371%2Fjournal.pone.0138140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubner, R.</span></span> <span> </span><span class="NLM_article-title">Inflammatory Models of Pain and Hyperalgesia</span>. <i>ILAR J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1093/ilar.40.3.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1093%2Filar.40.3.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=11406689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADC%252BC2srjs1Gmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=111-118&author=K.+Renauthor=R.+Dubner&title=Inflammatory+Models+of+Pain+and+Hyperalgesia&doi=10.1093%2Filar.40.3.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory Models of Pain and Hyperalgesia</span></div><div class="casAuthors">Ren Ke; Dubner Ronald</div><div class="citationInfo"><span class="NLM_cas:title">ILAR journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">111-118</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article addresses important pain research models in nonhuman animals.  These models attempt to mimic human persistent pain conditions.  Models of persistent pain employ inflammatory agents that produce discomfort and hyperalgesia (i.e., an enhanced response to a noxious stimulus).  The models are associated with skin, subcutaneous tissue, and joint inflammation (somatic structures).  Studies employing such models have led to significantly improved understanding of mechanisms of somatic pain.  It is important that investigators assess the level of pain produced in these animals and provide analgesic agents whenever it does not interfere with the purpose of the experiment.  Pain can be inferred from ongoing behavioral variables such as feeding and drinking, sleep-waking cycle, grooming, and social behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTp4mVi1DOWUUwlCcfExbvbfW6udTcc2eaEJ03l_Gx23bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjs1Gmsg%253D%253D&md5=f297e3756d02c459c75e2ef76849a74c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Filar.40.3.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Filar.40.3.111%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DK.%26aulast%3DDubner%26aufirst%3DR.%26atitle%3DInflammatory%2520Models%2520of%2520Pain%2520and%2520Hyperalgesia%26jtitle%3DILAR%2520J.%26date%3D1999%26volume%3D40%26spage%3D111%26epage%3D118%26doi%3D10.1093%2Filar.40.3.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jasmin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franssen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, J. R.</span></span> <span> </span><span class="NLM_article-title">The Cold Plate as a Test of Nociceptive Behaviors: Description and Application to the Study of Chronic Neuropathic and Inflammatory Pain Models</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1016/S0304-3959(98)00017-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2FS0304-3959%2898%2900017-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1998&pages=367-382&author=L.+Jasminauthor=L.+Kohanauthor=M.+Franssenauthor=G.+Janniauthor=J.+R.+Goff&title=The+Cold+Plate+as+a+Test+of+Nociceptive+Behaviors%3A+Description+and+Application+to+the+Study+of+Chronic+Neuropathic+and+Inflammatory+Pain+Models&doi=10.1016%2FS0304-3959%2898%2900017-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2898%2900017-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252898%252900017-7%26sid%3Dliteratum%253Aachs%26aulast%3DJasmin%26aufirst%3DL.%26aulast%3DKohan%26aufirst%3DL.%26aulast%3DFranssen%26aufirst%3DM.%26aulast%3DJanni%26aufirst%3DG.%26aulast%3DGoff%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Cold%2520Plate%2520as%2520a%2520Test%2520of%2520Nociceptive%2520Behaviors%253A%2520Description%2520and%2520Application%2520to%2520the%2520Study%2520of%2520Chronic%2520Neuropathic%2520and%2520Inflammatory%2520Pain%2520Models%26jtitle%3DPain%26date%3D1998%26volume%3D75%26spage%3D367%26epage%3D382%26doi%3D10.1016%2FS0304-3959%2898%2900017-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koltzenburg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stucky, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, G. R.</span></span> <span> </span><span class="NLM_article-title">Receptive Properties of Mouse Sensory Neurons Innervating Hairy Skin</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1841</span>– <span class="NLM_lpage">1850</span>, <span class="refDoi"> DOI: 10.1152/jn.1997.78.4.1841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1152%2Fjn.1997.78.4.1841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=9325353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A280%3ADyaK2svmslajuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1997&pages=1841-1850&author=M.+Koltzenburgauthor=C.+L.+Stuckyauthor=G.+R.+Lewin&title=Receptive+Properties+of+Mouse+Sensory+Neurons+Innervating+Hairy+Skin&doi=10.1152%2Fjn.1997.78.4.1841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Receptive properties of mouse sensory neurons innervating hairy skin</span></div><div class="casAuthors">Koltzenburg M; Stucky C L; Lewin G R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurophysiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1841-50</span>
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    </div><div class="casAbstract">Using an in vitro nerve skin preparation and controlled mechanical or thermal stimuli, we analyzed the receptive properties of 277 mechanosensitive single primary afferents with myelinated (n = 251) or unmyelinated (n = 26) axons innervating the hairy skin in adult or 2-wk-old mice.  Afferents were recorded from small filaments of either sural or saphenous nerves in an outbred mice strain or in the inbred Balb/c strain.  On the basis of their receptive properties and conduction velocity, several receptor types could be distinguished.  In adult animals (>6 wk old), 54% of the large myelinated fibers (Abeta, n = 83) showed rapidly adapting (RA) discharges to constant force stimuli and probably innervated hair follicles, whereas 46% displayed a slowly adapting (SA) response and probably innervated Merkel cells in touch domes.  Among thin myelinated fibers (Adelta, n = 91), 34% were sensitive D hair receptors and 66% were high-threshold mechanoreceptors (AM fibers).  Unmyelinated fibers had high mechanical thresholds and nociceptive functions.  All receptor types had characteristic stimulus-response functions to suprathreshold force stimuli.  Noxious heat stimuli (15-s ramp from 32 to 47 degrees C measured at the corium side of the skin) excited 26% (5 of 19) of AM fibers with a threshold of 42.5 +/- 1.4 degrees C (mean +/- SE) and an average discharge of 15.8 +/- 9.7 action potentials and 41% (7 of 17) C fibers with a mean threshold of 37.6 +/- 1.9 degrees C and an average discharge of 22.0 +/- 6.0 action potentials.  Noxious cold stimuli activated 1 of 10 AM fibers and 3 of 10 C fibers.  One of 10 C units responded to both heat and cold stimuli.  All types of afferent fibers present in adult mice could readily be recognized in mice at postnatal day 14.  However, fibers had reduced conduction velocities and the stimulus-response function to mechanical stimuli was more shallow in all fibers except for the D hairs.  In juvenile mice, 22% of RA units also displayed an SA response at high stimulus intensities; these units were termed RA/SA units.  We conclude that all types of cutaneous afferent fibers are already committed to their phenotype 2 wk after birth but undergo some maturation over the following weeks.  This preparation has great potential for the study of transgenic mice with targeted mutations of genes that code factors that are involved in the specification of sensory neuron phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRX3Zr3olesLPtos8R3JUhXfW6udTcc2eaw0jfJxb9Jtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svmslajuw%253D%253D&md5=3884440a177af6eccac988fa92919969</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1152%2Fjn.1997.78.4.1841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.1997.78.4.1841%26sid%3Dliteratum%253Aachs%26aulast%3DKoltzenburg%26aufirst%3DM.%26aulast%3DStucky%26aufirst%3DC.%2BL.%26aulast%3DLewin%26aufirst%3DG.%2BR.%26atitle%3DReceptive%2520Properties%2520of%2520Mouse%2520Sensory%2520Neurons%2520Innervating%2520Hairy%2520Skin%26jtitle%3DJ.%2520Neurophysiol.%26date%3D1997%26volume%3D78%26spage%3D1841%26epage%3D1850%26doi%3D10.1152%2Fjn.1997.78.4.1841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span> <span> </span><span class="NLM_article-title">Facile Synthesis of Acyl sulfonamides from Carboxylic Acids Using the Mukaiyama Reagent</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2018.12.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.tetlet.2018.12.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2019&pages=268-271&author=L.+Chenauthor=G.+Luo&title=Facile+Synthesis+of+Acyl+sulfonamides+from+Carboxylic+Acids+Using+the+Mukaiyama+Reagent&doi=10.1016%2Fj.tetlet.2018.12.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2018.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2018.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DG.%26atitle%3DFacile%2520Synthesis%2520of%2520Acyl%2520sulfonamides%2520from%2520Carboxylic%2520Acids%2520Using%2520the%2520Mukaiyama%2520Reagent%26jtitle%3DTetrahedron%2520Lett.%26date%3D2019%26volume%3D60%26spage%3D268%26epage%3D271%26doi%3D10.1016%2Fj.tetlet.2018.12.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mothes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavielle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karoyan, P.</span></span> <span> </span><span class="NLM_article-title">Amino-Zinc-Ene-Enolate Cyclization: A Short Access to cis-3-Substituted Prolino-Homotryptophane Derivatives</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">6706</span>– <span class="NLM_lpage">6710</span>, <span class="refDoi"> DOI: 10.1021/jo801006a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo801006a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVGjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=6706-6710&author=C.+Mothesauthor=S.+Lavielleauthor=P.+Karoyan&title=Amino-Zinc-Ene-Enolate+Cyclization%3A+A+Short+Access+to+cis-3-Substituted+Prolino-Homotryptophane+Derivatives&doi=10.1021%2Fjo801006a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-zinc-ene-enolate cyclization: A short access to cis-3-substituted prolino-homotryptophane derivatives</span></div><div class="casAuthors">Mothes, Celine; Lavielle, Solange; Karoyan, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6706-6710</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proline chimeras are useful tools for medicinal chem. and/or biol. applications.  The asym. synthesis of cis-3-substituted prolines can be easily achieved via amino-zinc-ene-enolate cyclization followed by transmetalation of the cyclic zinc intermediate for further functionalization.  Syntheses of prolino-homotryptophane derivs. were achieved through Negishi cross-coupling of the zinc intermediate with indole rings.  The use of Pd catalyst derived from Fu's [(t-Bu3)PH]-BF4 was required to avoid the undesired β-hydride elimination.  Optically pure and orthogonally protected compds. were obtained readily usable for peptide synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo5KvhXDhBVbVg90H21EOLACvtfcHk0lip0UGjpvfLOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVGjs7o%253D&md5=c039bdf833efbab59b2984fd6e8ab88e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo801006a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801006a%26sid%3Dliteratum%253Aachs%26aulast%3DMothes%26aufirst%3DC.%26aulast%3DLavielle%26aufirst%3DS.%26aulast%3DKaroyan%26aufirst%3DP.%26atitle%3DAmino-Zinc-Ene-Enolate%2520Cyclization%253A%2520A%2520Short%2520Access%2520to%2520cis-3-Substituted%2520Prolino-Homotryptophane%2520Derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D6706%26epage%3D6710%26doi%3D10.1021%2Fjo801006a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merkul, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T. J.</span></span> <span> </span><span class="NLM_article-title">Rapid Synthesis of Bis(Hetero)Aryls by One-Pot Masuda Borylation-Suzuki Coupling Sequence and Its Application to Concise Total Synthesis of Meridianins A and G</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3139</span>– <span class="NLM_lpage">3141</span>, <span class="refDoi"> DOI: 10.1039/c1ob05310h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1039%2Fc1ob05310h" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=3139-3141&author=E.+Merkulauthor=E.+Schaferauthor=T.+J.+Muller&title=Rapid+Synthesis+of+Bis%28Hetero%29Aryls+by+One-Pot+Masuda+Borylation-Suzuki+Coupling+Sequence+and+Its+Application+to+Concise+Total+Synthesis+of+Meridianins+A+and+G&doi=10.1039%2Fc1ob05310h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2Fc1ob05310h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1ob05310h%26sid%3Dliteratum%253Aachs%26aulast%3DMerkul%26aufirst%3DE.%26aulast%3DSchafer%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DT.%2BJ.%26atitle%3DRapid%2520Synthesis%2520of%2520Bis%2528Hetero%2529Aryls%2520by%2520One-Pot%2520Masuda%2520Borylation-Suzuki%2520Coupling%2520Sequence%2520and%2520Its%2520Application%2520to%2520Concise%2520Total%2520Synthesis%2520of%2520Meridianins%2520A%2520and%2520G%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D3139%26epage%3D3141%26doi%3D10.1039%2Fc1ob05310h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. B.</span>; <span class="NLM_string-name">Paek, S. Y.</span>; <span class="NLM_string-name">Yoon, S. K.</span>; <span class="NLM_string-name">Yoon, S. H.</span>; <span class="NLM_string-name">Choi, J. S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Heterocyclyl Substituted (hetero)aryl Carboxylic Acids as GPR40 Receptor Agonists</span>. PCT Int. Appl. <span class="NLM_patent">WO 201473904</span>, May 15th, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+B.+Lee&author=S.+Y.+Paek&author=S.+K.+Yoon&author=S.+H.+Yoon&author=J.+S.+Choi&title=Preparation+of+Heterocyclyl+Substituted+%28hetero%29aryl+Carboxylic+Acids+as+GPR40+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BB.%26atitle%3DPreparation%2520of%2520Heterocyclyl%2520Substituted%2520%2528hetero%2529aryl%2520Carboxylic%2520Acids%2520as%2520GPR40%2520Receptor%2520Agonists%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Littke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumeillant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaltenbach, R. F.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarby, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiau, S.</span></span> <span> </span><span class="NLM_article-title">Mild and General Methods for the Palladium-Catalyzed Cyanation of Aryl and Heteroaryl Chlorides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1714</span>, <span class="refDoi"> DOI: 10.1021/ol070372d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol070372d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVait7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1711-1714&author=A.+Littkeauthor=M.+Soumeillantauthor=R.+F.+Kaltenbachauthor=R.+J.+Cherneyauthor=C.+M.+Tarbyauthor=S.+Kiau&title=Mild+and+General+Methods+for+the+Palladium-Catalyzed+Cyanation+of+Aryl+and+Heteroaryl+Chlorides&doi=10.1021%2Fol070372d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mild and General Methods for the Palladium-Catalyzed Cyanation of Aryl and Heteroaryl Chlorides</span></div><div class="casAuthors">Littke, Adam; Soumeillant, Maxime; Kaltenbach, Robert F., III; Cherney, Robert J.; Tarby, Christine M.; Kiau, Susanne</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1711-1714</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New methods for the palladium-catalyzed cyanation of aryl and heteroaryl chlorides have been developed, featuring sterically demanding, electron-rich phosphines.  E.g., Pd(TFA)2/(binaphthyl)P(t-Bu)2/Zn catalyzed the cyanation of 4-ClC6H4NH2 by Zn(CN)2 to give 93% 4-NCC6H4NH2.  Highly challenging electron-rich aryl chlorides, in addn. to electron-neutral and electron-deficient substrates, as well as nitrogen- and sulfur-contg. heteroaryl chlorides can all undergo efficient cyanation under relatively mild conditions using readily available materials.  In terms of substrate scope and temp., these methods compare very favorably with the state-of-the-art cyanations of aryl chlorides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2pNIsHoeonLVg90H21EOLACvtfcHk0ljYrN7xCspJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVait7k%253D&md5=e4685437e438d9d0df3cfe64b9fb3ee5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fol070372d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol070372d%26sid%3Dliteratum%253Aachs%26aulast%3DLittke%26aufirst%3DA.%26aulast%3DSoumeillant%26aufirst%3DM.%26aulast%3DKaltenbach%26aufirst%3DR.%2BF.%26aulast%3DCherney%26aufirst%3DR.%2BJ.%26aulast%3DTarby%26aufirst%3DC.%2BM.%26aulast%3DKiau%26aufirst%3DS.%26atitle%3DMild%2520and%2520General%2520Methods%2520for%2520the%2520Palladium-Catalyzed%2520Cyanation%2520of%2520Aryl%2520and%2520Heteroaryl%2520Chlorides%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D1711%26epage%3D1714%26doi%3D10.1021%2Fol070372d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT Int. Appl. <span class="NLM_patent">WO 2012007868</span>, January 19th, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraley, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brnardic, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrington, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanney, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirdivant, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drakas, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepp-Lorenzino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikuta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreatsoulas, C.</span></span> <span> </span><span class="NLM_article-title">3-(Indol-2-yl)Indazoles as Chek1 Kinase Inhibitors: Optimization of Potency and Selectivity via Substitution at C6</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6049</span>– <span class="NLM_lpage">6053</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=10.1016%2Fj.bmcl.2006.08.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=16978863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2jsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=6049-6053&author=M.+E.+Fraleyauthor=J.+T.+Steenauthor=E.+J.+Brnardicauthor=K.+L.+Arringtonauthor=K.+L.+Spencerauthor=B.+A.+Hanneyauthor=Y.+Kimauthor=G.+D.+Hartmanauthor=S.+M.+Stirdivantauthor=B.+A.+Drakasauthor=K.+Rickertauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=J.+Hardwickauthor=W.+Taoauthor=S.+C.+Beckauthor=X.+Maoauthor=R.+B.+Lobellauthor=L.+Sepp-Lorenzinoauthor=Y.+Yanauthor=M.+Ikutaauthor=S.+K.+Munshiauthor=L.+C.+Kuoauthor=C.+Kreatsoulas&title=3-%28Indol-2-yl%29Indazoles+as+Chek1+Kinase+Inhibitors%3A+Optimization+of+Potency+and+Selectivity+via+Substitution+at+C6&doi=10.1016%2Fj.bmcl.2006.08.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6</span></div><div class="casAuthors">Fraley, Mark E.; Steen, Justin T.; Brnardic, Edward J.; Arrington, Kenneth L.; Spencer, Keith L.; Hanney, Barbara A.; Kim, Yuntae; Hartman, George D.; Stirdivant, Steven M.; Drakas, Bob A.; Rickert, Keith; Walsh, Eileen S.; Hamilton, Kelly; Buser, Carolyn A.; Hardwick, James; Tao, Weikang; Beck, Stephen C.; Mao, Xianzhi; Lobell, Robert B.; Sepp-Lorenzino, Laura; Yan, Youwei; Ikuta, Mari; Munshi, Sanjeev K.; Kuo, Lawrence C.; Kreatsoulas, Constantine</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6049-6053</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of 3-(indol-2-yl)indazoles as inhibitors of Chek1 kinase is described.  Introduction of amides and heteroaryl groups at the C6 position of the indazole ring system provided sufficient Chek1 potency and selectivity over Cdk7 to permit escape from DNA damage-induced arrest in a cellular assay.  Enzyme potency against Chek1 was optimized by the incorporation of a hydroxymethyl triazole moiety in compd. 21 (I) (Chek1 IC50 = 0.30 nM) that was shown by X-ray crystallog. to displace one of three highly conserved water mols. in the HI region of the ATP-binding cleft.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1iEFdjN7eWrVg90H21EOLACvtfcHk0ljYrN7xCspJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2jsrbO&md5=5ce4094132e1e200a96ebb75282bd4a6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.118%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DSteen%26aufirst%3DJ.%2BT.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DSpencer%26aufirst%3DK.%2BL.%26aulast%3DHanney%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DDrakas%26aufirst%3DB.%2BA.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DHardwick%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DKreatsoulas%26aufirst%3DC.%26atitle%3D3-%2528Indol-2-yl%2529Indazoles%2520as%2520Chek1%2520Kinase%2520Inhibitors%253A%2520Optimization%2520of%2520Potency%2520and%2520Selectivity%2520via%2520Substitution%2520at%2520C6%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D6049%26epage%3D6053%26doi%3D10.1016%2Fj.bmcl.2006.08.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gossas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Easy-to-Execute Carbonylations: Microwave Synthesis of Acyl Sulfonamides Using Mo(CO)<sub>6</sub> as a Solid Carbon Monoxide Source</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3094</span>– <span class="NLM_lpage">3098</span>, <span class="refDoi"> DOI: 10.1021/jo050080v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo050080v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVynurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=3094-3098&author=X.+Wuauthor=R.+Ronnauthor=T.+Gossasauthor=M.+Larhed&title=Easy-to-Execute+Carbonylations%3A+Microwave+Synthesis+of+Acyl+Sulfonamides+Using+Mo%28CO%296+as+a+Solid+Carbon+Monoxide+Source&doi=10.1021%2Fjo050080v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Easy-to-Execute Carbonylations: Microwave Synthesis of Acyl Sulfonamides Using Mo(CO)6 as a Solid Carbon Monoxide Source</span></div><div class="casAuthors">Wu, Xiongyu; Roenn, Robert; Gossas, Thomas; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3094-3098</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of a robust palladium-catalyzed amidocarbonylation protocol for the prepn. of arom. acyl sulfonamides utilizing high-d. microwave heating is described.  This synthetic approach employs Mo(CO)6 as a convenient CO-releasing reagent and allows for the direct prepn. of acyl sulfonamides from both aryl iodides and aryl bromides.  The reactions can be performed under air, employing only 15 min of microwave irradn., to produce acyl sulfonamide derivs. in good to excellent yields.  To illustrate the usefulness of this method, we reported the synthesis of a novel hepatitis C virus NS3 protease inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp281_WOJXTW7Vg90H21EOLACvtfcHk0ljYrN7xCspJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVynurg%253D&md5=443608fb9917b8194efc9fb778a2aede</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo050080v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050080v%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DRonn%26aufirst%3DR.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DEasy-to-Execute%2520Carbonylations%253A%2520Microwave%2520Synthesis%2520of%2520Acyl%2520Sulfonamides%2520Using%2520Mo%2528CO%25296%2520as%2520a%2520Solid%2520Carbon%2520Monoxide%2520Source%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D3094%26epage%3D3098%26doi%3D10.1021%2Fjo050080v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal-Regulating Kinase 1 Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2011097079</span>, August 11th, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Chang&title=Apoptosis+Signal-Regulating+Kinase+1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26atitle%3DApoptosis%2520Signal-Regulating%2520Kinase%25201%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i177"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01550">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_35128"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01550">10.1021/acs.jmedchem.8b01550</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01550/suppl_file/jm8b01550_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01550/suppl_file/jm8b01550_si_001.csv">jm8b01550_si_001.csv (4.44 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01550%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01550" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aa1731f4e3d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
